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Abstract
The major cause of corneal opacity and resultant visual loss is a critical 
decrease in corneal endothelial cell density. Due to the fact that corneal 
endothelial cells do not generally proliferate, cell densities gradually decrease in 
the corneal endothelium with age. Before we can begin to aid patients with 
decreasing endothelial cell densities, by inhibiting cell death or stimulating cell 
proliferation, it is necessary to understand the basic cell signalling that underlies 
these processes. As human tissue is difficult to obtain, a representative animal 
model of corneal endothelium was devised. Analysis of cell morphology and 
expression of a1 type VIII collagen were used to verify that primary cells derived 
from an explant model of mouse corneal cells were endothelial. A range of 
phenotypic and functional cellular features were also analysed to assess the 
usefulness of primary mouse corneal endothelial cultures as a model for human 
corneal endothelium. These included tight junction protein localization, 
proliferative responses to growth factor stimulation and ERK1/2 activation 
following growth factor stimulation. From these analyses, it was shown that 
primary mouse corneal endothelial cultures provide a representative model of the 
human corneal endothelium.
A similar comparison was also made between primary mouse corneal 
endothelial cultures and an SV40 transformed mouse corneal endothelial cell 
line. Studies revealed significant differences in propensity to proliferate, 
junctional integrity, ERK1/2 activation, expression of apoptotic proteins and 
sensitivity to staurosporine-induced apoptosis between primary cells and the 
SV40 transformed cell line, suggesting that the SV40 transformed cell line is a 
less appropriate model for primary mouse corneal endothelial cells.
In conclusion, the derivation and characterisation of mouse primary corneal 
endothelial cells provides a better model of the corneal endothelium, that offers 
greater understanding of cellular responses and which may eventually lead to the 
development of alternative therapies for primary corneal endotheliopathies.
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Chapter 1: Introduction
1.1 The cornea
The cornea is a multicomponent, transparent, avascular tissue with a smooth 
surface and uniform curvature, found at the anterior of the eye. The structure of 
the cornea sheds light on the diverse functions of the tissue, which include 
transparency, light refraction, containment of intraocular pressure and protection 
from the external environment (Bron et al., 2001). The specialized organisation 
of the cornea allows it to perform all these functions in the absence of blood 
vessels.
The main function of the cornea is optical as it forms the principal refractive 
surface, accounting for 70% (40-45 diopters) of the total refractive power of the 
eye. Refraction is accomplished through the regular curvature of the cornea and 
the optically smooth overlying tear film. Most of the total refraction within the eye 
takes place at the surface of the cornea at the tear/air interface (Bron et al.,
2001). Deeper into the middle of the cornea lies the corneal stroma. The 
collagenous base of the corneal stroma allows the cornea to provide resistance 
to ocular pressure and also provides a protective layer. Closeness, regularity 
and the homogeneity of the packing of the collagen fibrils within the corneal 
stroma are also responsible for corneal transparency (Waring, III et al., 1982; (
Bron et al., 2001; Meek and Boote, 2004). The perpendicular packing of the 
collagen fibrils within the stroma is maintained by regulation of corneal hydration. 
Stromal water content is controlled by pump actions of the corneal endothelium, 
preventing stromal swelling and corneal clouding (Waring, III et al., 1982; Kenney 
et al., 1986; Bron et al., 2001).
The curvature of the cornea is slightly greater than that of the sclera so as to 
produce a slight furrow between the cornea and the sclera, the sulcus sclerae 
(Bron et al., 2001). The overlying tear film aids in the identification of this furrow 
within the living eye. The overlapping sclera may be greater above and below 
the cornea than it is laterally, helping to explain the elliptical, frontal appearance
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of the cornea. The horizontal meridian of the cornea is slightly greater than the 
vertical meridian. The central third of the cornea is typically referred to as the 
optical zone and is almost spherical, and the peripheral cornea becomes 
progressively flatter as it encounters the sclera (Arffa, 1997; Bron et al., 2001). 
This results in a variance of the radius of curvature between the anterior and 
posterior sections of the cornea, with the anterior surface having a greater radius 
of curvature. Overall, the surface area of the cornea composes one-sixth the 
surface area of the entire eye globe, with that of males being slightly larger than 
females (Bron et al., 2001).
A
Human Comeal Endothelium Human Comeal Epithelium Human Comeal Fibroblast
Figure 1.1 Cell types of the human cornea. Cross section of the cornea (A) reveals 
outer, epithelial cell layers (E), Bowman’s layer (Bw), the stroma (St), which makes up the 
majority of the tissue, Descemet’s membrane (De) and the endothelial cell monolayer 
(En). The morphology of each of the corneal cell types is distinct in cell culture conditions 
(B). Both endothelial and epithelial cells form monolayers of polygonal cells, however, 
their appearances are distinguishable. Corneal fibroblasts are elongated and form a 
swirling pattern in culture, (images from: Joyce 2003. Proliferative capacity of the corneal 
endothelium. Prog.Retin.Eye Res. 22:361 &380)
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There are 5 major tissue layers that make up the cornea beneath the 
precorneal film (Figure 1.1). Each of these layers is further detailed below.
i. Epithelium
ii. Bowman’s layer
iii. Stroma
iv. Descemet’s membrane
v. Endothelium
1.1.1 Corneal epithelium
The corneal epithelium is stratified, squamous and non-keratinized. The 
epithelium is continuous with the conjunctiva at the corneal limbus and is 
composed of three types of cells, typically forming five or six layers of nucleated 
cells. Basal cells form the deepest cell layer of the epithelium. They are 
continuous peripherally with the cells of the limbus and form the germinative 
layer of the epithelium. Basal cells are columnar in shape with rounded heads 
and flat bases, and perfect alignment on the basal lamina. Their nuclei are oval 
and oriented parallel to the cells’ long axis (Pfister and Burnstein, 1977).
‘Wing’ or ‘umbrella’ cells make up the next layers of the epithelium. These 
polyhedral cells sit atop the basal cells and send processes between them (Bron 
et al., 2001). Their nuclei lie parallel to the surface and there is extensive 
interdigitation between wing cells with numerous desmosomal attachments. The 
closer the wing cell to the basal layer the more columnar in shape the cell tends 
to be (Arffa, 1997).
The most exterior two or three cell layers are also polyhedral and become 
wider and flattened towards the surface. Surface cells have the largest surface 
area, with cells at the periphery having the greatest surface area. Their flattened 
nuclei typically project backwards, leaving the surface smooth (Arffa, 1997; Bron 
et al., 2001). Superficial cells attach to each other by straight cell boundaries but 
have numerous microprojections and an extensive fibrillar glycocalyx on the 
surface membrane. These aid in the adherence of tear film to the glycocalyx 
(Arffa, 1997). Tight junctions along the circumference of contiguous cells prevent 
the passage of substances into the intercellular spaces (Ban et al., 2003).
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Epithelial cells tend to be actively metabolising cells and as such contain 
organelles typical of active cells. Mitochondria are small and scarce in the basal 
cell layer, which is primarily germinative, but are more abundant in the wing and 
middle cell layers. The Golgi apparatus and rough endoplasmic reticulum of 
corneal epithelial cells are relatively small (Pfister and Burnstein, 1977). 
Electron-dense tonofibrils form a cytoplasmic meshwork within the cells similar to 
other epithelia composed of cytokeratins. Wing and basal cells possess 
numerous tonofibrils and basal cells also contain anchoring filaments which pass 
through the hemidesmosomal structures and inserted directly into the underlying 
basal lamina. Plasma membranes of contiguous cells interdigitate with their 
neighbours with an intervening space of no more than 20nm. Desmosomes form 
the majority of junctions between epithelial cells, presumably because they are 
labile so as to allow movement over time as the cells migrate to the surface of 
the cornea (Arffa, 1997; Bron et al., 2001). Superficial cells are the only cell 
layers to show tight junctions. The most superficial of these are hexagonal and 
firmly attached to each other by straight cell boundaries (Ban et al., 2003).
These cells also show surface microvilli, which may serve to stabilize deep 
precorneal tear film. The density of microvilli has been shown to be variable by 
scanning electron microscopy with cells of darker appearance proposed to be 
older and ready to desquamate (Sellheyer and Spitznas, 1988).
Occasionally, dendritic cells have also been noted within the superficial layers 
of the corneal epithelium. These members of the immune recognition system are 
thought to be responsible for the processing and presentation of foreign antigens 
to lymphocytes (Arffa, 1997; Bron et al., 2001). The majority of these cells 
remain along the periphery of the cornea and only migrate into the central 
corneal region in response to disease.
The basal lamina or basement membrane lies beneath and is produced by 
the basal layer of epithelial cells. Its composition makes it an irregular zone with 
a posterior lamina densa and a superficial lamina lucida. These two zones can 
be distinguished ultrastructurally. The components of the basal lamina are 
similar to those of skin, containing type IV collagen, laminin, fibronectin, fibrin and
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bullous pemphigoid antigen (Arffa, 1997; Bron et al., 2001). Basal epithelial cells 
are anchored to the lamina by the hemidesmosome, which consists of an 
electron-dense attachment plaque. Electron-dense anchoring fibrils, composed 
of type VII collagen, form narrow bundles and insert into the subjacent stroma or 
Bowman’s layer to terminate in anchoring plaques, composed of type IV and type 
VII collagen (Arffa, 1997; Bron et al., 2001). This arrangement allows for the tight 
adherence of the basal epithelium to the cornea.
Epithelial cell migration occurs centripetaliy across the corneal surface. Basal 
and wing cells slide toward the central cornea, as well as towards the surface, 
where desquamation occurs (Arffa, 1997). Thoft and Friend (1983) proposed 
that the higher mitotic rate and lower superficial cell slough rate in the corneal 
periphery relative to the central cornea was responsible for the centripetal sliding 
of basal epithelial cells. Epithelial stem cells are located in the limbal region and 
are thought to give rise to a transient amplifying cell population, which move 
centrally and become fully differentiated (Arffa, 1997; Chung et al., 1999). The 
rate of migration of cells is believed to be quite slow with migration from the 
limbus to the central cornea taking up to a year (Bron et al., 2001). During 
wound healing, the opposite effect is noted. Epithelial cells distal to the wound 
enhance their proliferative rate, however, cells migrating to cover the wound Q 
decrease their proliferation to almost zero (Chung et al., 1999). Of all the cells 
that make up the cornea, the epithelial cells are the only ones which are known 
to be actively continually cycling.
1.1.2 Bowman’s layer (anterior limiting lamina)
Bowman’s layer is a narrow, acellular zone, 8-14jam in thickness. Though the 
layer appears homogeneous, electron microscopy reveals a randomly arranged 
meshwork of short collagen fibrils in a ground substance. Collagen fibril 
diameter in Bowman’s layer is smaller than in the stroma but in the posterior 
region, the fibrils become progressively larger in diameter and more ordered to 
blend and interweave with the fibrils of the anterior stroma (Jacobsen et al.,
1984). The compacted arrangement lends strength to this region of the cornea.
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Bowman’s layer is relatively resistant to trauma, mechanical and infective, but 
once it is destroyed it is not renewed. A thin layer with a structure similar to 
Bowman’s layer is formed during wound healing but it does not regain its original 
thickness (Arffa, 1997). Bundles of stromal lamellae randomly insert into the 
Bowman’s layer, as do unmyelinated nerves in transit to the epithelium (Bron et 
al., 2001). At normal or raised intraocular pressure, Bowman’s layer is under 
tension and appears smooth. When surface tension is relaxed, however, a 
series of convex ridges can be generated at its surface. The ridges correspond 
to the stromal bundles inserted into Bowman’s layer which form a polygonal 
pattern (Jacobsen et al., 1984).
Bowman’s layer was previously thought to be a specialized corneal 
membrane but is now recognized as a modified region of the anterior stroma.
While the smooth, anterior surface borders the basal lamina of the epithelium, 
the posterior surface meshes into the corneal stroma.
1.1.3 Corneal stroma (substantia propria)
The stroma constitutes approximately 90% of the entire cornea. It is typically 
500nm thick and consists of regularly arranged lamellae of collagen bundles,
200-300 centrally and 500 in the periphery (Meek and Boote, 2004). The 
collagen bundles lie in a proteoglycan ground substance and interspersed 
between the collagen bundles lies a small population of cells known as 
keratocytes. Lamellae of the stroma are arranged in layers parallel to each other 
and with the corneal surfaces. Generally, they run from limbus to limbus 
although in the anterior third of the stroma, there is interweave with the fibrils of 
the Bowman’s layer (Jacobsen et al., 1984; Meek and Boote, 2004). Deeper in 
the stroma, lamellae form strap-like ribbons which run at almost right angles to 
those in consecutive layers (Muller et al., 2004). ^  w
Each stromal lamella comprises a band of collagen fibrils arranged in parallel.
This banding pattern is most apparent by negative staining following the removal 
of proteoglycan (Bron et al., 2001). Cross-section reveals that the individual 
fibrils are composed of subunits of very fine fibrils (Arffa, 1997). Fibrils of type I
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collagen are the most common within the stroma but type V and type VI collagen 
comprise 10% and 25% respectively of the total. It is also thought that type III 
collagen may be present in small amounts (Arffa, 1997). Collagen in the stroma 
is fairly stable with little annual turnover. It is the precise ordering of the collagen 
fibrils within the cornea which is responsible for corneal transparency.
As previously mentioned, stromal collagens are contained within a ground 
substance composed primarily of proteoglycans. Proteoglycans are a type of 
glycoprotein composed of non collagenous protein chains with covalently bound 
oligosaccharides and glycosaminoglycan (GAG) side chains. The primary GAGs 
of the corneal stroma are keratan sulphate and chondroitin sulphate in 
approximately 3:1 ratio (Muller et al., 2004). Decorin is the core protein that 
contains the chondroitin /dermatan sulphate chains, while lumican is the core 
protein containing keratan sulphate. These ground substances are thought to 
play a role in maintaining the regular arrangement of the collagen fibrils, as both 
decorin and lumican inhibit fibril diameter growth. Even during stromal swelling 
and oedema, individual collagen fibril size does not change but the volume of 
ground substance increases, thus increasing the space between collagen fibrils 
(Danielson et al., 1997; Song et al., 2003).
The predominant cell population of the corneal stroma is the keratocytes, 
which occupies between 2.5-5% of its volume. Keratocytes are responsible for 
the synthesis of stromal collagen and proteoglycan during development, and 
maintenance thereafter (Bron et al., 2001). They are large, thin, flattened cells 
that run parallel to the corneal surface. Viewed from the corneal surface, the 
cells appear with many tangential projections extending out of the cell body in 
stellate fashion. Keratocytes are dispersed throughout the entire cornea, 
predominantly between the stromal lamellae, with only occasional keratocytes 
found within lamellae (M^ller-Pedersen and Ehlers, 1995). Stellate processes 
extend between the lamellae and frequent contacts are made with other 
keratocytes in the same horizontal plane. Contacts are made between 
keratocytes with a 20nm gap or with the formation of maculae occludentes, 
adherens or gap junctions (Watsky, 1995). Connections between keratocytes in
adjacent planes do not occur. Within the cell, there is a long, flattened nucleus 
surrounded by a complement of organelles that are few in number and sparsely 
distributed. The rough endoplasmic reticulum and Golgi are normally limited but 
become extensive in activated keratocytes of injured corneas (Arffa, 1997; Bron 
et al., 2001). Correspondingly, the cytoplasmic processes of the cells are 
reduced during injury. Stromal repair following small injuries involves keratocyte 
activation, migration and transformation into fibroblasts, and as a by product scar 
tissue is generated. The remodelled or scar tissue typically involves the laying 
down of collagen fibrils without regularity. Collagen fibrils deposited during injury 
also tend to be larger than normal. Remodelling of the scar tissue involves the 
thinning of the fibrils and reformation of the lamellae over a number of months to 
increase transparency (Bron et al., 2001).
There are three additional cell types that are occasionally encountered in the 
corneal stroma; lymphocytes, macrophages and very rarely polymorphonuclear 
leukocytes (Arffa, 1997; Bron et al., 2001; Hamrah et al., 2003). These can 
either enter from tear fluid before surface defects are covered by an epithelial 
plug, or, in larger wounds, from rapid vascular responses.
1.1.4 Descemet’s membrane (posterior limiting layer)
Descemet’s membrane is a thick basal lamina produced by the corneal 
endothelium. Schwalbe’s ring marks the termination of Descemet’s membrane 
peripherally (Arffa, 1997). By electron microscopy, it is evident that Descemet’s 
membrane is composed of an anterior banded zone and a posterior 
homogeneous zone. The anterior third is produced in utero and is therefore 
oldest, while the posterior region is produced after birth and thickens with age. 
Continual production of Descemet’s membrane means that thickness of the 
membrane accordingly changes with age; from 3-4pm at birth to 5jnm in 
childhood and 10-12^im in adults. Though the entire membrane appears 
homogeneous, the laminated structure demonstrates differences in the postnatal 
component. The membrane is known to be composed of type IV collagen, type 
VIII collagen and fibronectin but there is also a large glycoprotein and
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proteoglycan content (Waring, III et al., 1982). Unlike Bowman’s layer, it is 
sharply defined and forms a resistant sheet along the back of the stroma, which 
is easy to distinguish from the stroma along a plane of separation. Also unlike 
Bowman’s layer, there is a strong regenerative capacity following injury such that 
the fresh basal lamina is structurally identical to that surrounding it, while
Bowman’s is replaced by disorganized, fibrillar scar tissue (Arffa, 1997; Bron et ^
/ '/ )
al., 2001). During some pathologic conditions, metallic substances can be 
deposited in the membrane or there is an excessive production of abnormal 
basal lamina, containing type I collagen, such that the membrane becomes 
thickened and warts of matrix can be formed. With these multiple layers,
Descemet’s membrane can provide a morphologic record of previous episodes of 
disease (Arffa, 1997; Bron et al., 2001).
I/O
The posterior two thirds of Descemet’s membrane, which ^secre ted  after 
birth, consist of a homogeneous fibrillogranular material (Bron et al., 2001). The 
area closest to the endothelial cell layer is formed last and is attached to the 
endothelia by hemidesmosomes. With age, there may be polymerization of 
collagens to produce bands of long-spacing collagen may be found in 
Descemet’s membrane. Focal overproduction of the basal laminar material 
produces peripheral excrescences called Hassal-Henle warts (Tuft and Coster, 
1990). While these are considered normal in the aged cornea, they resemble 
warts of the central cornea, known as cornea guttata, which are associated with 
corneal abnormalities and an increase in endothelial permeability. Excrescences 
of cornea guttata also increase in number with age (Tuft and Coster, 1990).
1.1.5 Corneal endothelium
The corneal endothelium is a monolayer of hexagonal, cuboidal cells that lie 
posterior to Descemet’s membrane. The lateral borders of the cells are markedly 
convoluted, producing complex interdigitation with neighbouring cells. Both the 
basal and apical membranes are relatively flat. Like the epithelium, the 
endothelium is attached to its basement membrane by modified 
hemidesmosomes. These are found in numerous focal areas of increased
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density and are thought to be derived from the absorption of pinocytotic vesicles. 
Lateral membranes of contiguous cells are very interdigitated at the posterior 
plane. These interdigitations fold over one another, to form a marginal fold at the 
apical surface (Bron et al., 2001). For the majority of its length, the lateral 
intercellular space at these interdigitations is approximately 20nm. The cells are 
bound together by cell junctions and junctional complexes, including tight 
junctions and gap junctions on the posterior third and the apical interface 
(Waring, III et al., 1982). At the gap junctions the membrane separations are 
close to approximately 2nm, while at the tight junctions there effectively 
membrane fusion (Williams and Watsky, 2002).
The appearance of the corneal endothelial monolayer changes slightly with 
age. At birth, the corneal endothelium exists at a density of approximately 3000 
cells/mm2 arranged in a continuous monolayer of 4 to 6pm thick. The youthful 
endothelium has an uninterrupted uniform paving-stone mosaic appearance with 
cells approximately 20pm in diameter and a surface area of approximately 
250pm2 (Waring, III et al., 1982). Typically, the cells are fairly evenly distributed 
over the surface of the cornea, with a slightly higher density of cells at the 
periphery (Schimmelpfennig, 1984; Holley et al., 2000). Endothelial cells also 
become more irregular in shape and tend to have more cilia closer to the 
periphery (Waring, III et al., 1982; Schimmelpfennig, 1984; Holley et al., 2000).
In addition, cells cultured from the periphery of the cornea were found to have 
less tight cell-cell attachments and proliferate more readily (Bednarz et al., 1998). 
The observed differences between the endothelial cell population at the centre 
versus those at the periphery have prompted some researchers to suggest that 
the periphery may contain a progenitor cell population for the endothelium 
(Joyce, 2003).
The posterior surface of the cell membrane shows 20 to 30 microvilli per cell. 
Other than increasing the absorptive surface area, their function remains 
unknown (Collin and Barry Collin, 2004). Cilia rarely occur and are directed into 
the anterior chamber, related to a pair of centrioles in the posterior of the 
cytoplasm. Cilia tend to be more frequent towards the periphery of the cornea.
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This may represent the median of a continuum of cells from the corneal 
endothelium to the trabecular meshwork (Bron et al., 2001). The plasma 
membranes of these cells have also been noted to have inward vesiculations that 
form pinocytic vesicles, and while these are infrequent, the possibility of 
increased pinocytic activity in response to increased particulate matter in the 
anterior chamber has been demonstrated (Bron et al., 2001). These vesicles 
have been noted to transfer particulate matter from the anterior chamber to 
anterior intercellular spaces or the inner surface of Descemet’s membrane and 
appear as small pits on the apical surface of the endothelial monolayer (Waring, 
III et al., 1982).
The subcellular organization of corneal endothelial cells is consistent with the 
highly metabolically active state of these cells. Nuclei are large and oblong in 
shape causing low, flat bulges on the apical surface of the monolayer. There are 
large numbers of mitochondria distributed throughout the cell, though 
mitochondria tend to be concentrated around the nucleus (Waring, III et al.,
1982). The Golgi apparatus is also found in a perinuclear location, facing the 
anterior chamber. There is an extensive endoplasmic reticulum and free 
ribosomes. A terminal web of actin lies close to the posterior membrane and is 
thought to be connected with the tight junctions, joining the cell monolayer 
together (Bron et al., 2001).
Maintenance of corneal transparency, by regulation of corneal hydration, is 
the major function of the corneal endothelial monolayer. The leaky barrier is 
balanced by the pumping action of the endothelial cells. The leaky barrier also 
allows essential nutrients to pass from the aqueous humor to supply the cellular 
needs of the other corneal layers. Oxygen derived from aqueous also supplies 
the endothelium and the posterior stroma with all their needs (Bron et al., 2001).
1.2 Development of the corneal endothelium
The human eye is derived from a number of different embryological tissues, 
including surface ectoderm, neural ectoderm, neural crest and mesodermal
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mesenchyme. This dispersed population of tissues are all originally derived from 
the mesoderm or neural crest (Tuft and Coster, 1990). At approximately 40 days 
of human gestation (18mm stage), mesenchymal cells separate from the rim of 
the optic cup and spread along the newly invaginated lens vesicle. These cells 
eventually differentiate into the corneal and trabecular endothelium (Waring, III et 
al., 1982). At this point, the cornea consists of a superficial squamous cell layer, 
a basal, cuboidal epithelial cell layer, a primary stroma and a double layer of 
flattened endothelial cells (Bron et al., 2001). Subsequently, two additional 
waves of mesenchymal cells migrate to the centre; presumptive corneal 
keratocytes anterior to the endothelium and presumptive iris stromal cells 
posterior to that (Waring, III et al., 1982). Chromatin studies in birds suggest that 
this tissue is derived from the neural crest rather than mesoderm, possibly 
explaining discrepancies between behaviours of corneal endothelium and 
vascular endothelium, which originates from mesoderm (Johnston et al., 1979; 
Waring, III et al., 1982). Immunofluorescence staining of neuron-specific enolase 
in human keratocytes and endothelium has also demonstrated their origin to be 
from the neural crest (Adamis et al., 1985; Bron et al., 2001).
By the third month of gestation (63mm stage), the endothelium in the central 
cornea has become a single, flattened layer of cells resting on an interrupted 
basal lamina (Bron et al., 2001). At this point, the basal lamina has separated 
into two zones dependent upon their proximity to the endothelial cell layer. The 
lamina densa is closer to the corneal stroma and forms an electron dense band 
while the lamina lucida, adjacent to the corneal endothelium, forms an electron- 
lucent zone (Bron et al., 2001). The secretion of Descemet’s membrane, by the 
embryonic endothelium, begins primarily in the fourth month of gestation.
Further differentiation and growth of Descemet’s membrane is accomplished 
through a series of sequential secretions, which form a multilayered structure 
(Bron et al., 2001). The process is rapid with only one layer at three months 
gestation, to 10 layers at six months and 30-40 layers at birth (Waring, 111 et al., 
1982; Bron et al., 2001). In the third trimester, cross-linking bridges bind the 
adjacent layers together and aid in the compaction of this portion of matrix, to
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form Descemet’s membrane (Bron et al., 2001). Because of the unique pattern 
of interconnected nodes in this zone, as seen by transmission electron 
microscopy, it is named the ‘fetal’ banded zone of Descemet’s membrane 
(Waring, III et al., 1982; Arffa, 1997; Bron et al., 2001). This ‘fetal’ region of 
Descemet’s membrane is approximately 3jam in thickness at birth and remains 
that thickness throughout life (Waring, III et al., 1982; Bron et al., 2001).
Deposition of Descemet’s membrane in the fourth month of gestation 
corresponds with the onset of production of aqueous humour by the ciliary 
processes. In order to maintain the water balance of the developing cornea, the 
apices of the endothelial cells join by zonulae occludentes, also known as tight 
junctions (Bron et al., 2001). Immature tight junctions begin to develop at the 
eighth week of gestation but only begin to mature with the formation of aqueous 
humor (Bron et al., 2001). By the fifth month of gestation, the tight junctions have 
matured substantially and are similar to those at birth (Bron et al., 2001). By the 
sixth month of gestation, Descemet’s membrane is clearly demarcated and the 
stroma consists of an immature matrix including collagen fibrils and active 
keratocytes (Bron et al., 2001).
In the newborn, the cornea is relatively quite large with a steeper curvature 
than the cornea of adults (Arffa, 1997). Premature babies have smaller corneas 
and the steepness of curvature is even greater than that of full term newborns 
(Bron et al., 2001). While the peripheral cornea is consistently thicker than the 
central cornea throughout life, corneal thickness at birth is slightly higher than 
that of adults (Arffa, 1997). Continual growth and flattening continues with age 
and the cornea approaches adult measurements following the first year of life 
(Arffa, 1997).
After birth, there is a negligible amount of cell proliferation to maintain corneal 
endothelial cell densities. As the tissue ages, some cells within the monolayer 
die and spaces are filled predominantly by cell enlargement and cell spreading. 
The appearance of the monolayer, therefore, shifts from a homogeneous 
population of hexagonal cells to a heterogeneous population of irregular sized 
and shaped cells. The enlargement of the cells is termed polymegathism and the
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irregular cell shape termed pleomorphism. When the cell density falls below 
500cells/mm2, endothelial cell function is compromised and the monolayer can M  
no longer perform its barrier function. The result is stromal swelling, leading to 
corneal opacification.
1.3 Corneal endothelial barrier function
Corneal hydration is controlled solely by the corneal endothelial cell 
monolayer and plays a major role in the maintenance of corneal thickness and 
transparency. However, the mechanisms that control corneal endothelial barrier 
function remain unclear. The pump-leak hypothesis is generally accepted as the 
basic model of water balance between the cornea and the aqueous humor 
(Figure 1.2). In its original formulation, Maurice (1951) suggested the swelling 
pressure of the stroma was balanced by an excess of ions in the aqueous humor. 
Ionic excess was maintained by active transfer of one of the major ions, N a \ K+, 
Cl' or HC03-, to create a difference in electrical potential across the endothelium. 
Ions of opposite charge would be in electrochemical equilibrium across the layer 
(Maurice, 1951). The two principal elements of the hypothesis are the leak of the 
aqueous fluid into the stroma, driven by stromal swelling pressure controlled by 
the ionic permeability of the endothelium, and the pump which moves fluid out of 
the stroma, also located in the endothelium (Maurice, 1951).
One of the remaining debatable elements of this hypothesis is whether 
corneal thickness is passively or actively regulated. With passive regulation, the 
pumps would continually operate at maximum capacity and swelling pressure 
would increase as the cornea thins until the pumps are balanced. Active 
regulation would involve a sensing mechanism to reduce pump activity as 
corneal thickness approaches a physiologically normal value (Fischbarg & 
Maurice, 2004).
Maintaining the balance of stromal swelling is a complex process and is 
broken down into a number of components, which are further detailed below.
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These include stromal swelling pressure, endothelial monolayer permeability, 
endothelial pumps, thickness regulation and endothelial cell junctions.
Endo
Leak Rate -  Metabolic Pump Rate
Figure 1.2 Schematic representation of corneal endothelial barrier function.
Leakage of fluid from the aqueous humor into the corneal stroma is balanced by pumps 
on the corneal endothelium. It remains unclear whether this regulation is under active or 
passive controls, (image from: Waring III et al. 1982. The corneal endothelium. Normal and 
pathologic structure and function. Ophthalmology. 89:545)
1.3.1 Swelling pressure and leak
Swelling pressure created by the stroma is described by the Donnan effect, 
which suggests the existence of swelling pressure in a charged gel results from 
the ionic imbalances that it creates. Hodson and Earlam (1993) demonstrated a 
good correlation between the swelling pressure and the fixed charge density in 
the stroma. Fixed negative charge in the stroma has been attributed to different 
molecules by different groups. Hodson et al. (1992) suggest that this negative 
charge arises from the relative amounts of Cl" in stromal tissue versus the 
aqueous humor. Another school of thought suggests that the principal source of 
the negative charge of the stroma arises from resident glycosaminoglycan 
molecules (Scott & Bosworth, 1990). Support for this latter theory is 
demonstrated by Maurice & Monroe (1990), who showed digestion of individual 
glycosaminoglycans reduced swelling pressure according to their concentration.
PumpBarrier
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1.3.2 Endothelial monolayer permeability
Comparisons of the permeability of small solvents indicate that these 
molecules diffuse through paracellular spaces in the endothelial cell monolayer 
(Maurice, 1985). It has been suggested that the main controlling factor of 
permeability is steric hindrance. Control of permeability is thought to be 
dependent upon which junctional proteins are expressed by the endothelium, as 
junctional complexes have been suggested to act as pores or channels which 
allow the passage of small solutes and ions (Bazzoni and Dejana, 2004). The 
flow of aqueous across the endothelium was also shown to be proportional to its 
viscosity, suggesting that the passage of water across the endothelium takes 
place through paracellular spaces (Baum et al., 1984). These results have led 
some to believe the fluid pump system is also located at the paracellular space 
(Fischbarg & Maurice, 2004).
1.3.3 Endothelial cell pumps
Early investigations implicated the bicarbonate ion as the prime molecule of 
the endothelial fluid pump (Hull et al., 1977; Hodson & Miller, 1976). Results 
from more recent studies, however, suggest some inconsistencies. Some 
studies have even questioned the importance of the bicarbonate ion to pump 
function, instead suggesting that the differences noted with alterations in 
concentration of bicarbonate ion are not due to the ion itself but rather pH 
changes (Kuang et al., 1990; Doughty & Maurice, 1988). In the most recent 
model of electro-osmotic fluid pumping, bicarbonate plays a partial role in fluid 
transport. The remaining fluid pump is thought to be maintained by sodium 
recirculation via apical Na+ pumps (Sanchez et al., 2002). A further challenge to 
the most recent theory remains with suggestions by Doughty (1991), who reports 
differences in pump behaviour according to whether bicarbonate concentrations 
are varied on the apical or basolateral side of the endothelium. Clearly, there is 
no consensus as to which pumps are vital for endothelial pump function and 
more research is needed.
1.3.4 Thickness regulation
The active model of the pump-leak hypothesis would require a set of 
receptors or sensors in the corneal stroma to assess the hydration of the tissue, 
another set to regulate the activity of the corneal endothelial pumps and a 
mechanism to link the two sets (Fischbarg & Maurice, 2004). As yet, no such 
receptor sets have been found, however, a number of putative receptors, which 
could alter pump rate have been determined.
The muscarinic acetylcholine receptor has been characterized and localized 
in the corneal endothelium (Lind & Cavanagh, 1995). While there is no evidence 
for a role for this receptor in fluid transport in the corneal endothelium, 
acetylcholine has been linked to increased fluid transport in other systems and 
may have a similar role in the corneal endothelium. Additionally, the abundance 
of acetylcholine in the cornea has also never been adequately explained.
The adenosine receptor has also been suggested to play a role in regulation 
of endothelial permeability. This suggestion is supported by studies in bovine 
corneal endothelium (Walkenbach & Chao, 1985; Walkenbach & LeGrand,
1982). Stimulation of the adenosine receptor was shown to activate adenyl 
cyclase and the resultant increase in cAMP also increased net endothelial fluid 
transport (Riley et al., 1996). These pathways are thought to converge with the 
activation of protein kinase A (PKA) (Fischbarg & Maurice, 2004).
Perhaps the most compelling evidence to date is that of platelet activating 
factor (PAF), which has been shown to inhibit fluid transport in a dose- 
dependent, saturable manner (Zhu et al., 1996). PAF stimulation in other 
systems has been shown to stimulate calcium mobilization and activation of 
protein kinase C (PKC). It is possible that the PKA and PKC pathways provide 
competitive regulation of endothelial pump control (Fischbarg & Maurice, 2004).
In addition to receptors, the corneal endothelium has been found to contain a 
number of water channel proteins. The role of these water channels is unclear 
as they do not appear to be evenly distributed across the monolayer. It has been 
suggested that certain cells, requiring rapid water passage through their 
membranes, contain these water channels while others do not (Fischbarg &
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Maurice, 2004). Of additional interest is the fact that when water channels are 
present on the plasma membrane, they appear to cover the entire surface of the 
endothelial cell membrane (Li et al., 1999). However, these channels are more 
likely to play only a minor role in the regulation of water flow, as aquaporin 
knockout mice appear to have transparent corneas with fairly normal flow (Kuang 
et al., 2003).
1.3.5 Cell junctions
Endothelial cells adhere to one another at junctional structures. These are 
formed by homophilic cell-cell adhesion of transmembrane adhesive proteins. 
Stabilization of the junction is achieved through binding of specific intracellular 
partners to both the transmembrane proteins and the actin cytoskeleton. There 
are two major types of junctions described in both endothelial and epithelial cells; 
adherens junctions (AJs) and tight junctions (TJs). Both cell types also form gap 
junctions, which mediate cell-to-cell communication by allowing intercellular 
passage of ions and low molecular weight molecules (Simon and Goodenough,
1998). In addition to the aforementioned junctions, epithelial cells also form 
desmosomes but these are lacking in the endothelium (Bazzoni and Dejana, 
2004). The organization of junctional complexes in a polarized cell is illustrated 
in Figure 1.3. Generally, junctions in the epithelium are better organized and 
more clearly defined than those in the endothelium, which occasionally displays 
mixing of the AJ and TJ. In the endothelium, the development of the mature 
junction is also a longer process than in the epithelium, with fully mature 
junctions only reached late in development. In general, junctions are not 
completely differentiated in the embryo (Bazzoni and Dejana, 2004).
Junctions are dynamic structures and organization of the endothelial 
monolayer follows a number of different steps to maturation. Evidence from 
epithelial cells suggests that adhesive membrane proteins of AJ and TJ form 
adhesion complexes at sites of cell-cell contact, which then organize into zipper
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Tight junctions 
Adherens junctions
Desmosomes
Lateral
Gap junctions
Basal Hemidesmosomes
Figure 1.3 Epithelial intercellular junctions. This schematic representation of a 
polarized epithelial cell indicates the positioning of various junctions. The tight junctions 
and adherens junctions are linked to the actin cytoskeleton, while the desmosomes and 
hemidesmosomes are linked to the intermediate filaments. Desmosomes are only present 
in epithelial, not endothelial, cell layers. Hemidesmosomes anchor the cell to its matrix, 
(image from: Matter & Baida. 2003. Signalling to and from tight junctions. Nat. Rev. Mol. Cell Biol. 
4:226)
like structures by lateral adhesion along the cell border (Matter and Baida, 2003; 
Bazzoni and Dejana, 2004). The organization of endothelial junctions may vary 
slightly from that in the epithelium, as the AJ and TJ are less well defined. 
Intracellular partners of transmembrane adhesive proteins vary during junction 
maturation and stabilization. Even after contacts have been stably established, 
adhesion proteins are still in a dynamic equilibrium and recycle continuously 
between the plasma membrane and intracellular compartments (Bazzoni and 
Dejana, 2004).
Junctions have been implicated in a number of different functions including 
the mediation of intracellular signals. These signals have been shown to affect 
both growth and apoptosis. It is suspected that information from the junction
Apical
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dictates cell positioning, mediates contact-dependent growth inhibition and 
establishes cell polarity (Bazzoni and Dejana, 2004). Perhaps the most 
important aspect of junctional formation in the corneal endothelium is the 
establishment of barrier function and impermeability (see section 1.3.2).
1.3.5.1 Adherens junctions
The main component of the adherens junction (AJ) is the cadherin-catenin 
complex. The cadherin family of proteins, which mediate homophilic adhesion 
between cells, are transmembrane protein components. E- and N-cadherin have 
been shown to be expressed in the corneal endothelium (Beebe and Coats,
2000; Ickes et al., 2002). Studies in vascular endothelium suggests that N- 
cadherin may play a role in cell adhesion and also cell-cell communication with 
other cell types expressing N-cadherin (Gilbertson-Beadling and Fischer, 1993). 
Additionally, it has been suggested that N-cadherin may offer protection from 
apoptosis and may be able to induce growth, through activation of fibroblast 
growth factor receptors (Williams et al., 2001). The cytoplasmic tail of the classic 
cadherins are homologous and bind p-catenin and plakoglobin (y-catenin), both 
of which bind a-catenin and anchor the complex to actin. a-Catenin also binds 
a-actinin and vinculin, which further anchors the AJ to the cytoskeleton (Weiss et 
al., 1998; Bazzoni and Dejana, 2004).
While ZO-1 is commonly considered an intracellular component of TJ, it can 
also be found at the AJ in the early stages of junctional organization. ZO-1 
binding to a-catenin is responsible for its localization at the AJ, but this is 
transient, as the junction matures, ZO-1 moves away and concentrates at the TJ 
(Itoh et al., 1997).
While the classic cadherins tend to bind essentially the same molecules at 
their cytoplasmic domain, they may exert different biological activities (Bazzoni 
and Dejana, 2004). A prominent feature of p-catenin and plakoglobin are their 
ability to translocate to the nucleus to modulate gene expression with other 
transcription factors. These roles are thought to be more critical during 
development than later in life. Mutations in this machinery, especially p-catenin,
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have been implicated in increased cell proliferation and decreased sensitivity to 
apoptosis (Ben-Ze'ev and Geiger, 1998). These findings support a role in 
tumorigenic transformation, as many tumor cells have altered junction formation. 
Similarly, expression and clustering of some cadherins (E-cadherin) at the 
junctions has been shown to activate small GTPases such as Rac, while 
reducing RhoA activation, which in turn help to stabilize the monolayer 
(Nakagawa et al., 2001). Other cadherins (N-cadherin), however, have been 
found to be associated with migratory phenotypes, inducing Rho activation and 
inhibiting Rac (Charrasse et al., 2002). In addition to GTPases, AJ have been 
noted to interact with several phosphatases and intracellular signalling 
molecules, including PI3 kinase and MAPK (Bazzoni and Dejana, 2004).
The AJ is key to the maintenance of a number of cell-specific properties and 
its molecular organization is complex. It is likely that further investigations will 
uncover more molecules that interact with or make up AJ (Bazzoni and Dejana, 
2004).
1.3.5.2 Tight junctions
TJ were first described by electron microscopy as a specialization of the 
plasma membrane, named zonula occludens, in which it appeared as though the 
membranes of two cells were fused at one point on the apical side of the cell. 
However, closer investigation revealed that the membranes of the two cells were 
in fact separate but in tight contact with each other (Bazzoni and Dejana, 2004). 
The major function of TJ is to regulate paracellular permeability and maintain cell 
polarity by restricting both diffusion of solutes across the intercellular space 
(barrier function) and movement of molecules between the apical and basolateral 
faces of the plasma membrane (fence function).
Most research into TJ has been performed in epithelial cell lines, and while 
many of the details about epithelial TJ can be extrapolated to fit endothelial TJ, 
there are a few caveats to keep in mind. First, the precise location of the TJ and 
its definition from other junctions is less distinct in most endothelial cells as 
compared to epithelial cells. Second, even though the components of the
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junction may be the same, their assembly and regulation may be different in ^
epithelial and endothelial cells. Third, there is more variability across endothelial 1 j 
barriers with regard to development of TJ and permeability across monolayers 
(Bazzoni and Dejana, 2004).
The TJ plaque is composed of both transmembrane and intracellular 
molecules. There are 3 classes of transmembrane proteins that form TJ; 
occludin, claudins and adhesion proteins of the immunoglobulin superfamily, 
such as junctional adhesion molecules (JAMs). Occludin was the first 
transmembrane TJ protein to be discovered. It is composed of two extracellular 
loops and four transmembrane regions with both ends of the protein terminating 
in the cytoplasm, and exists as at least two different splice variants. Interestingly, 
the levels of occludin expressed have been found to correlate to the permeability 
of different monolayers. Endothelial cells of non-neural tissues tend to express 
occludin at a lower levels and have a greater permeability (Hirase et al., 1997). It 
was first thought that occludin contributed to intercellular adhesion, but surface 
expression and adhesion are not intrinsic properties of occludin. Organization of 
occludin at the membrane first requires that endogenous ZO-1 be organized at 
the membrane, possibly at AJ (Medina et al., 2000). The cytoplasmic domain of 
occludin binds directly to the ZO proteins in a reaction that is saturable (Furuse et 
al., 1994; Schmidt et al., 2001). Additionally, occludin-deficient mice are born 
with no gross phenotype, suggesting that occludin is dispensable for tight 
junction formation (Saitou et al., 1998). Further analysis determined that mice 
lacking occludin had postnatal growth retardation in a number of tissues, 
suggesting that occludins’ role may not be related to its positioning at the tight 
junction, and that its positioning may merely be a regulatory mechanism (Saitou 
et al., 2000).
There are over 20 proteins which make up the family of claudins. Like 
occludin, these have four transmembrane domains, two extracellular loops and 
two cytoplasmic termini, however, the proteins are much smaller and bear no 
sequence similarity to occludin. The types of claudin expressed by cells are 
thought to determine the leakiness of the TJ barrier (Furuse et al., 1998).
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Claudin-5 has been found to have an expression pattern restricted to endothelial 
cells (Morita et al., 1999). Interestingly, investigations into claudin expression in 
corneal endothelial cells revealed that these cells do not express claudin-5. Only 
claudin-1, -6 and -8 were found to be expressed in corneal endothelial cells 
(Kuanget al., 2003). It is clear that claudin-1 is vital for survival as genetic 
ablation of claudin-1 induces neonatal death and wrinkling of the skin due to 
increased permeability of water (Furuse et al., 2002). The claudins and occludin 
are thought to assemble into heteropolymers that form intramembrane strands. 
These strands have been proposed to contain fluctuating channels to allow 
selective diffusion of ions and small hydrophilic molecules (Matter and Baida, 
2003; Bazzoni and Dejana, 2004). The ion size and selectivity of the paracellular 
diffusion pathway is dependent on the types and concentrations of claudins and 
occludin (Matter and Baida, 2003).
The most recently discovered transmembrane TJ proteins are junctional 
adhesion molecule-A (JAM-A) and related molecules. JAM-A is a glycoprotein 
with a single extracellular domain, with two Ig-like domains, one transmembrane 
segment and a short cytoplasmic tail. It is thought to play a role in 
transendothelial migration of leukocytes (Bazzoni and Dejana, 2004). Related 
molecules JAM-B, JAM-C, endothelial cell-selective adhesion molecule (ESAM) 
and Coxsackie- and adeno-virus receptor (CAR) are also thought to play roles in 
TJ assembly and regulation of paracellular permeability. Like the other 
transmembrane TJ proteins, JAM-A binds intracellular TJ protein ZO-1, possibly 
anchoring this protein to F-actin or other transmembrane TJ proteins (Bazzoni 
and Dejana, 2004). This feature may be instrumental in the stabilizing of the TJ 
strands.
In addition to the transmembrane components of TJ, there are a number of 
intracellular components of TJ. Cytoplasmic plaques are formed by a number of 
different proteins that include adaptor proteins and other proteins containing PDZ 
(postsynaptic density protein/disc large-A/ZO-1) domains, regulatory components 
and signalling components. Adaptor proteins, including the zonula occludins 
(ZO), are thought to bind to transmembrane proteins and recruit other cytosolic
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components to the tight junction. Protein kinases, GTPases and transcription 
factors, are among the cytosolic components recruited to TJ. The most 
extensively studied of the intracellular components is zonula occludens-1 (ZO-1). 
This was also the first protein component of the tight junction to be discovered 
(Stevenson et al., 1986). ZO-1 and its related proteins, ZO-2 and ZO-3, belong 
to the family of membrane-associated guanylate kinases (MAGUKs), which 
mediate a number of cellular functions, including anchoring to actin, 
establishment of cell polarity, membrane trafficking, cell signalling and control of 
gene expression (Bazzoni and Dejana, 2004). The distribution of ZO-1 is 
variable among cells, and only those cells forming distinct junctional complexes 
show restricted expression of ZO-1 at TJ. Cells with incomplete junctional 
development display ZO-1 localization at both TJ and AJ. The PDZ domains of 
ZO-1 are thought to be responsible for its binding to various other TJ proteins, 
including the transmembrane TJ proteins and other ZO proteins. ZO-1 is known 
to contain three PDZ domains, a Src homology 3 (SH3) domain, a guanylate 
kinase domain and an acidic and a proline-rich region (Bazzoni and Dejana, 
2004). In addition to other TJ proteins, ZO-1 is also known to engage in 
interactions with a number of additional intracellular molecules. Interactions with 
F-actin are thought to be responsible for anchoring the TJ to the cytoskeleton 
and may play a role in the control of permeability (Cordenonsi et al., 1999). ZO-1 
has also been shown to interact with a number of intracellular signalling 
molecules and transcription factors. Among these is the Y-box transcription 
factor ZONAB, which inhibits expression of the ErbB2 gene product (Baida and 
Matter, 2000). This interaction suggests a role for TJ and ZO-1 in the regulation 
of cell growth and proliferation. Interactions with members of the Ras family and 
Ras effectors also suggest that these proteins may play a role in the regulation of 
cell growth (Bazzoni and Dejana, 2004).
In human corneal endothelium, immature tight junctions begin to develop 
at the eighth week of gestation (Bron et al., 2001). Coinciding with the formation 
of aqueous humor, in the middle of the fourth month of gestation, the tight
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Figure 1.4: Composition of the tight junction. The tight junction plaque is made up of 
transmembrane proteins, which form heteropolymers that form the intramembrane 
strands. These transmembrane proteins bind to adaptor proteins, which help recruit other 
proteins to the tight junction. These include transcriptional and post-transcriptional 
regulators and regulatory proteins. Some examples of proteins involved in the formation 
of the tight junction are named above but this is by no means a comprehensive list, (image 
adapted from: Matter & Baida. 2003. Signalling to and from tight junctions. Nat. Rev. Mol. Cell 
Biol. 4:227)
junctions begin to mature. By the fifth month of gestation, the tight junctions are 
similar to those at birth (Bron et al., 2001). Further maturation and definition of 
TJ continues to take place after birth and may continue through the entire life of 
the individual. Immunofluorescence staining of human and cat corneal 
endothelium has revealed the junctional organization in these two species to be 
similar. Both show apical ZO-1 and cortical F-actin organization (Petroll et al.,
1999). While cadherin and catenin form a tight band around the cells, ZO-1 
staining appears to be discontinuous, with the largest gaps at the Y-junctions of 
adjacent cells (Petroll et al., 1999). These differences in staining suggest that 
ZO-1 localizes to the TJ and not the AJ, however, no transmembrane tight 
junction proteins have yet been visualized in the corneal endothelium.
&
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While little research has been done on the maturation of the human corneal 
endothelial TJ, the maturation of the rabbit TJ has been investigated. The 
development of the rabbit cornea is slightly different from that of human, as 
corneal transparency is only achieved 20 days after birth in the rabbit cornea. In 
the rabbit, formation of TJ begins at 21 days gestation and is thought to be fairly 
well developed by birth. The morphology of TJ is similar to that of the adult when 
corneal transparency is established at day 20, however, freeze-fracture analysis 
demonstrated incomplete junctional strands in the 3 month old rabbit (Stiemke et 
al., 1991b). Similarly, paracellular flux was found to be slightly elevated in 
younger endothelium, suggesting incomplete junctional formation (Stiemke et al., 
1991b). With age, the rabbit corneal endothelium, like the human corneal 
endothelium, was found to become more interdigitated and the intramembranous 
particle density was found to be increased (Stiemke et al., 1991b). This may 
represent a continually maturing junction with a continual recruitment of more 
junctional proteins. Some of these proteins may be endothelial cell pumps, 
responsible for maintenance of corneal clarity, as concentrations of the Na/K 
ATPase were found to increase with age, and newer models of the pump-leak 
hypothesis suggest that junctions are the sites for endothelial cell pumps 
(Stiemke et al., 1991a; Fischbarg and Maurice, 2004).
While it is clear that endothelial TJs play a major role in corneal hydration 
control, the development of these barriers in the human endothelium remains 
unclear.
1.4 Corneal endothelial cell survival
Unlike endothelial cells in most other tissues, corneal endothelial cells are 
almost incapable of proliferation, meaning that cell death has a significant impact 
on corneal endothelial cell densities. Human corneal endothelial cell densities are 
highest around birth and decrease slowly with age. Their incredibly long life span 
makes it is difficult to investigate factors that affect corneal endothelial cell 
survival. At present, the best model for studying decreasing corneal endothelial
cell densities are corneas which have been stored for transplantation. It has 
been documented that both cold storage (4°C) as well as organ culture methods 
(34°C) of corneal storage lead to an increase in cell death of the corneal 
endothelial cell monolayer, limiting the useful lifespan of corneas in storage 
(Albon et al., 2000; Crewe and Armitage, 2001; Thuret et al., 2003a). The cell 
death mechanisms which underlie these decreasing densities remain unknown 
and while most studies suggest that apoptosis is the main source of cell death in IJ
the corneal endothelial cell monolayer, necrosis is also thought to occur (Komuro 
et al., 1999; Albon et al., 2000).
1.4.1 Apoptosis
Apoptosis, or programmed cell death, is a distinctive mechanism of active 
cellular death characterized by a set of physiologically and chemically defined 
processes culminating in distinct cellular biochemical events (Wyllie et al., 1980). 
These cellular events include loss of membrane phospholipid asymmetry, loss of 
mitochondrial permeability and function, chromatin condensation, fragmentation 
of genomic DNA, compartmentalization of cellular cytosol and DNA and discrete 
packaging and blebbing of cellular components (Reed, 2000). By contrast, the 
less controlled process of cell death, necrosis, can be characterised by 
progressive swelling of the cell and random DNA and organelle degradation 
resulting in the eventual rupture of the cell and the spilling of cytosolic 
components. Due to the release of cellular components with necrotic cell death, 
it is also associated with an inflammatory response. This response is not, 
however, associated with apoptotic cell death, as the cell contents remain 
contained as they are degraded.
While there are many molecules involved in apoptotic signalling, most 
apoptotic pathways lead to the activation of a cascade of key proteases. This 
family of proteins is referred to as cysteine aspartyl-specific proteases, or 
caspases, and these are responsible for many of the morphologic changes noted 
during apoptosis (Reed, 2000). These changes are induced by interactions of 
caspases with specific target proteins including structural proteins (cytoskeletal
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proteins), regulatory proteins (PKC, PARP) and other pro-apoptotic proteins. 
Caspases reside in the cell as inactive zymogens, which can be triggered into the 
active state with proteolytic processing. Cleavage of the pro-protein at 
conserved asparagine residues generates two subunits of the active protein; a 
large apd small subunit (Donepudi and Grutter, 2002). Similarly, caspases 
cleave their substrates at asparagine residues, which activate their proteolytic 
activity, suggesting that these proteins act in a proteolytic cascade. These 
cascades may include more than one caspase with one caspase activating 
another. Upstream caspases are typically referred to as initiator caspases, while 
the downstream caspases are termed effector caspases (Donepudi and Grutter,
2002).
There are two apoptosis pathways which can result in the activation of 
caspases; the intrinsic and extrinsic pathways. The intrinsic pathway involves 
the release of caspase-activating proteins from the mitochondria to the cytosol. 
Specifically, cytochrome c released from the mitochondria binds to caspase- 
activating protein Apaf-1. The binding of cytochrome c initiates a change in the 
conformation of Apaf-1 such that the protein aggregates and binds pro-caspase- 
9. The activation of caspase-9 is thought to be mediated by the induced 
proximity model, which suggests that the zymogen forms of caspases are not 
inactive but possess a very weak protease activity, such that when the proteins 
are brought into close proximity, the zymogens trans-process each other, 
resulting in fully active proteases (Martinou et al., 2000). Even after activation of 
caspase-9, the protease remains bound to Apaf-1 for full activity (Reed, 2000). 
The extrinsic pathway is mediated by ligand binding to death receptors, of these, 
the best studied is the TNF death receptor family. The cytosolic domains of the 
death receptors interact with adaptor proteins, which recruit pro-caspase-8.
These complexes of caspases and adaptor proteins stimulate the activation of 
downstream caspases by the induced proximity mechanism. Upon activation, 
the N-terminus of the pro-protease is cleaved off to release the caspase into the 
cytosol to initiate apoptosis (Ashkenazi and Dixit, 1998). While these pathways
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are commonly regarded as separate, there is often cross talk between the two at 
a number of different levels (Reed, 2000).
Proteins that control and participate in caspase activation pathways exist as 
families that can be recognized based on amino acid sequence or structural 
similarities. Interactions of these proteins are typically mediated by domains, 
which are associated with the regulation of apoptosis (Reed, 2000). These 
include caspase-associated recruitment domains (CARDs), death domains 
(DDs), death effector domains (DEDs), Bcl-2 homology (BH) domains, 
baculovirus inhibitor of apoptosis protein(IAP), repeat (BIR) domains of IAP 
proteins and NB-ARC domains, which represent nucleotide binding 
oligomerization domains (Reed, 2000).
Little research has been done on the cellular pathways activated in the 
apoptotic response of corneal endothelial cells, however, there are a number of 
studies concerning the expression of anti-apoptotic protein Bcl-2 (Li et al., 1998; 
Joo et al., 1999; Gain et al., 2001; Yamamoto et al., 2001). The mitochondrial- 
dependent apoptotic pathway is governed by the Bcl-2 family of proteins. Many 
of these proteins are constitutively located on mitochondrial membranes, while 
others are induced to target organelles, including the ER and nuclear envelope, 
in response to stimulation (Martinou et al., 2000). Others are normally found in 
the cytosol but can be induced to target the mitochondria, where they have a role 
in the release of cytochrome c, initiating the activation of cytosolic caspases 
(Martinou et al., 2000). There are both pro- and anti-apoptotic proteins within 
the Bcl-2 family, with many of the proteins binding to each other to form a 
network of homo- or heterodimers (Chao and Korsmeyer, 1998). Relative ratios 
of pro- and anti-apoptotic proteins present dictate the sensitivity of the cells to 
various apoptotic stimuli (Gross et al., 1999). At present, 20 members of the Bcl- 
2 family have been described comprising 6 anti-apoptotic and 14 pro-apoptotic 
proteins. Some of these are the products of alternative mRNA splicing, and may 
have opposing effects on apoptosis (eg anti-apoptotic Bcl-XL and pro-apoptotic 
Bcl-Xs). Other proteins display differing activities in different cellular 
backgrounds (eg Boo/Diva, Bcl-2 and Bax). The Bcl-2 family can also be divided
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into two groups according to protein structure. One sub-set is thought to form an 
a-helical pore or channel, similar to the pore-forming domains of bacterial toxins. 
Most of these proteins have conserved stretches of amino acid sequence 
homology, including Bcl-2 homology (BH) domains BH1, BH2, BH3 and 
occasionally BH4 (Gross et al., 1999). The other sub-set of proteins only 
contains the BH3 domain and all of these proteins are pro-apoptotic in function. 
Their cell death activity is dependent upon their ability to dimerize with anti- 
apoptotic Bcl-2 family proteins. These observations demonstrate that the 
dimerization of Bcl-2 family members is dependent upon the BH3 domain of the 
proteins (Gross et al., 1999).
1.4.2 Age-related effects on the corneal endothelium
It is well known that, with age, there is a general trend towards a decrease in 
endothelial cell densities and a corresponding increase in polymegathism and 
pleomorphism. This decrease reflects small accumulated cell loss over time from 
cell death from age or injury and negligible amounts of cell proliferation.
Between the ages of 20 and 80 years, there is an annual reduction in cell density 
average of approximately 0.6%. These decreasing densities are illustrated in 
Figure 1.5. As the mean age of the population sample increases, however, there 
is an increased spread in the range of endothelial cell counts, suggesting 
environmental influences as well as age effects play a role in decreasing 
endothelial cell densities (Faragher et al., 1997). In the event of excessive cell 
loss, the barrier function of the endothelium can be compromised. Endothelial 
cells compensate for decreasing cell numbers by increasing the density of pumps 
on each cell (Crawford et al., 1995). There is, however, a cut off point at which 
the increased number of pumps on the remaining endothelial cells can no longer 
compensate for the increased leakage, due to loss of barrier function at 
decreased cell densities. At this point the function of the monolayer is 
compromised resulting in corneal hydration and opacity.
44
AGE
(years)
•30 -20 -10 0
FETAL AGE A 
(weeks)
BIRTH
POST-NATAL AGE 
. (years)
Figure 1.5 Corneal endothelial cell densities decrease with age. Clinical specular 
micrographs of the corneal endothelium of normal subjects; (A) 20 year old, (B) 44 year 
old, (C) 59 year old, (D) 69 year old and (E) 83 year old. Quantitation of the age-related 
decrease in corneal endothelial cell density suggests that this phenomenon occurs on a 
logarithmic scale, with the majority of cell death occurring in the first few years of life (F). 
(images from: Laing et al. 1976. Changes in the corneal endothelium as a function of age. Exp. 
Eye Res. 22:590; graph from: Murphy et al. 1984. Prenatal and postnatal cellularity of the human 
corneal endothelium. A quantitative histologic study. Invest.Ophthalmol.Vis.Sci. 25:316)
In addition to gradual cell loss with time, senescent phenotypes develop in 
some cells of the endothelium. Cellular senescence is the process that imposes 
a limit on the replicative lifespan of a cell, aiding in tumor suppression and 
lengthening the reproductive lifespan of an individual, however, the emergence of 
senescent cells contributes to the aging process (Faragher et al., 1997). There 
are two main routes by which cells become senescent. Constitutive cell 
senescence reflects the chance of senescence with each cell division and is 
typically explained in terms of shortened telomere lengths. Reactive cell 
senescence is similar to constitutive cell senescence but occurs more rapidly and 
is induced by mutation or mitogenic overload. It requires little, if any cell division 
(Faragher et al., 1997). As the corneal endothelium is not made up of actively 
proliferating cells, but senescent phenotypes occasionally develop in the
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monolayer, reactive cell senescence is thought to be involved (Faragher et al., 
1997). Among the morphological changes observed in corneal endothelial 
monolayers are large, multi nucleated cells, increased vacuolation and an 
increase in population doubling times (Wilson and Lloyd, 1991; Joyce, 2003). Of 
these changes, the most studied are the multinuclear cells. Two mechanisms 
have been suggested to explain the presence of these multinucleate cells. One 
explanation arose from studies of the wound healing response of the 
endothelium suggesting that wound closure may result in coalescence of cells 
rather than cell division (Liang et al., 1983; Neubauer et al., 1983; Neubauer et 
al., 1984). An alternative explanation is that some cells of the population 
undergo amitotic division, in which DNA is duplicated, but the cells do not 
complete cytokinesis to produce two daughter cells (Landshman et al., 1989; 
Tuberville et al., 1989). These observations were noted in both the wound 
healing response of the endothelium and in the normal human corneal 
endothelium, which displayed an age-related increase in the number of polyploid 
cells (Ikebe et al., 1988). There also appeared to be a correlation between DNA 
content of the cell and the surface area of the cell, with multinucleate cells having 
a larger mean and maximum size and a more irregular shape than normal diploid 
cells (Ikebe et al., 1988). Similar results were noted for human corneal 
endothelial cell cultures, with those remaining longer in culture displaying 
senescent phenotypes (Wilson and Lloyd, 1991).
In addition to the development of a senescent phenotype, significant age- 
related differences were detected in the kinetics of cell cycle progression. Cells 
from older donors were found to enter the cell cycle more slowly than those from 
younger donors. In addition, fewer cells from older donors entered the cell cycle 
(Senoo and Joyce, 2000). Interestingly, sensitivity to mitogenic factors may also 
be decreased in older cells, as these cell require longer, stronger mitogenic 
stimulation in order to proliferate (Senoo and Joyce, 2000).
Assays of telomerase activity also reflect notable age-related differences in 
the human corneal endothelium. No measurable telomerase activity was found 
to be present in central corneal endothelial cells, but low levels of telomerase
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activity was detected in the peripheral region (Egan et al., 1998). This low level 
of peripheral telomerase activity was higher in younger populations (Egan et al., 
1998; Whikehart et al., 2002; Joyce, 2003). Higher cell densities and greater 
variations in cell shape at the periphery have also been noted (Schimmelpfennig, 
1984; Holley et al., 2000). These observations have led some to suggest that 
these peripheral cells may represent a progenitor cell population for the corneal 
endothelium (Joyce, 2003).
1.4.3 Factors affecting corneal endothelial survival
Advanced glycation end products (AGEs) have been proposed as mediators 
for the pathogenesis of age-related diseases (Kaji et al., 2001). AGEs are 
produced by nonenzymatic reduction, oxidation and condensation of reducing 
sugars and proteins, collectively known as glycoxidation (Kaji et al., 2003).
These modified proteins accumulate in tissue and cartilage with age, resulting in 
a deterioration or elimination of protein function. In addition, AGEs impair cellular 
function by increasing cellular oxidative stress by binding to specific cell surface 
receptors, including the receptor for AGE (RAGE) and galectin-3, to induce the 
deleterious effects commonly associated with the ageing process (Kaji et al.,
2003). The presence of AGEs in the human cornea has been described, with 
levels of AGEs in Descemet’s membrane found to increase with time (Kaji et al.,
2000). The presence of AGEs in basement membranes has been reported to 
affect attachment and cell spreading in a number of cell types. Studies 
investigating glycation of fibronectin and laminin in corneal endothelial matrix 
showed a decreased number and surface area of attached corneal endothelial 
cells (Kaji et al., 2001). The expression of RAGE and galectin-3 was also noted 
in corneal endothelial cells (Kaji et al., 2003). The accumulation of AGEs in 
corneal endothelial cells was shown to result in increased generation of reactive 
oxygen species by the cells and consequently, increased apoptosis. It has been 
proposed that AGEs induce apoptosis partly by increasing amounts of reactive 
oxygen species (Kaji et al., 2003). Reactive oxygen species have been noted to 
induce both apoptosis and necrosis in cultured corneal endothelial cells (Cho et
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al., 1999). Similarly, hydrogen peroxide, which is produced by the cornea and 
neighbouring tissues, has been shown to induce apoptosis in corneal endothelial 
cells (Hull et al., 1984; Hudde et al., 2002). The effects of oxidative stress have 
been found to be alleviated with catalase (Hull et al., 1984; Hudde et al., 2002). 
Extracellular superoxide dismutase (SOD) may also to have a cytoprotective role 
in protection of the corneal endothelium from oxidative stress. SOD null mice 
have been shown to have an increased concentration of extracellular superoxide 
radicals, enhancement of spontaneous age-related corneal endothelial cell loss 
and increased susceptibility to acute inflammation (Behndig et al., 2001). 
Cytoprotective effects were also noted in proteins found in the aqueous humor. 
One such protein is vasoactive intestinal peptide (VIP), which has been shown to 
increase corneal endothelial cell survival from oxidative insults (Koh and 
Waschek, 2000). Additionally, expression of anti-apoptotic proteins by corneal 
endothelial cells, themselves, may offer protection from cell death. Studies have 
noted expression of heat shock proteins (Hsp) 27, 60, 70 and 90, Bcl-2, Bax, Bcl- 
XL, interleukin-1 p converting enzyme, Fas and Fas-ligand by corneal endothelial 
cells (Wilson et al., 1996; Gain et al., 2001). The best studied of these is the 
anti-apoptotic protein Bcl-2, which was found in the nuclei and nuclear envelope 
of corneal endothelial cells (Yamamoto et al., 2001). Bcl-2 was found to be a 
negative regulator of caspase-dependent apoptosis in corneal endothelial cell 
cultures (Joo et al., 1999). External controls of corneal endothelial cell survival 
have been suggested from studies demonstrating protein(s) produced by the 
iris/ciliary body and present in the aqueous humor, which increase Bcl-2 gene 
transcription (Li et al., 1998). Also, because corneal endothelial cells express 
both Fas and Fas-ligand, additional controls by endothelial cells themselves are 
thought to help maintain their survival (Mohan et al., 1997).
1.4.4 Eye bank storage technique as a factor of endothelial cell survival 
Various methods have been devised to prolong the viability of corneas 
destined for transplantation. Storage techniques preferred by eye banks in the 
United States differ from those in Europe. Organ preservation in Optisol-GS at
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4°C is the preferred method of corneal storage in the United States and at 
Moorfields Eye Hospital, UK. Other UK Eye Banks and European Eye Banks ^(W
tend to favour organ culture techniques in Chen’s media at 31-34 C. Both ^
storage techniques are designed to provide essential nutrients, stabilize 
metabolism and preserve cellular integrity of the cornea. Cell death in the 
endothelial cell layer is most important, as corneas with endothelium of
insufficient quality for transplantation are discarded. Falling endothelial cell -
©densities during storage accounts for approximately 30% of corneas being 
discarded from eye banks (Armitage and Easty, 1997). However, the integrity of 
the tight junction and actin cytoskeleton were found to be maintained in the 
corneal endothelium of organ cultured corneas for up to 3 weeks of storage 
(Crewe and Armitage, 2001). Cold storage (4°C) of corneas was found to 
increase the size of gaps in ZO-1 at the Y-junctions, however, this phenomenon 
was reversible with 24 hour incubation at 37°C (Hsu et al., 1999).
Despite attempts to maintain corneal tissue, cell viability has been found 
inversely correlate with storage time (Komuro et al., 1999). The gradual death of 
corneal cells during preservation may occur by two pathways: necrosis or 
apoptosis. Studies have suggested that apoptotic cell death occurs more often in t 
the corneal endothelial cell monolayer than necrotic death (Komuro et al., 1999;
Albon et al., 2000). The main distribution of apoptotic cells was found at the 
corneal folds, suggesting mechanic damage may affect corneal endothelial cell 
viability (Albon et al., 2000).
Corneal endothelial cell death in stored tissue may be the result of a number 
of factors. Bacterial contamination is a common problem in organ cultured
corneas (Albon et al., 2001). Both bacterial LPS and endotoxins were detected /Z)
iL>
in corneal culture media, which were found to enhance release of interleukin-6 
(IL-6) and IL-8. Both of these cytokines increased degenerative phenotypes and 
death in the corneal endothelium (Sobottka Ventura et al., 1997). The addition of 
pentoxifylline to organ culture media was found to suppress the release of IL-6 
and IL-8 and therefore increase corneal endothelial cell survival (Sobottka 
Ventura and Bohnke, 2001). Studies of corneal culture in serum-free media
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show that corneal endothelial cell survival is comparable to that in Chen’s media 
but with a lower risk of bacterial effects due to the lack of serum (Hempel et al., 
2001; Moller-Pedersen et al., 2001).
Finally, effects of cryopreservation of corneal tissue have been examined and 
preliminary reports suggest that it may be sufficiently tolerated by endothelium. If 
further research validates this storage practice, it would have significant appeal in 
eye banking (Brunette et al., 2001; Armitage et al., 2002).
1.4.5 Mechanisms of corneal endothelial cell death
The intracellular mechanisms which underlie corneal endothelial apoptosis 
are largely unknown, though a number of studies implicate caspase-3 in the 
signalling cascade to cell death (Thuret et al., 2003a; Thuret et al., 2003b; 
Bourges et al., 2004). Cleavage of PARP, a molecule typically responsible for 
DNA repair, was also shown to play a role in staurosporine-induced apoptosis 
(Thuret et al., 2003b). Apoptosis induced by reactive oxygen species, however, 
was found to involve translocation of transcription factor NF-kB to the nucleus 
(Cho et al., 1999). Similarly, apoptosis by inflammatory cytokines was 
demonstrated to involve sustained activation of NF-kB, p38 and STAT-1 and de 
novo generation of nitric oxide (NO) by the inducible nitric oxide synthase (iNOS) 
(Sagoo et al., 2004).
In contrast to these results, Bourges et al. (2004) demonstrated corneal 
endothelial cell apoptosis, during acute graft rejection, to be caspase-3 
independent and TUNEL negative, suggesting there may be additional 
mechanisms for activating apoptosis in the corneal endothelium. The cellular 
pathways which underlie the apoptotic response are still largely unclear and it 
may be that apoptosis resulting from different insults involve different cellular 
mechanisms, which terminate in the same response.
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1.5 Diseases of the corneal endothelium
Classification of primary corneal endotheliopathies indicates four diseases 
within this category. These are Fuchs’ dystrophy, posterior polymorphous 
dystrophy (PPD), congenital hereditary endothelial dystrophy (CHED), 
iridocorneal endothelial (ICE) syndrome and their intermediate forms.
Examination of patients with primary corneal endotheliopathies also reveals a 
number of individuals with features of more than one of these categories, or a 
few characteristics of a number of these primary diseases. These have been 
classed as intermediate types. It may, in the future, be possible to diagnose 
these patients through genetic testing as genetic studies have indicated shared 
mutations leading to both Fuchs’ and PPD, while other investigators have linked 
CHED to ICE syndrome (Biswas et al., 2001). Each of the four primary corneal 
endotheliopathies is discussed in further detail below.
1.5.1 Fuchs ’ dystrophy
Fuchs’ dystrophy is an autosomal dominant trait which results in bilateral, but 
asymmetrical, disease whereby the endothelial cells gradually malfunction. It is 
by far the most common primary corneal endothelial disease but shows variable 
expressivity. Fuchs’ dystrophy generally affects women more severely, and 
exhibits racial variation (Waring, III et al., 1982; Bourne, 2003). Typically, the 
disease becomes apparent in the later stages of life with the first changes 
appearing at middle age or later. There are three phases which characterize the 
clinical course of the disease, all of which begin at the centre of the cornea and 
progress toward the periphery over a period of 10 to 20 years (Waring, III et al., 
1982). The first phase of the disease is asymptomatic as the posterior cornea 
develops small guttate excrescences. Some pigment is phagocytosed by the 
endothelium, and Descemet’s membrane thickens to adopt a grey, uneven 
appearance. During the second stage, the patient experiences hazy visual acuity 
and glare as oedema develops. Increasing oedema results in water clefs within 
the stroma and within and beneath the epithelium. This oedema in turn leads to
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an increased corneal thickness, which may even reach 1mm, a doubling from 
normal thickness. The third phase is the most severe as vascular subepithelial 
connective tissue invades the central region, rendering it completely opaque 
(Bergmanson et al., 1999). It is the presence of increased numbers of corneal 
guttae accompanied by corneal oedema which constitute Fuchs’ dystrophy, with 
the corneal guttate forming the clinical hallmark of the disease (Waring, III et al., 
1982). These discrete excrescences laid down by the endothelium are also the 
most striking histopathologic features of Fuchs’ dystrophy. There are four 
patterns of excessive, abnormal matrix deposition; simple excrescences which 
protrude into the anterior chamber; multilaminar excrescences; excrescences 
buried in the multilaminar tissue and; multilaminar tissue without excrescences 
(Waring, III et al., 1982; Bergmanson et al., 1999). The excrescences, or warts, 
are most disruptive to the endothelial barrier as they interrupt the endothelial 
mosaic by pushing the endothelial nuclei into dumbbell or sickle shapes and 
thinning the overlying endothelial cells. The number of endothelial cells 
remaining is thought to be inversely proportional to the number of guttate 
excrescences (Waring, III et al., 1982; Borderie et al., 2000). The endothelial 
cells enlarge to fill the spaces left by cell death and can enlarge up to 1000pm2, 
two and a half times greater than normal 400pm2 cells (Waring, III et al., 1982; 
Bergmanson et al., 1999). This enlargement causes the cells to lose their 
characteristic hexagonal shape, but they maintain their covering. Remaining 
endothelial cells are often large and thin, with a shift in the uniform population of 
endothelium to a population containing cells with a dilated endoplasmic 
reticulum, in which can be found finely granulated material, phagocytosed 
pigment granules and increased cytolasmic filaments. This new cell population 
has been interpreted as endothelial cells which have differentiated to a 
fibroblastic phenotype and which may be responsible for the excretion of the 
posterior collagenous layer (Waring, III et al., 1982).
Recent genetic analyses have suggested a potential role for the extracellular 
matrix molecule type VIII collagen in Fuchs’ dystrophy, with a mutation in the a1
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chain of type VIII collagen linked to the disease (Biswas et al., 2001). Presently, 
the only effective treatment for Fuchs’ dystrophy is corneal transplantation.
1.5.2 Posterior polymorphous dystrophy (PPD)
Posterior polymorphous dystrophy (PPD) covers a spectrum of inherited 
bilateral disorders (Bourne, 2003). While normally inherited as an autosomal 
dominant trait with extremely variable expressivity, in some families these traits 
have been found to be inherited as autosomal recessive (Waring, III et al., 1982). 
Possible genetic loci affecting the inheritance PPD have been identified (Biswas 
et al., 2001; Shimizu et al., 2004). Similarly, while PPD is typically bilateral, it has 
also been found to be asymmetrical or unilateral, such that one cornea 
demonstrates advanced polymorphic changes while the other has only a small 
area of grouped vesicles (Waring, III et al., 1982; Anderson et al., 2001). 
Ultrastructural studies have shown a normal anterior banded fetal Descemet’s 
membrane but little or no posterior homogeneous Descemet’s membrane, 
suggesting abnormal endothelial function begins at or around the time of birth 
(Waring, III et al., 1982). Despite its suspected early onset, many patients 
remain asymptomatic and are only identified during routine ophthalmologic 
exams or during family studies. Rarely is there a large compromise in visual 
acuity, as stromal opacities and epithelial oedema are uncommon. Only 
occasionally does the disorder progress to a state of stromal oedema requiring 
corneal transplantation (Waring, III et al., 1982; Cockerham et al., 2002).
Changes associated with PPD are at the level of Descemet’s membrane with 
clusters of discrete vesicular lesions, with faint grey halos, larger blister-like 
lesions with denser halos, broad bands of matrix with ridges and sheets of 
irregular grey material that appear as beaten metal (Waring, III et al., 1982). The 
lesions are scattered randomly and vary from single discrete vesicles to total 
corneal opacity. The lesions are also regarded as distinct from the corneal 
guttata noted in Fuchs’ dystrophy (Waring, III et al., 1982; Cockerham et al.,
2002). Close examination of the posterior collagenous layers reveals a variety of 
morphologies. These layers constitute the lesions in Descemet’s membrane.
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Though termed vesicles, electron microscopy reveals these areas as 
depressions or pits (Waring, III et al., 1982).
Another of the distinguishing features of PPD is the presence of two distinct 
populations of cells. One population of cells resembles normal endothelial cells, 
albeit more pleomorphic and larger than average. The second cell population is 
found as clusters of epithelial like cells. Under specular microscopy, these 
abnormal cells show extreme pleomorphism, indistinct cell boundaries and in the 
area of the vesicular lesions, have the appearance of a bomb crater (Waring, III 
et al., 1982). Electron microscopy reveals microvilli, multilaminar stratification, 
desmosome junctions, minimal interdigitation of cell borders and sparse 
organelles. These cells also stain positively for human epidermal keratin, they 
may appear in isolated areas, across the entire endothelium or an intermediate 
between the two (Bourne, 2003). Extensive proliferation of the epithelial-like 
cells can, in severe cases, result in diffuse corneal oedema, peripheral anterior 
synechiae, glaucoma and a glassy membrane on the surface of the iris. 
Proliferation of this epithelial-like cell makes PPD similar to ICE syndrome, but 
can be distinguished by identification of discrete polymophic lesions in the 
posterior collagenous layer, observing the disease bilaterally and the 
identification of PPD in family members (Anderson et al., 2001).
1.5.3 Congenital hereditary endothelial dystrophy (CHED)
CHED is a corneal dystrophy characterised by diffuse bilateral corneal 
clouding resulting in impaired vision (Callaghan et al., 1999; Bourne, 2003). The 
cause of corneal oedema, resulting in corneal clouding, is severe endothelial 
dysfunction that begins relatively late in embryologic development. CHED is 
thought to arise as a result of mesenchymal dysgenesis (Waring, III et al., 1982). 
An autosomal recessive (AR) form is present at birth and is relatively stationary. 
AR CHED has been shown to be clinically and genetically distinct from the 
autosomal dominant (AD) variety, which develops in the first years and may 
progress to severe oedema (Callaghan et al., 1999). Stromal changes consistent 
with long-standing oedema are present in CHED with some cases showing
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greatly enlarged collagen fibrils in the stroma. Descemet’s membrane ranges in 
thickness from a complete absence to more than 40pm in width. Cases with thin 
or absent Descemet’s membrane suggest that complete endothelial dysfunction 
occurred in utero, such that only the fetal banded portion of Descemet’s 
membrane was secreted, whereas those with a thickened Descemet’s 
membrane suggest a persistent dystrophic endothelium that has secreted a 
posterior collagenous layer (Waring, III et al., 1982; Cockerham et al., 2002).
1.5.4 Iridocorneal endothelial (ICE) syndrome
There are three syndromes (essential iris atrophy, Chandler’s syndrome and 
Cogan-Reese iris nevus syndrome) that are now recognized to be varied 
manifestations of the same disorder known as iridocorneal endothelial (ICE) 
syndrome (Waring, III et al., 1982; Bourne, 2003). Typically unilateral, although 
occasionally bilateral, ICE syndrome appears to be acquired between the ages of 
30 and 50 years and tends to be more prevalent among women (Waring, III et 
al., 1982; Bourne, 2003). The appearance of the endothelial monolayer is greatly 
varied with cells showing a beaten metal appearance and many epithelial cell 
characteristics, including microvilli, expression of cytokeratin markers and 
decreased permeability to fluorescein (Levy et al., 1995; Levy et al., 1996;
Bourne, 2003). These epithelial-like cells also have opposite reflective properties 
to normal endothelium, with cell junctions appearing light and cell bodies dark. 
Corneal epithelial cells have these same reflective properties (Bourne, 2003; 
Grupcheva et al., 2004).
In most cases, the abnormal cells occupy only a portion of the cornea so that 
there is only partial coverage of the endothelial monolayer. Demarcation 
between the abnormal and normal cells is evident and it has been suggested that 
the abnormal cells are forcing the normal endothelium into smaller spaces, 
because the normal cells are smaller and at a higher density in the ICE cornea 
than in the normal cornea (Bourne, 2003; Grupcheva et al., 2004). The 
epithelial-like cells spread peripherally from the cornea to the iris to form a 
membrane across the anterior chamber angle, which can sometimes lead to a
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small bridging synechiae between the iris and the cornea (Waring, III et al., 1982; 
Bourne, 2003). These complications typically only occur in the more severe 
forms of the disease.
1.5.5 Secondary corneal endotheliopathies
There are a number of factors which can disrupt the corneal endothelium but 
are not classically disease. These include endothelial effects of contact lens 
wear and surgical procedures. Hypoxia resulting from contact lens wear is 
thought to be responsible for the resulting polymegathism and pleomorphism of 
the endothelial layer. However, studies have failed to detect reliable effects on 
mean endothelial cell size and barrier or pump function with long-term contact 
lens wear. The effects of two surgical procedures have also been well studied 
and shown to elicit changes in corneal endothelial cell densities. These are 
cataract extractions and penetrating keratoplasty (corneal transplantation).
Variable decreases in endothelial cell density are noted 1-5 days after 
cataract extraction, depending on trauma incurred during surgery. After initial 
cell loss, endothelial cell density continues to decrease at an accelerated rate up 
to four times greater than that in unoperated eyes, for at least 10 years (Ing et al., 
1998). The causes of accelerated density decrease are unknown but may relate 
to decreased nutrients from the aqueous humor, decreased innervation, 
increased subclinical inflammation and exposure to vitreous humor (Bourne,
2003).
During corneal transplantation, the central recipient cornea is replaced with 
that of an allogenic donor cornea. Immediately following transplantation, 
endothelial cell densities decrease by amounts that depend on method and 
duration of corneal storage and surgical trauma. This immediate cell loss is fairly 
rapid but gradually decreases over several years. 53% of the preoperative 
endothelial cell density was found to be lost by 3 years postop. Over this time, 
the endothelial cells spread from recipient to donor and vice versa to cover the 
cornea. As the transplanted corneas age and endothelial densities decrease, the 
donor cornea thickens.
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1.6 Corneal endothelial cell proliferation
Human corneal endothelial cells are remarkably resistant to proliferative 
stimuli, even when freed from the constraints of contact inhibition. The ability to 
drive human corneal endothelial cells into the cell cycle would raise the possibility 
of restoring corneal endothelial cell densities in patients in situ, and therefore 
have significant therapeutic potential.
1.6.1 Cell cycle
The cell cycle is composed of four phases: S-phase for DNA synthesis, M- 
phase for mitosis and two gap or growth phases G1 (prior to DNA synthesis) and 
G2 (before mitosis). In addition to these four phases, there is a resting phase 
termed GO, from which the cells can re-enter the cell cycle.
The cycle is regulated by a family of proteins known as cyclin-dependent 
kinases (CDKs), which are in turn regulated by a family of proteins known as 
cyclins. Different cyclin/CDK complexes are formed throughout the cell cycle as 
illustrated in Figure 1.6. In mammalian cells, mitogenic stimulation induces the 
synthesis of D-type cyclins, which are absent in GO cells. The first cyclin/CDK 
complex formed in the cell cycle is pairing of a D-type cyclin with CDK4 or CDK6 
(Hulleman and Boonstra, 2001; Zieske et al., 2004). As the cells progress 
through G1, cyclin E is synthesized and becomes associated with CDK2. This 
association is necessary for the transition from G1 to S-phase. As the cells 
progress to S-phase, cyclin E is degraded and CDK2 associates with cyclin A, 
the synthesis of which is initiated late in G1. Active cyclin A/CDK2 complex is 
required for the passage through S-phase, as it is responsible for the 
phosphorylation of a number of transcription factors and other proteins necessary 
for DNA synthesis (Hulleman and Boonstra, 2001; Zieske et al., 2004). Finally, 
cyclin A and cyclin B complex with CDK1. Both of these complexes appear to be 
necessary for the cell to complete mitosis. Cyclin A/CDK2 activity peaks in G2 
and is rapidly degraded in M phase, while cyclin B/CDK2 is required for S-phase
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mFigure 1.6: Representation of the cell cycle. The four phases of the cell cycle are the 
first growth phase (G1), DNA synthesis (S), second growth phase (G2) and mitosis (M). 
The G1 phase is contains the restriction point (R), beyond which the cell is committed to 
completing the cell cycle. Cyclin and cyclin dependent kinases (CDKs) associated with 
each of the stages of the cell cycle are illustrated at their approximate time of 
appearance. Additionally, some cells remain in a resting phase (GO), (adapted from: 
Zieske et al. 2004. Cell cycle regulators at the ocular surface. Exp. Eye Res. 78:449)
entry and exiting mitosis. There are also a number of additional cyclins and 
CDKs which play a lesser role in the regulation of the cell cycle (Hulleman and 
Boonstra, 2001; Zieske et al., 2004).
The decision to proliferate is made during the G1 phase of the cell cycle and 
is regulated by the cyclin D/CDK4(6) and cyclin E/CDK2 complexes. Mitogenic 
signals, including growth factors, trigger intracellular pathways to induce gene 
expression necessary for proliferation, including genes for cyclin D. Once 
expressed, cyclin D binds and activates CDK4(6), which phosphorylates target 
protein pRb. Resting cells contain a hypophosphorylated form of pRb that binds 
and inactivates transcription factor E2F (Joyce, 2003; Zieske et al., 2004). 
Phosphorylation of pRb, by the cyclin D/CDK4(6) complex, releases E2F, which 
stimulates a number of additional genes for DNA synthesis. One of these gene 
products is cyclin E, which binds to CDK2. The cyclin E/CDK2 complex also
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phosphorylates pRb leading to a cascade of events ending in S-phase (Joyce, 
2003; Zieske et al., 2004). Both cyclin D and E must reach critical mass before 
the cell enters S-phase. This point, which occurs late in G1, is also known as the 
restriction point and beyond this point, cells proceed through the remainder of the 
cell cycle (Zieske et al., 2004).
Both cyclin D and E have been noted to be present in normal corneal 
endothelium, suggesting that these cells are arrested in G1-phase rather than in 
the GO-phase (Joyce et al., 1996b). This suggested that corneal endothelial cells 
may be actively inhibited from proliferating rather than being non-proliferative due 
to a passive mechanism (Zieske et al., 2004). Additional studies of cell cycle 
proteins have revealed a number of insights as to the proliferative tendencies of 
different corneal endothelial cell populations. Mitogen-deprived or TGF-p treated 
cells were noted to have decreased levels of CDK4 compared to normal (Kim et 
al., 2001b). Conversely, SV40 transformed corneal endothelial cell lines showed 
elevated levels of CDK4 compared to normal (Schonthal et al., 1999). Inhibition 
of some protein kinase C isoforms was found to result in a decrease in levels of 
cyclin E, which corresponded with inhibition of corneal endothelial cell 
proliferation (Graham et al., 2000). Different localizations of cyclin E within the 
cell may also be responsible for differences in proliferative potential of rabbit and 
human corneal endothelium (Joyce et al., 1996b; Joyce, 2003).
In addition to positive regulatory factors, there are a number of CDK inhibitory 
proteins (OKI), which negatively regulate the cell cycle. There are two major 
families of CKI; INK4 and CIP/KIP. The INK4 family are selective inhibitors of 
CDK4 and CDK6, which act by binding the CDK subunit and prevent its 
association with cyclins (Zieske et al., 2004). Two of the INK4 family of 
inhibitors, p16INK4a and p15INK4b, have been localized to the corneal 
endothelium (Joyce et al., 1998) but were not found to have a direct role in the 
inhibition of proliferation in this tissue (Joyce et al., 2002). The CIP/KIP family of 
CKIs bind and inhibit the cyclin/CDK complexes involved in G1 and S-phase of 
the cell cycle. Of the three proteins making up this family, both p21cip1 and 
p27kip1 have been localized to the corneal endothelium. In many cell types,
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p27kip1 helps to maintain cell cycle arrest in response to cell-cell contact and 
TGF-p (Polyak et al., 1994). p27kip1 inhibits both the cyclin D/CDK4(6) and 
cyclin E/CDK2 complexes and is phosphorylated and consequently degraded by 
the end of G1, such that the cells may progress in the cell cycle (Pagano et al., 
1995; Morisaki et al., 1997). A number of recent studies have implicated p27kip1 
in maintaining the corneal endothelium in a non-proliferative state. Levels of 
p27kip1 were found to be lower than normal in SV40 transformed cells 
(Schonthal et al., 1999) and also in cells stimulated with FGF-2 (Lee and Kay, 
2003b). Conversely, p27kip1 was found to be upregulated when cells became 
contact inhibited and non-proliferative (Joyce et al., 2002).
1.6.2 Proliferative capacity of the corneal endothelium
Cell proliferation and migration of the neural crest-derived mesenchymal cells 
are responsible for the formation of the corneal endothelium. Proliferation of the 
presumptive endothelial cells ceases upon formation of cell contacts. 
Morphometric analyses of cell density provides evidence that, following 
monolayer formation, the human corneal endothelium does not replicate at a rate 
sufficient to replace dead or injured cells. Proliferation does not contribute 
significantly to cell density beyond the second trimester of gestation and it plays 
only a minor role in repair to the mature endothelial monolayer thereafter 
(Murphy et al., 1984). Instead, the corneal endothelium uses cell enlargement 
and migration as the major means of maintaining the monolayer. With injuries to 
small numbers of cells, healing involves enlargement of cells immediately 
adjacent to the wound site. Enlargement is initiated by membrane ruffling of the 
cells surrounding the wound area until they make contact with neighbouring cells. 
This mode of wound healing leads to a gradual flattening of the cells and the 
polymegathism and pleomorphism noted in aged and diseased endothelial 
monolayers (Sherrard, 1976). Repair of larger wounds occurs in a similar 
manner with a coordinated enlargement of cells adjacent to the wound, and also 
those cells a few rows behind the wound edge. These cells enlarge and migrate 
to cover the wound area without losing contact with neighbouring cells (Honda et
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al., 1982; Schilling-Schon et al., 2000). This form of repair has been designated 
monolayer spreading (Joyce et al., 1990).
Due to the minor role played by proliferation in the wound healing response, it 
was suggested that corneal endothelial cells may lack proliferative capacity. 
Transformation with viral oncogenes to induce proliferation provides evidence 
that these cells do have proliferative capacity. Both the SV40 large-T antigen 
and E6/E7, from human papilloma virus, have been transformed into human (J3
corneal endothelial cultures to produce immortalized cells. With large numbers 
of population doublings, these cells retain normal morphologic characteristics 
and do not develop a senescent phenotype like untransfected cells (Feldman et 
al., 1993; Wilson et al., 1995; Bednarz et al., 2000). Further study of these cell 
lines revealed that populations of endothelial cells transformed with the E6/E7 
proto-oncogene showed decreased telomere lengths but increased proliferation, 
with respect to normal cell populations (Egan et al., 1998). Telomere lengths of 
endothelial cells were also, on average, longer than those in corneal epithelial 
cells, which are known to be highly proliferative (Egan et al., 1998). Shortened 
telomere lengths can therefore not explain the lack of proliferation in corneal 
endothelial cells. The telomerase activity in corneal endothelial cells, however, 
may be insightful, since it is negligible in the corneal endothelium, with only low 
levels noted in peripheral cells (Egan et al., 1998).
The extent to which the corneal endothelium is likely to proliferate also 
appears to vary between species. In vivo, cell densities appear to decrease 
similarly with ag# however, bovine, rabbit and rat endothelium have been found 
to proliferate readily in culture, whereas cat, monkey and human do not 
(Faragher et al., 1997; Joyce, 2003). Joyce et al. (1996) investigated the 
localization of various cell cycle proteins in both the highly proliferative rabbit 
corneal endothelium as well as the non-proliferative human corneal endothelium.
It was found that the localization of all cyclins and cyclin dependent kinases 
(CDK) were the same with the exception of cyclin E, which was found in the 
nucleus of human corneal endothelial cells, but in the cytoplasm of rabbit corneal 
endothelial cells (Joyce et al., 1996a; Joyce et al., 1996b). Levels of CDK
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inhibitors (CKI), p21cip1 and p27kip1, were also found to be lower in rabbit 
endothelium than in human endothelium (Schonthal et al., 1999). These results 
suggest that the mechanisms that regulate cell proliferation are controlled in 
different ways between species.
1.6.3 Age-related differences in proliferative capacity
Preliminary attempts to culture corneal endothelial cells revealed that cells 
derived from older donor tissue were more difficult to culture. Samples et al. 
(1991) noted human corneal endothelial cells from donors 20 years of age or 
younger showed a greater propensity to grow than those from older donors. 
Tritiated thymidine incorporation studies, used to quantify the proliferative 
response to wounding in young and old corneas, indicated that the younger 
specimens showed more proliferation (Simonsen et al., 1981). Proliferative 
capacity, however, was shown to be retained regardless of age with a modest 
degree of proliferation also occurring in an 89 year old donor (Simonsen et al., 
1981). Further studies indicated that some of these differences may be related 
to the kinetics of cell cycle progression. Cells from older donors were found to 
enter the cell cycle more slowly than those from younger donors. It has also 
been suggested that a stronger mitogenic stimulus is required to induce cell 
proliferation in older donors (Senoo and Joyce, 2000).
1.6.4 Signals affecting proliferation in the corneal endothelium
There are a number of positive and negative regulatory factors which 
influence corneal endothelial cell proliferation, including the presence or absence 
of growth factors, cell contact and extracellular matrix. The combination of 
factors present at any time may determine the likelihood of the cell to proliferate. 
By understanding these mechanisms, it is hoped that we may be able to 
overcome the non-proliferative nature of the corneal endothelium.
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1.6.4.1 Growth factors induce corneal endothelial cell proliferation
In vivo, the corneal endothelium is known to be bathed in aqueous humor 
containing a number of growth factors. These include fibroblast growth factor 
(FGF), epidermal growth factor (EGF), transforming growth factor p (TGF-p), 
insulin-like growth factor-l and -II (IGF-I and -II) and hepatocyte growth factor 
(HGF) (Joyce, 2003). In addition to those growth factors found in the aqueous 
humor, mRNAs for a number of growth factors and their receptors are expressed 
in corneal endothelial cells (Wilson and Lloyd, 1991). Expression of these 
mRNAs was found to be decreased in cultures with large numbers of cells with 
senescent morphology, as compared to proliferative populations (Wilson and 
Lloyd, 1991). It is thought that these growth factors may act in an autocrine or 
paracrine fashion to induce proliferation. The most extensively studied of these 
is basic FGF (FGF-2), which has been reported to be synthesized by the 
endothelium and deposited into Descemet’s membrane through binding the 
heparan sulphate proteoglycan (Rieck et al., 1995). While some isoforms of 
FGF-2 remain unsecreted, the bioactive 18kDa FGF-2 isoform was found to be 
deposited in Descemet’s membrane (Gu and Kay, 1998).
The FGFs belong to a family of multifunctional growth modulating peptides 
consisting of at least nine members. FGF-2 is one of the prototypic members of 
this family and is 10 to 100 fold more potent than FGF-1 in the eye 
(Gospodarowicz et al., 1977; Mason, 1994). One of the main features of FGFs is 
their high affinity for heparin. FGF also has a high affinity for its cell surface 
receptor, which is a single chain transmembrane glycoprotein containing a 
phosphotyrosine kinase (PTK) domain. Binding of FGF to its receptor has been 
found to trigger cell shape changes, mitosis and chemotaxis in the corneal 
endothelium of a number of species (Gospodarowicz et al., 1977; Landshman et 
al., 1987; Dabin and Courtois, 1991; Rieck et al., 1992; Grant et al., 1992; Woost 
et al., 1992; Hoppenreijs et al., 1994a; Rieck et al., 1995; Gualandris et al., 1996; 
Gu and Kay, 1998; Schilling-Schon et al., 2000; Imanishi et al., 2000).
Similar to FGF-2, the proliferative response of the endothelium to EGF has 
also been extensively studied. EGF is known to have a number of biological
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activities, both mitogenic and non-mitogenic in nature. Its biological activities are 
regulated by binding to the EGF receptor, which belongs to PTK subclass I. 
Expression of EGF receptor mRNA was found in both proliferative and senescent 
culture^however, the level of mRNA coding for EGF was decreased in (jJ)
senescent cells, suggesting an autocrine down-regulation (Wilson and Lloyd,
1991). Studies in numerous species have shown that while EGF is capable of 
inducing corneal endothelial cell proliferation in a variety of settings, the 
proliferative response to EGF is minimal (Gospodarowicz et al., 1977; Raymond 
et al., 1986; Couch et al., 1987; Brogdon et al., 1989; Lee et al., 1991; Samples 
et al., 1991; Grant et al., 1992; Hoppenreijs et al., 1992; Schultz et al., 1992;
Woost et al., 1992; Raphael et al., 1993; Joyce et al., 1995; Imanishi et al., 2000; 
Mitsumoto et al., 2001).
In addition to EGF and FGF-2, the effects of a number of additional growth 
factors have been investigated, albeit less extensively. These growth factors 
include insulin (Schultz et al., 1992; Woost et al., 1992), insulin-like growth factor- 
1 (IGF-1) (Woost et al., 1992; Choi et al., 1995; Imanishi et al., 2000), 
hepatocyte growth factor (HGF) (Hoppenreijs et al., 1996; Imanishi et al., 2000; 
Mitsumoto et al., 2001), platelet derived growth factor (PDGF) (Hoppenreijs et al., 
1994b; Kamiyama et al., 1995; Imanishi et al., 2000) and transforming growth 
factor-p (TGF-p) (Grant et al., 1992; Gipson and Inatomi, 1995; Imanishi et al.,
2000; Chen et al., 2002). The most interesting of these is TGF-p, which has 
been noted to inhibit the G1/S phase transition in some cell types (Polyak et al., 
1994). In order for TGF-p to exert an effect, both TGF-p receptor types I and II 
must be expressed (Wrana et al., 1994). Binding of ligand to TGF-p receptor II 
recruits TGF-p receptor I to form a complex, which then stimulates 
phosphorylation and intracellular signalling. Another receptor subtype, TGF-p 
receptor III, is not thought to participate directly in signal transduction but 
cooperates with the other receptor subtypes for signalling by TGF-P2, which 
otherwise has a low affinity for TGF-p receptor II. TGF-pi was reported to be 
expressed by human corneal endothelium and TGF-p2 is known to be present in 
relatively high concentrations in aqueous humor (Cousins et al., 1991). RT-PCR
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also demonstrated that all three TGF-p receptor subtypes are expressed in 
human (Joyce and Zieske, 1997) and rabbit corneal endothelial cultures (Harris 
and Joyce, 1999). Proliferation studies using TGF-p1 and TGF-p2 showed that 
both isoforms suppress proliferation in serum and FGF-stimulated cells (Chen et 
al., 1999; Harris and Joyce, 1999). Aqueous humor, at a dilution 1/10, showed a 
similar inhibition of proliferation, which was obliterated by pre-treatment with anti- 
TGF-p2 antibodies (Chen et al., 1999). These data suggest that, under normal 
conditions, TGF-p1, acting in autocrine/paracrine manner, and TGF-p2, from the 
aqueous humor, may be partially responsible for maintaining the G1-phase arrest 
of corneal endothelial cells (Joyce, 2003). Part of these actions may be due to 
effects of TGF-p on a cell cycle inhibitor, p27kip1 (Kim et al., 2001a; Kim et al., 
2001b).
1.6.4.2 Cell contact
Contact-dependent inhibition of proliferation is common in many cell types. 
High cell densities induce cell cycle arrest even in the presence of mitogenic 
factors (Kato et al., 1997). Compelling evidence from a number of studies have 
shown that stable cell-cell contacts modulate gene expression, cell proliferation 
and differentiation (Matter and Baida, 2003). While the details remain unclear, 
expression levels of tight junction proteins, like ZO-1 have been shown to 
increase in cells at high density (Baida et al., 2003). Similarly, overexpression of 
ZO-1 in subconfluent cultures inhibits proliferation (Matter and Baida, 2003). The 
transcription factors ZONAB and CDK4 become sequestered at TJ in confluent 
cultures, thereby inhibiting their actions (Baida and Matter, 2000).
As maintenance of cell contact is vital to the functions of the corneal 
endothelial monolayer, it seems likely that cell-cell contact within the monolayer 
may play a role in establishing cell cycle arrest. Evidence in support of this 
hypothesis was first discovered in wound healing models, which showed small 
numbers of proliferating cells at the edge of the wound, following growth factor 
treatment. Cells distal to the wound, however, did not proliferate with the same 
treatment (Landshman et al., 1989; Huang et al., 1989; Hoppenreijs et al., 1992;
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Hoppenreijs et al., 1994a; Hoppenreijs et al., 1994b; Petroll et al., 1995; Imanishi 
et al., 2000). Since the exposure of both cell populations to mitogen was similar, 
it is hypothesized that the difference in proliferation between cells at the wound 
edge and those distal to the wound was due to the lack of cell contact of cells at 
the wound edge. Additionally, releasing cell contacts, with the use of calcium 
chelators, and treatment with growth factors, was found to induce cell 
proliferation in a proportion of endothelial cells on the cornea, while treatment 
with growth factor alone did not (Senoo et al., 2000). These results further 
support the idea that cell contact plays an important role in maintaining cell cycle 
arrest of the corneal endothelium.
1.6.4.3 Extracellular matrix
The extracellular matrix (ECM) produced by cells is their natural substrate 
upon which to migrate, proliferate and differentiate in vivo. The importance of the 
ECM for normal growth and development in vivo is well established. The 
components of the corneal endothelial cell matrix, Descemet’s membrane, are 
extensive and include matrix proteins, glycosaminoside and growth factors. All 
or some of these may contribute to the inhibition of proliferation in the corneal 
endothelium. Cancer cell lines seeded onto matrix generated by bovine corneal 
endothelial cells generated contact-inhibited monolayers with a regular 
morphology and appearance, supporting the idea that ECM plays a role in the 
regulation of the corneal endothelial monolayer (Fridman et al., 1985). In 
addition, alterations in matrix expression during injury or wound healing suggest 
that matrix proteins play a role in migration or proliferation (Ohkoshi et al., 1989). 
Expression of fibronectin by corneal endothelial cells was found to decrease with 
injury (Kenney et al., 1986), whereas expression of type I collagen was induced 
by polymorphonuclear cells, present during inflammatory responses (Kay et al., 
1985). In addition, both TGF-(31 and TGF-p2, known to regulate the cell cycle, 
were shown to induce up regulation of fibronectin and laminin (Usui et al., 1998). 
A number of studies have also examined the effects of matrix proteins on the 
proliferative response. Increased proliferation of human and rabbit corneal
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endothelial cells cultured on bovine corneal endothelial cell matrix was observed 
(Gospodarowicz and III, 1980; Blake et al., 1997) and, in some cases, the 
addition of growth factors produced further proliferative effects. Thus, the 
proliferative response of rabbit corneal endothelial cells was unaffected by FGF-2 
(Gospodarowicz and III, 1980), whereas that of human corneal endothelium was 
enhanced by keratinocyte growth factor (KGF) or endothelial cell growth 
supplement, but unaffected by EGF or HGF (Blake et al., 1997). The 
proliferation of bovine corneal endothelial cells cultured on various matrices 
demonstrated the greatest response on fibronectin > laminin > tissue culture 
plastic > type I collagen > type IV collagen. The overall surface area covered by 
cells on these matrices, however, was found to be greatest for cultures grown on 
type IV collagen > type I collagen » fibronectin > laminin > tissue culture plastic, 
with type IV and type I collagen showing the largest number of giant cells 
(Mitsumoto et al., 2001). These results suggest that different matrices may aid in 
the maintenance of the monolayer by enhancing either cell proliferation or cell 
spreading. The primary wound healing response of cell spreading may be 
partially explained by the fact that Descemet’s membrane is primarily composed 
of type IV collagen. The proliferation of cells cultured on type IV collagen, 
however, was shown to be greatly enhanced with growth factor stimulation. Both 
EGF and HGF enhanced the proliferative response of cells cultured on type IV 
collagen, while treatment with TGF-p 1, greatly decreased proliferation 
(Mitsumoto et al., 2001).
Despite the species-specific differences in these observations, the picture that 
emerges is one in which a combination of growth factors, extracellular matrix and 
cell contact all contribute to the proliferative response of the corneal endothelium 
in situ.
1.6.5 Intracellular signalling
In order to understand the reasons why the corneal endothelium remains in 
its non-proliferative state, studies have attempted to dissect signalling pathways 
that might overcome the mitotic block and lead to corneal endothelial cell
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proliferation. The proliferative response of rabbit corneal endothelium is the best 
studied of all species. Lee et al. (2004) suggest that FGF-2 is responsible for the 
endothelial mesenchymal transformation. This proposed transformation involves 
not only proliferation but also cell shape changes and altered collagen 
expression. Prolonged and continuous exposure to FGF-2, for a period of at 
least 16 hours, was shown to increase rabbit corneal endothelial cell proliferation 
by approximately 60% (Kay et al., 1993; Kay et al., 1994). Initial studies 
suggested phospholipase Cy1 (PLCyl) signalling to be important, with antisense 
oligonucleotides able to inhibit basal levels of proliferation by 25% (Gu et al., 
1996). Further studies, however, indicated that the effects of PLCyl may be 
more related to changes in cell shape, than the proliferative response (Kay and 
Oh, 1988; Gu et al., 1996; Kay et al., 1998). Kay et al. (1998) showed that the 
SH2 domains of PLCyl bind the FGF receptor, while the SH3 domain of PLCyl 
targets the cytoskeletal protein vinculin, bringing the two together. Antisense 
oligonucleotides generated against PLCyl, however, could not override the 
mitogenic actions of FGF-2, suggesting that this may not be a major intracellular 
pathway involved in the mitogenic actions of FGF-2 (Gu et al., 1996). More 
recent studies have shown the phosphotidylinositol 3- kinase (PI3 kinase) 
pathway to be vital for FGF-2 mediated proliferation and migration (Kay et al., 
1998; Rieck et al., 2001; Lee and Kay, 2003b; Lee et al., 2004). The selective 
PI3 kinase inhibitor, LY294002, completely blocked the proliferative response of 
rabbit corneal endothelial cells to FGF-2. Additionally, FGF-2 was shown to 
activate the PI3 kinase pathway with induction of phosphatidylinositol-3- 
phosphate (PI3P) and phosphorylation of Akt, two major downstream targets of 
PI3 kinase (Lee and Kay, 2003b). Lee et al. (2003) also found that treatment 
with FGF-2 increased protein levels and nuclear translocation of CDK4, 
indicating entry into the cell cycle. Consistent with this, levels of p27Kip1 were 
decreased due to increased phosphorylation and degradation of the protein 
following treatment with FGF-2 (Lee and Kay, 2003b). Antisense 
oligonucleotides targeting p27Kip1 have been shown to induce rat corneal 
endothelial cell cultures to proliferate (Kikuchi et al., 2004). p27Kip1 is also
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thought to play a role in mediation of cell cycle arrest during the maturation of the 
endothelial monolayer (Joyce et al., 1998). Further studies in rat corneal 
endothelium suggest that protein kinase C (PKC) plays a role in serum-induced 
proliferation, as PKC inhibitors, and antisense targeting PKCa, significantly 
reduced proliferation and levels of cyclin E (Graham et al., 2000).
Studies of bovine corneal endothelium indicate that Ras may also play an 
important role in the proliferative response (Sosnowski et al., 1993). Activation of 
GTPases such as Ras, by FGF-2, was found to lead to changes in the F-actin 
cytoskeleton. FGF-2 treatment induced a phenotype with abundant stress fibres 
(Lee and Kay, 2003a). Disruption of cytoskeletal organization may aid 
proliferation, as disruption of microfilaments has been shown to induce mitosis in 
corneal endothelial monolayers (Gordon, 2002). Serum-induced proliferation 
was also found to increase the expression of immediate early genes c-fos 
(Feldman et al., 1992) and c-jun (Nguyen et al., 1994).
1.7 Project aims
Human corneal tissue that cannot be used for transplantation makes up the 
tissue available for research. While the annual number of corneal grafts in the 
UK has remained fairly constant over the past decade, the number of corneas 
donated to UK Eye Banks has been in slow decline (Figure 1.7). The small 
number of corneas available for research has necessitated the development of 
animal models of the human corneal endothelium. Currently, the most commonly 
used models include rat, rabbit and bovine corneal endothelium, all of which are 
known to be highly proliferative. Among the primary goals of this project was the 
development of a more reliable model for the human corneal endothelium. The 
culture of primary mouse corneal endothelium has been previously explored and 
SV40 transformed cell lines have been established (Joo et al., 1994). The 
methodology described by Joo et al. (1994) for the culture of mouse corneal 
endothelium relies on difficult microdissection techniques and descriptions of 
primary mouse corneal endothelial cell cultures are almost non-existent.
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Figure 1.7 Numbers of corneas donated and corneas grafted in the UK from April 
1993 -  March 2003. While the numbers of corneas grafted each year has remained 
fairly constant, the numbers of corneas donated has been slowly decreasing, (from: 
Transplant activity in the UK 2002-2003, NHS UK Transplant)
One study revealed a similar propensity of both primary and SV40 transformed 
mouse corneal endothelial cells to adhere to Descemet’s membrane and similar 
levels of EGF receptor and PDGF receptor expression (Joo et al., 1994).
Primary mouse corneal endothelial cell cultures were also reported to stop 
proliferating by the third passage (Joo et al., 1994). Given these details, our goal 
was to establish a novel, simpler method of primary mouse corneal endothelial 
cell culture, which would yield reproducible and sufficiently pure cultures for 
research. Further characterisation of primary mouse cultures would then allow 
for meaningful comparisons between mouse and human corneal endothelium, 
and determine whether mouse cultures provide an appropriate model of the 
human endothelium. In addition, the culture of mouse corneal endothelial cells 
would open up the possibility of using the numerous transgenic and knockout 
strains of mice available to investigate corneal endothelial cell biology. 
Characterisation of the primary mouse corneal endothelial cell cultures would
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involve localization of junctional proteins, expression of various apoptotic 
markers, mitochondrial morphology changes during apoptosis and proliferative 
responses and ERK 1/2 activation in response to growth factors EGF, FGF-2 and 
PDGF BB.
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Chapter 2: Materials and Methods
2.1 Tissue Culture of Mouse Corneal Endothelial Cell Line
Immortalized mouse corneal endothelial cells were a gift from Dr. J. Wayne 
Streilein (Schepens Eye Research Institute, Boston). Cells were maintained in 
Minimum Essential Media with Earle’s salts (Life Technologies) containing 10% 
fetal bovine serum (Life Technologies), 2mM L-glutamine (Life Technologies),
1% penicillin/streptomycin (Life Technologies), 1mM sodium pyruvate (Life 
Technologies) and 1% MEM vitamin solution (Life Technologies) at 37°C and 5% 
CO2. Cells were split 1 in 5 at confluence, approximately every 3 to 5 days.
2.2 Primary Mouse Corneal Endothelial Cell Culture
The outer surfaces of mouse corneas were covered with 70% ethanol and the 
epithelial cell layers were scraped off using a razor blade. Eyes were enucleated 
from the mouse and washed for approximately 1 minute in povidone iodine, then 
dipped in 70% ethanol before dissecting the cornea from the eye in PBS. 
Corneas, free of epithelium, were placed endothelium side down onto tissue 
culture dishes. Approximately 5 drops of tissue culture media were carefully 
placed on top of each cornea. Corneas were incubated at 37°C and 5% C 02 
overnight to allow the endothelial cells to attach to the tissue culture dish. The 
following day, 1ml of culture media was slowly added to each cornea.
Endothelial cell proliferation and migration from the cornea onto the tissue culture 
dish was monitored daily by microscopy (Figure 2.1 A). Corneas were removed 
from the tissue culture dish after approximately 3 to 7 days in culture, dependent 
upon the rate of migration and proliferation of corneal endothelial cells onto 
tissue culture dishes. Growing cell populations were also monitored to ensure 
homogeneous cultures of corneal endothelial cells free of keratocytes. Following 
removal of corneas, endothelial cells were maintained at 37°C and 5% C 02 for at 
least 2 weeks before use (Figure 2.1 B). During this time, the tissue culture
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media was changed approximately every 4 days. Culture media used for primary 
corneal endothelial cell culture was the same as that used for the SV40 
transformed mouse corneal endothelial cell line.
Figure 2.1: Primary mouse corneal endothelial cell culture. (A) Cornea placed 
endothelial side down to allow the endothelial cells to migrate out onto tissue culture 
plastic. (B) Once the cornea is removed, endothelial cells are allowed to proliferate to 
form a monolayer with classic hexagonal shape.
2.3 Primary Human Corneal Endothelial Cell Culture
Human corneal tissue was obtained from the eye banks in Moorfields Eye 
Hospital and CTS Eye Bank, Bristol. Tissue from Moorfields Eye Hospital had 
been maintained in Optisol-GS at 4°C for at most 2 weeks, while tissue from 
Bristol was organ cultured at 34°C in Chen’s media according to EU regulations 
for at most 4 weeks. Irrespective of storage conditions, the corneas were 
transferred to Media 199 for at least an hour prior to dissection. For dissection, 
the cornea was placed on a 10 cm dish and Descemet’s membrane was slowly 
peeled away from the corneal stroma. Pieces of Descemet’s membrane, 
containing corneal endothelial cells, were placed in 1 ml of 0.02% EDTA solution 
and incubated for 1-2 hours at 37°C. Following incubation, the solution was 
triturated at least 50 times in a flame polished glass pipette. Cells were pelleted 
by centrifugation at 1000g for 5 minutes. Without disturbing the cell pellet, the 
EDTA solution was removed and cells were resuspended in 500 pi of growth 
media (Optimem-I media (Invitrogen) containing 10% FCS (Invitrogen), 200 
pg/ml CaCb (Sigma), 0.08% chondroitin sulfate (Sigma), 20 pg/ml ascorbic acid
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(Sigma), 1/100 multiple vitamin solution (Invitrogen), 1/200 gentamicin 
(Invitrogen), 1/100 antibiotic/antimycotic solution (Invitrogen), 50 mg pituitary 
extract (Biogenesis), 5 ng/ml EGF (CN Bioscience) and 20 ng/ml NGF 
(Biogenesis)). Cells were again titurated at least 50 times in a flame polished 
glass pipette before plating onto dishes pre-coated with FNC coating (Athena 
ES). Cells were allowed to adhere to the culture dish and proliferate for 
approximately 1 week before the first media change. Cells were maintained at 
37°C and 5% CO2 and split 1 in 2 when confluent.
2.4 Reverse Transcriptase Polymerase Chain Reaction
2.4.1 Extraction of total RNA
Confluent 10 cm dishes of cells were used to extract RNA. Total RNA was 
extracted from corneal endothelial cells using the RNeasy kit according to the 
manufacturers instructions (Qiagen). Briefly, tissue culture media was discarded 
and dishes were placed on ice. 500pL of buffer RLT was added to each dish.
Cell scrapers were used to remove all the cellular debris and the lysate was 
passed through a 21 gauge needle at least 5 times to shear the DNA. 1 volume 
(500 pi) of 70% ethanol was added to the homogenized lysate, and samples 
were mixed by pipetting up and down. 700 jul of lysate was added to an RNeasy 
mini spin column in a 2 ml collection tube. Tubes were pulse spun for 
approximately 30 seconds at 4°C, and flow-through was discarded. 700 pi of 
wash buffer RW1 was added to the RNeasy mini spin column. Following a pulse 
spin at 4°C, the collection tube and flow-through were discarded, and the 
RNeasy mini spin column was transferred to a new collection tube. 500 pi of 
buffer RPE was added to the spin column, and flow-through was discarded 
following a pulse spin at 4°C. A final wash of 500 pi of buffer RPE was added to 
the spin column, and the column was centrifuged at full speed for 2 minutes at 
4°C to dry the membrane. Flow through was discarded and the empty spin 
column was cold centrifuged at full speed for 1 minute. The RNeasy mini spin 
column was then added to a 1.5 ml collection tube and 50 pi of RNase-free water
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was added directly to the membrane. The column was cold centrifuged again at 
full speed for 1 minute to elute RNA. The concentration of RNA obtained was 
determined using an Eppendorf BioPhotometer.
2.4.2 Generation of cDNA
Generation of cDNA from total RNA was accomplished using the ProSTAR 
First-Strand RT-PCR kit (Stratagene). 10 pg of total RNA was used for each 
reaction. RNA was diluted to a final volume of 38 pi with DEPC-treated water. 3 
pi of random primers (100 ng/ml) was added to each of the reactions. Reactions 
were mixed gently before incubation at 65°C for 5 minutes, followed by slow 
cooling to room temperature (approximately 10 minutes), to allow annealing of 
primers to RNA. For first strand synthesis, the following components were added 
to each reaction in order:
5 pi of 10x first strand buffer
1 pi of RNase Block Ribonuclease inhibitor (40 U/pl)
2 pi of 100 mM dNTPs (mix of all 4)
1 pi of StrataScript reverse transcriptase (50 U/pl)
Reactions were gently mixed and incubated at 42°C for 1 hour, followed by 
incubation at 90°C for 5 minutes. Completed first strand cDNA reactions were 
placed on ice for immediate use in PCR reaction or kept at -20°C for storage.
2.4.3 Polymerase Chain Reaction
Different annealing temperatures and elongation temperatures, as well as 
different primers, were used for different PCR reactions. Primers were designed 
for PCR amplification of a1 type VIII collagen in mouse and human corneal 
endothelial cell cultures. Primers targeting the p-actin sequence were used as a 
positive control. While these primers were designed to target the human p-actin
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sequence, there was minimal mismatch of base pairs, such that the primers were 
also suitable for the mouse p-actin sequence.
Mouse type VIII collagen
COL8A1_forward 5’ -  cca gga cct cat gga ctt cc -  3’
COL8A1_reverse 5’ -  etc ggc cca aga acc cca gg -  3’
Human type VIII collagen
COL8A1_forward 5’ -  gtt cca tea ggc tea ttc ag -  3’
COL8A1_reverse 5’ -  tcc ttt tgc ccc agg cat -  3’
p-actin
bact_forward 5’ -  taa gga gaa get gtg eta eg -  3’
bact_reverse 5’ -  ggc agt gat etc ctt ctg c -  3’
* highlighted, bold bases are those that differ between the human and mouse p- 
actin sequence
2.5 Immunofluorescence staining
2.5.1 Methanol fixation of cells
Cells were incubated on ice for 3 minutes. Cell culture medium was removed 
and cold methanol was added to fix the cells. Dishes of cells were incubated at - 
20°C for approximately 5 minutes. Cells were placed back on ice as the 
methanol was removed. Room temperature phosphate buffered saline (PBS) 
was added to rehydrate the cells. Cells were incubated in PBS at room 
temperature for approximately 5 minutes. Following rehydration, cells were 
incubated in a blocking solution containing 2% BSA in PBS, for approximately 30 
minutes at room temperature.
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2.5.2 Methanol fixation of whole corneal tissue
Corneas were fixed in cold methanol for 10 minutes at -20°C. Rehydration of 
the tissue using PBS was accomplished with 3 washes of 10 minutes each, at 
room temperature. Overnight treatment with 1% Triton-X100 solution in PBS 
was used to permeabilize the tissue, followed by an hour incubation in blocking 
solution, containing 4% BSA and 1% Triton-X100 in PBS.
2.5.3 Paraformaldehyde fixation of cells
Culture medium was removed and cells were treated with 3% 
paraformaldehyde solution for 15-30 minutes at room temperature. PBS was 
used to wash remaining paraformaldehyde from the cells prior to blocking with 
2% BSA in PBS for approximately 30 minutes at room temperature.
2.5.3 Staining and Imaging
After blocking, primary antibody was used to target the proteins of interest. 
Dilutions of primary antibodies were routinely made in blocking solution. A list of 
antibodies used, the dilutions of antibody and sources of antibodies are listed in 
Table 2.1. Cells were treated with primary antibody for approximately 1-2 hours 
at room temperature. Following incubation with primary antibody, cells were 
washed 3 times with PBS before incubation with secondary antibody. For whole 
tissue staining, each wash was at least 10 minutes duration. Whole tissue 
staining also required another 10 minute treatment in block solution prior to 
secondary antibody. All secondary antibodies were used at a 1/500 dilution in 
PBS and incubated with the cells for at least an hour at room temperature. All 
secondary antibodies were coupled to Alexa fluorophores (Molecular Probes). In 
addition to secondary antibodies, occasionally a nuclear stain or actin stain would 
also be added to the cells during incubation with secondary antibody. Nuclear 
stains used included propidium iodide (Sigma, 5 mg/ml) used at 1/2000 dilution, 
To-Pro-3 (Molecular Probes, 1 mM) used at 1/500 dilution or DAPI (Sigma, 5 
mg/ml) used at 1/100. Rhodamine phalloidin (Molecular Probes) was used at a 
dilution of 1/60 to stain actin.
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Following treatment with secondary antibody, cells were washed 3 times with 
PBS and mounted with Vectashield (Vector Labs). Each wash for whole tissue 
samples was at least 10 minutes duration. Typically, staining of cells was 
imaged immediately using a confocal fluorescence microscope (Zeiss, Axiovert 
S100 TV) equipped with a Ne, He laser and software (Lasersharp 2000). 
Staining of whole tissue was imaged the following day using a confocal 
fluorescence microscope (Leica DMIRE2, sp2AOBS) with software (LCS version 
2.v).
Table 2.1 List of primary antibodies used for immunofluorescence staining.
Antibody target Species Dilution Source
Antibody 9.3E Mouse 1/100 Dr. J. Bednarz
Claudin-1 rabbit 15 pg/ml Zymed
Lamin B goat 1/50 Santa Cruz
Occludin mouse 1/200 Zymed
Pan-cadherin rabbit 1/300 Sigma
PAR-3 rabbit 1/100 Zymed
Paxillin rabbit 1/60 Santa Cruz
Phospho-ERK mouse 1/1000 Sigma
ZO-1 mouse 20 ng/ml Zymed
ZO-1 rabbit 1/400 Dr. Karl Matter
ZO-2 rabbit 1/500 Dr. Karl Matter
2.6 Live cell imaging using confocal microscopy
Live cell imaging was used to image mitochondrial morphology changes 
during staurosporine induced apoptosis. Cells were loaded with 300 nM 
Mitotracker Red (Molecular Probes) in growth media at 37°C for approximately 
10 minutes. Once loaded, cells were washed twice in PBS and maintained in 
MEM with Earle’s salts without phenol red (Life Technologies). Apoptosis was 
induced with 200 nM staurosporine in primary cells and 500 nM staurosporine in
78
the cell line. Images were captured approximately every 10 minutes to examine 
changes in mitochondrial morphology. Images were captured using a confocal 
fluorescence microscope (Zeiss, Axiovert S100 TV) equipped with a He laser and 
software (Lasersharp 2000).
2.7 Western blotting
Cultured cells were treated with growth factors, inhibitors or left untreated 
before lysing cells. Lysates were made using a 2x reducing sample buffer (125 
mM Tris pH 8.0, 20% glycerol, 2% SDS and 350 mM DTT). Samples were 
forced through a 21G needle and heated to 95°C for at least 5 minutes before 
loading onto a 10% SDS-PAGE gel. Gels were run at 150V for approximately 90 
minutes before transferring proteins to a P-Hybond membrane (Amersham). 
Membranes were treated with a blocking solution of 5% powdered milk in PBS 
for at least half an hour. Primary antibody solutions were prepared in blocking 
solution and membranes were incubated in primary antibody for at least an hour. 
A list of antibodies used and their dilutions can be found in Table 2.2. Following 
treatment with primary antibody, membranes were washed 3 times with PBST 
(PBS containing 0.2% Tween-20). Secondary antibody solutions were prepared 
in PBST and incubated with membranes for at least an hour. Following 
treatment with secondary antibody, membranes were treated to five 5 minute 
washes in PBST. Excess PBST was allowed to drip off the membranes and 
each blot was treated with 2 ml of ECL reagent (Amersham). Blots were imaged 
using the FujiFilm LAS-1000 system with Image Reader LAS-1000 software.
2.8 Proliferation assay
To examine the regulation of the corneal endothelial cell proliferative 
response, cells were treated with growth factors for 24 or 48 hours. Cells 
entering the cell cycle during this time were marked with 5-bromo-2-deoxyuridine 
(BrdU) (Sigma). Because BrdU is a thymidine analog, it is incorporated into DNA
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Table 2.2 Primary and secondary antibodies used for western blotting
Primary antibodies Dilutions Source
a-tubulin 1/1000 Zymed
Apaf-1 1/250 Cell Signalling Technologies
Bad 1/500 Cell Signalling Technologies
Bax 1/250 Cell Signalling Technologies
Bcl-2 1/500 Cell Signalling Technologies
Bcl-X 1/500 Cell Signalling Technologies
BRUCE 1/250 Cell Signalling Technologies
CAS 1/1000 Cell Signalling Technologies
Caspase-2 1/1000 Cell Signalling Technologies
Caspase-3 1/1000 Cell Signalling Technologies
Caspase-7 1/1000 Cell Signalling Technologies
DFF45 1/500 Cell Signalling Technologies
FADD 1/250 Cell Signalling Technologies
Fas 1/5000 Cell Signalling Technologies
Fas-L 1/500 Cell Signalling Technologies
hILP 1/250 Cell Signalling Technologies
Mcl-1 1/1000 Cell Signalling Technologies
Nip-1 1/250 Cell Signalling Technologies
p53 1/500 Cell Signalling Technologies
PARP 1/500 Cell Signalling Technologies
RIP 1/1000 Cell Signalling Technologies
TRADD 1/250 Cell Signalling Technologies
Phospho-ERK 1/200 Santa Cruz
Secondary antibodies Dilutions Source
Anti-mouse 1/2000 Dako
Anti-mouse 1/5000 Santa Cruz
Anti-rabbit 1/2000 Dako
Anti-rabbit 1/5000 Santa Cruz
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during S-phase and can therefore be used as a reporter of cell proliferation. 
Untreated cells served as a negative control, while cells treated with normal 
growth media, containing 10% serum, were used as a positive control.
In order to determine the intracellular pathways involved in these proliferative 
responses, cells were treated concomitantly with both growth factor and 
inhibitiors of various intracellular pathways. Again, cells entering the cell cycle 
were marked with BrdU.
2.8.1 Treatment of cells
All cells were maintained in media containing 100 i^M BrdU for the duration of 
the experiment, either 24 or 48 hours. As previously mentioned, cells in base 
media, containing no serum or growth factors, were used as a negative control, 
while cells in base media, containing 10% serum, were used as a positive 
control. Concentrations of growth factors and inhibitors used are listed in Table 
2.3.
Table 2.3 Growth factors and inhibitors used in proliferation assays
Treatment Concentration used Source
Epidermal growth factor (EGF) 100 ng/ml CN Bioscience
Basic Fibroblast growth factor (FGF-2) 25 ng/ml R & D
Platelet-derived growth factor BB 
(PDGF BB)
50 ng/ml R & D
LY294002 20 pM Calbiochem
PD980059 50 pM Calbiochem
Genistein 100 pM Calbiochem
2.8.2 Fixation and staining of cells
Treatment media containing growth factors were removed and cells were 
fixed in cold methanol for 10 minutes at -20°C. Remaining methanol was 
washed away with PBS and cells were treated with 1.5 M HCI for 30 minutes at 
room temperature, to denature DNA. Four washes of PBS, 10 minutes each, 
were used to wash away the remaining HCI before incubation in blocking solution
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(1% BSA in PBS) for at least 30 minutes. A monoclonal anti-BrdU antibody 
(Amersham) was used to visualize cells which had entered the cell cycle during 
the experiment. Cells were incubated with anti-BrdU antibody for at least an hour 
at room temperature. Three washes with PBS were used to remove remaining 
primary antibody. Alexa Fluor 488 chicken anti-mouse IgG (Molecular Probes) 
was used at a dilution of 1/500 to detect BrdU positive nuclei. Cells were also 
treated with propidium iodide (1/2000) for at least an hour. Three washes with 
PBS were used to wash away remaining secondary antibody and propidium 
iodide.
2.8.3 Imaging, cell counting and statistical analysis
Nuclei were imaged on a Leica DM1L microscope with epifluorescence. 
Images were captured using Leica DC Viewer software. Captured images 
represented the entire field of cells. Images were transferred to software 
program Metamorph-4 and the proportion of BrdU positive nuclei as a 
percentage of the total population was determined. Information was combined in 
an Excel spreadsheet and significance was determined using unpaired Student’s 
T-test.
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Chapter 3: Characterisation of primary mouse corneal 
endothelial cell cultures
Due to the scarcity of human corneal tissue available for research, there is a 
need to investigate and establish alternative models for human corneal 
endothelium. The majority of studies of corneal endothelium have been 
conducted using bovine, rabbit and rat corneal endothelium. These species have 
advantages for experimentation as they provide relatively large, accessible 
amounts of tissue. None of these species, however, has proved to have an 
endothelium representative of human corneal endothelium. Bovine corneal 
endothelium is valuable as the corneas are large and it is therefore possible to 
obtain large numbers of corneal endothelial cells. However, it is increasingly 
difficult to obtain neurally derived bovine tissue, such as eye tissue, for research 
due to safety concerns relating to Bovine Spongiform Encephalopathy (BSE). 
Rabbit corneal endothelium is useful because of its propensity to proliferate 
though this markedly differentiates it from human corneal endothelium (Joyce et 
al., 1996). Rat corneal endothelium is similar to rabbit corneal endothelium in 
being highly proliferative. Rat corneal endothelial cultures also deviate from 
human corneal endothelium in that the cells become elongated and take on an 
increasingly fibroblastic appearance, even within the monolayer (Joyce et al., 
1998). Because none of these models reliably represent the human corneal 
endothelium, there is a need to identify alternative models that may be useful for 
future research. Mouse corneal endothelium has been proposed as a potential 
model for human corneal endothelium, since this would have the benefit for 
further investigations using genetically modified animals. The major impediment 
of using mouse corneas is their extreme small size and consequent difficulties of 
microdissection and isolation. This also results in limited cell numbers for 
culture. Only one study has described a culture technique for mouse corneal 
endothelial cells, but the methodology requires extremely complicated 
microdissection techniques (Joo et al., 1994). A relatively simple experimental 
strategy for the derivation of mouse corneal endothelial cells that would yield
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reproducible and sufficiently pure cultures would therefore be valuable. These 
primary cultures could then be compared to an SV40 transformed mouse corneal 
endothelial cell line, which is currently the only widely used mouse model. 
Because relatively little is known about primary mouse corneal endothelial 
cultures, it remains to be seen whether the SV40 transformed cell line is in fact a 
suitable, representative cell line for corneal endothelial cell research.
3.1 Mouse corneal endothelial cell morphology
The first goal was to devise a rapid and technically straight forward technique 
for the generation of primary mouse corneal endothelial cell cultures. Explant 
cultures of mouse corneal endothelium were established by placing the cornea, 
denuded of epithelium, onto tissue culture plastic. Endothelial cells, in contact 
with plastic, migrated away from the corneal button, and limited cell proliferation 
resulted in a small, ring-shaped, monolayer of cells (Figure 3.1 A). Cells required 
2 to 7 days to migrate off the cornea onto the tissue culture dish, with most 
migration occurring after 3 to 5 days. At this point the corneas were removed 
from the tissue culture dish and the cells cultured for at least a further two weeks 
before beginning experiments. The morphology of the cells migrating off the 
cornea differed from the morphology of cells composing the intact monolayer 
(Figure 3.1A-C). Migrating primary mouse corneal endothelial cells tended to 
have an elongated phenotype, frequently with three projections, giving the cells a 
triangular shape. Two of these projections were typically short and located close 
to the cell nucleus, while the final projection tended to be elongated, extending 
away from the cell body. Subconfluent cultures of SV40 transformed mouse 
corneal endothelial cells showed a similar phenotype to migrating primary cells 
but displayed a more variable number of cytoplasmic projections from the cell 
body (Figure 3.1 D). As the cells became more densely packed, the cell 
phenotype shifted to a more typical endothelial appearance, resembling a 
cobblestone-like monolayer. However, cells in culture were not as regular and 
hexagonal in shape as cells on an intact, healthy cornea (Figure 3.1B,C,E).
Primary mouse corneal endothelial cells
lO O pm B 100 |jm lOOum
SV40 transformed mouse corneal endothelial cells
High densityLow density
Figure 3.1 Phase images of mouse corneal endothelial cells in culture. Primary 
mouse corneal endothelial cells proliferate and migrate off corneas onto plastic tissue 
culture dishes (A). Arrowheads indicate the edge of the cornea and the arrow illustrates 
the direction of migration of cells from the cornea. Once a sufficient number of cells 
have migrated away from the cornea, it is removed and the cells are allowed to 
proliferate and fill the tissue culture dish (B,C). As the cells proliferate, they enlarge and 
spread. Cells at the edge of the monolayer (C) are far more heterogeneous in size and 
shape than those nearer the centre of the monolayer (B). The morphology of migrating 
cells is dramatically different to that of cells within the monolayer for both primary and 
SV40 transformed mouse corneal endothelial cells. Transformed cells continue to divide 
even after formation of the monolayer and progressively grow on top of each other (E). 
Cells growing on top of the monolayer are indicated by arrowheads (E).
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Figure 3.2 Morphology of mouse corneal endothelial cells at high and low density.
Corneal endothelial cells cultured on tissue culture plastic were fixed with 4% 
paraformaldehyde and stained with antibody targeting paxillin. Staining of actin was 
obtained by treatment with rhodamine phalloidin and nuclei visualized with DAPI 
staining. Images were captured on a Leica AOBS microscope using software program 
LCS (v.2). At high density, the SV40 transformed mouse corneal endothelial cell line (A) 
and primary mouse corneal endothelial cultures (B) have a similar morphology, with thick 
bundles of cortical actin and focal adhesions dispersed around the edge of the cell and 
along the basal membrane. At low density, focal adhesions are concentrated at the 
ends of projections, which extend from the cell body. The migratory morphology of 
primary cells regularly showed three projections from the cell body, while that of the 
SV40 transformed cell line showed various numbers of projections.
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The monolayer formed by primary corneal endothelial cells was composed of 
cells varying greatly in size and shape. Cells at the centre of the monolayer 
tended to be smaller and of a relatively even density, while cells towards the 
periphery were more heterogeneous with respect to cell size and density, due to 
the available space for the cells to spread and proliferate (Figure 3.1C). As the 
cells spread, they also flattened, resulting in a monolayer of very thin cells, 
appearing to have large protruding nuclei (Figure 3.1C). In contrast, the SV40 
transformed cells formed a fairly homogeneous monolayer of cells, with respect 
to cell density and size. However, cell contact inhibition was impaired and the 
cells continued to grow on top of each other. While the cells of the bottom of the 
monolayer appeared to have the characteristic cobblestone appearance, the 
cells of the upper layers tended to have a slightly fibroblastic appearance (Figure 
3.1E).
In general, primary cultures of confluent mouse corneal endothelial cells
showed a more variable phenotype than confluent SV40 transformed cells and 
cells on the intact cornea. In this respect, primary cultures may be more 
representative of an aged human corneal endothelial monolayer in situ. In the 
aged cornea, endothelial cells spread and flatten to fill the space left by dying 
cells. The result is a heterogeneous monolayer of lower density and variable 
size (polymegathism) and shape (pleomorphism). A similar morphological 
arrangement is noted in primary cultures of mouse corneal endothelium.
Cultured cells are larger and flatter than those in the cornea, as the space 
available in the tissue culture dish is much greater than that on the cornea. Cell 
spreading results in large variations in cell shape, with cultures containing 
occasional giant cells, leading eventually to a heterogeneous monolayer of 
endothelial cells.
In order to determine whether morphological differences could be attributed to 
differences in the F-actin phenotype, cultures of primary and SV40 transformed 
mouse corneal endothelial cultures were examined by confocal microscopy 
following fixation and staining for the focal adhesion protein paxillin. 
Immunofluorescence staining of both primary and SV40 transformed mouse
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corneal endothelial cells revealed that focal adhesions were present at the ends 
of cytoplasmic projections in the migrating phenotype. These focal adhesions 
were connected to cortical actin strands, which extend around the circumference 
of the cell (Figure 3.2). Confluent cultures of both the primary and SV40 
transformed cells showed a thick ring of cortical actin and a fairly even 
distribution of focal adhesions along the basal membrane of the cell and at the 
cell contacts (Figure 3.2). The similarity in F-actin phenotypes between these 
two experimental models indicates that the cytoskeletal organization of these 
cells is comparable.
Primary cultures of mouse corneal endothelial cells were maintained in 
culture for periods as long as 4 months to determine the lifespan of primary 
cultures. Although, prolonged culture of primary mouse corneal endothelial cells 
was possible, it resulted in a number of additional phenotypic changes, 
specifically to the morphology of the nucleus. Alterations in the appearance of 
the nuclei coincided with an increased incidence of binucleate cells (not shown). 
The nuclei appeared to shift from a round or oval shape to a kidney bean shape 
in the majority of primary mouse corneal endothelial cells cultured for periods 
longer than a month. As many as 10% of the cells in primary mouse cultures 
were also found to have two or more nuclei. Propidium iodide staining of these 
nuclei also revealed a difference in the arrangement of genetic material within the 
nucleus. While cells on whole cornea show bright, even staining with propidium 
iodide, cultured cells had an overall fainter staining of the nucleus with smaller 
punctate regions, possibly nucleoli, staining brightly (Figure 3.3B). This punctate 
staining of nucleoli was also apparent in SV40 transformed cells, as was the 
occurrence of kidney bean shaped nuclei, though both were less common than in 
primary cultures (Figure 3.3A). No binucleate cells were noted in SV40 
transformed cultures.
Time spent in culture also appeared to affect the ability of cells to attach to 
the tissue culture dish. While two weeks in culture yielded relatively few cell 
numbers, passaging these cells proved to be uncomplicated. Beyond two weeks 
of culture, however, primary cells became increasingly difficult to remove from
A. SV40 transformed mouse corneal endothelial cell line
lamin B nuclear stain combined phase image
B. primary mouse corneal endothelial cells
lamin B nuclear stain combined phase image
Figure 3.3 Nuclear morphology of mouse corneal endothelial cells. Corneal 
endothelial cells cultured on tissue culture plastic were fixed in cold methanol and 
stained with antibodies targeting the nuclear envelope protein lamin B. Nuclei were also 
stained with propidium iodide. Images were captured using a Leica AOBS microscope 
with LCS (v.2) software. Nuclei of SV40 transformed mouse corneal endothelial cells 
tend to be oval in shape and regular in size (A). Primary mouse corneal endothelial cells 
also have oval nuclei but with increasing time in culture, nuclei begin to form a bean 
shape (B). Changes in nuclear shape were illustrated by a component of the nuclear 
envelope, lamin B.
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the tissue culture dish and longer, harsher treatments were required to 
encourage dissociation and dispersal of cells. Because of this, most primary 
cultures used in future experiments were not passaged prior to study.
Both primary mouse cultures and SV40 transformed cultures were grown on a 
number of different matrices to investigate the effects of these matrices on cell 
morphology. The matrices investigated included type I collagen, type IV 
collagen, laminin, fibronectin and matrigel. Of these matrices, only type IV 
collagen, laminin and fibronectin are found in Descemet’s membrane. No 
difference was noted in the cellular morphology or the overall appearance of the 
established monolayer with culture on any of the matrices tested when compared 
to tissue culture plastic (results not shown). All future experiments were 
therefore carried out on tissue culture plastic.
3.2 Type VIII collagen expression
Despite displaying a typical endothelial phenotype, it was necessary to verify 
that the isolated cultured cells were indeed corneal endothelial cells. Because 
the cells were derived from a cornea denuded of epithelium, there were only two 
possible cell types which could be present in the cultures; keratocytes or 
endothelial cells. Both corneal keratocytes and endothelial cells are thought to 
be derived from the neural crest and thus express an overlapping profile of 
neuronal markers (Waring III et al., 1982). However, a major difference between 
the two cell types are the matrix molecules expressed. Keratocytes produce 
large amounts of type I collagen, to maintain the corneal stroma, while corneal 
endothelial cells produce type VIII collagen, a major component of Descemet’s 
membrane. Reverse transcriptase polymerase chain reaction (RT-PCR) was 
therefore used to demonstrate type VIII collagen expression in corneal 
endothelial cell cultures. Similar reactions were performed on corneal keratocyte 
cultures as a negative control.
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Figure 3.4 Tissue cultured mouse corneal endothelial cells express a1 type VIII 
collagen. The a1 type VIII collagen gene contains 2 exons. A forward primer was 
designed at the end of exon 1 and a reverse primer designed at the beginning of exon 2 
such that an RT-PCR reaction would yield a product of 526bp (A). A PCR product using 
the same primers from contaminating genomic DNA would also contain an intron, 
generating a much larger product, allowing amplification from mRNA to be distinguished. 
Total mRNA was isolated from primary corneal endothelial and keratocyte cultures as 
well as cultures of the SV40 transformed mouse corneal endothelial cell line. RT-PCR 
reactions using total mRNA were used to determine expression of a1 type VIII collagen. 
Both primary mouse corneal endothelial cell cultures as well as those from the mouse 
corneal endothelial cell line show a 526bp RT-PCR product, corresponding to a1 type 
VIII collagen. Similar RT-PCR reactions for a transcript of p-actin was used to confirm 
the quality of the mRNA, particularly from the corneal keratocytes.
Primers for the PCR reaction were designed such that the forward primer- 
binding site lay in exon 1 of the a1 type VIII collagen gene, while the reverse 
primer-binding site was located in exon 2 of the same gene (Figure 3.4A). The 
total length of the expected PCR product amplified from mRNA was 526 base 
pairs. The length of a potential PCR product amplified from contaminating 
genomic DNA would have been much longer, as it would also contain the intron, 
thus ensuring that a PCR product of the correct predicted size could only be 
amplified from precursor mRNA. RT-PCR reactions from corneal keratocyte 
cultures and corneal endothelial cell cultures both showed mRNA expression of 
p-actin, demonstrating acceptable mRNA quality (Figure 3.4B). Only the corneal 
endothelial cell cultures yielded the predicted 526bp band indicating mRNA
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expression of a1 type VIII collagen (Figure 3.4). The SV40 transformed corneal 
endothelial cell line also showed expression of the a1 type VIII collagen 
transcript.
3.3 Junctional integrity of mouse corneal endothelial cell cultures
A crucial function of the corneal endothelial monolayer is to form a tight 
barrier between the aqueous humor in the anterior chamber of the eye and the 
cornea. The formation of tight junctions between endothelial cells is critical to 
maintain this barrier. Zonula occludin-1 (ZO-1) is a junctional protein, generally 
considered to be an obligatory component of a functional tight junction, and is 
expressed in tight junctions in epithelial and vascular endothelial monolayers 
throughout the body. In immature junctions, or cell layers which do not form tight 
juctions, ZO-1 can also be found at the adherens junctions. The distribution of 
ZO-1 can, therefore, be used to determine the relative maturity of the junctions.
Mouse corneal endothelial monolayers in situ showed a relatively tight band 
of ZO-1 distributed around the cell borders (Figure 3.5B). This pattern of ZO-1 
staining is consistent with mature tight junction formation, as would be expected 
in the cornea. While the SV40 transformed mouse corneal endothelial cell line 
appears to produce a proper monolayer, as judged by phase microscopy, the 
pattern of ZO-1 staining suggests that this is not the case. Immunofluorescence 
staining for ZO-1 shows that the cells are in contact only at small, regular, 
punctuate areas around the cell borders (Figure 3.5A). This discontinuous 
staining is likely to be representative of improper or early junction formation. The 
barrier function of such a monolayer is likely to be compromised.
The distribution of ZO-1 in primary cultures of mouse corneal endothelial cells 
was variable and differed from both the corneal endothelial cell line and 
endothelial monolayers of the cornea. The expression and localization of ZO-1 
appeared to be affected by the length of time cells remained in culture. Primary
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Figure 3.5 Distribution of ZO-1 in mouse corneal endothelial cells. Cultured 
corneal endothelial cells and whole corneal tissue was fixed in cold methanol and then 
stained using antibodies against tight junction protein ZO-1. Nuclei were stained with 
propidium iodide. Images were captured using the Zeiss axiovert microscope with 
Lasersharp 2000 software. The distribution of junctional protein ZO-1 is different in the 
mouse corneal endothelial cell line (A) compared to corneal endothelial cells in situ (B). 
Distribution of ZO-1 in the mouse corneal endothelial cell line is similar to that noted for 
immature junctions, while endothelial monolayers on the cornea form a tight band 
around the cell with gaps at the Y-junctions (arrowheads). The same discrepancy is 
noted between primary cultures that have been in culture for only a few weeks versus 
those in culture for a few months. Primary corneal endothelial cell monolayers, which 
have only spent a few weeks in culture (C) show a similar distribution of ZO-1 to the cell 
line while mature monolayers of primary corneal endothelial cells (D) have a similar 
pattern of ZO-1 staining to cells on the cornea. Primary cultured cells are also much 
larger than those of the cell line or those found on the cornea.
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cultures, which had been passaged or which had been in culture for only short 
periods of time (2 weeks or less), showed a distribution of ZO-1 which was 
similar to that of the mouse corneal endothelial cell line. ZO-1 staining of these 
cultures also produced a discontinuous, punctate pattern of staining around the 
cell borders (Figure 3.5C). This pattern of staining highlights the fact that these 
primary cells form an incomplete monolayer with small intercellular gaps, which 
are sometimes even apparent under phase microscopy.
Primary mouse corneal endothelial cells which had been cultured for a few 
months, however, presented a slightly different distribution of ZO-1, which more 
closely resembled that of the corneal endothelium in situ. In such cultures, a ^  
regular band of ZO-1 was evident, distributed around the cell borders (Figure 
3.5D). While these bands did not appear as tight or intense as those of the 
endothelium in situ, these data suggest that correct assembly of functional tight 
junctions may simply require an adequate period of time in culture. Also, these 
results are consistent with the appearance of the cells under phase microscopy.
Cells which have spent longer in culture no longer have discernable cell borders 
under phase microscopy. It is possible that as the monolayer matures, the cells 
become more interdigitated and develop more mature junctions, similar to 
development of the endothelial monolayer of the cornea. This in turn may be 
reflected in the tighter pattern of ZO-1 staining. While the junctional maturity of 
primary cells with prolonged culture closely resembles that of endothelial 
monolayers in situ, primary corneal endothelial cells are much larger than those 
of endothelial monolayers in vivo, with most primary cells appearing two to three 
times the size of endothelial cells in the cornea. This apparent difference in cell 
size is likely the result of cell spreading, rather than a difference in cell volume.
In addition to ZO-1, the distribution of the transmembrane tight junction 
proteins claudin-1 and occludin was also investigated. Immunofluorescence 
staining showed a similar pattern of expression of claudin-1 to that of ZO-1 in situ 
(Figure 3.6 A,B). Claudin-1 was localized in a band at the cell borders of corneal 
endothelial cells (Figure 3.6B). However, it was not possible to determine the 
distribution of occludin, although it is likely that occludin is present in the mouse
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corneal endothelial tight junctions. Similarly, it was not possible to establish the 
distribution of any transmembrane tight junction proteins in primary cultures or 
the SV40 transformed cell line. It is likely, therefore, that cultured cells, whether 
SV40 transformed or primary, are unable to fully recapitulate the molecular 
complexity and integrity of tight junctions observed in corneal endothelial cells in 
vivo.
A
ZO-1 nuclear stain combined
B
claudin-1 nuclear stain combined
Figure 3.6 Distribution of tight junction proteins ZO-1 and claudin-1 in the 
endothelial monolayer of the mouse cornea. Whole mouse corneas were fixed in 
cold methanol and stained with antibodies to either ZO-1 or claudin-1. Nuclei were 
visualized with propidium iodide stain and images captured using a Zeiss axiovert 
microscope with Lasersharp 2000 software. Both ZO-1 (A) and claudin-1 (B) localize to 
the cell borders in corneal endothelial monolayers of the mouse cornea.
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3.4 Apoptotic markers
Decreasing corneal endothelial densities are the consequence of two factors; 
negligible corneal endothelial cell proliferation and corneal endothelial cell death. 
Thus, in the absence of any proliferation, corneal endothelial cell survival is 
particularly important for the maintenance of cell densities in vivo. While the 
mechanisms of cell death in corneal endothelial cells are still largely unknown, it 
is thought that apoptotic cell death plays a more prominent role than necrotic cell 
death. The balance of pro- and anti-apoptotic signals present in both the primary 
corneal endothelial cell cultures and the SV40 transformed corneal endothelial 
cell line was determined by western blotting a panel of apoptotic markers.
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Figure 3.7 Apoptotic markers expressed in primary cultures of mouse corneal 
endothelial cells. Cell lysates of primary mouse corneal endothelial cells cultured on 
tissue culture plastic were used to determine the expression of a number of apoptotic 
markers, using the Transduction Labs Apoptosis Sampler Kits I and II. Primary mouse 
corneal endothelial cells showed expression of CAS, PARP, RIP, caspase-3, Fas-L, Fas, 
Bcl-2 and Bad (bands highlighted with pink boxes). A number of other non-specific 
bands also appeared on the blot but these did not correspond with the correct molecular 
weight for the expected product.
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Cultures of primary mouse corneal endothelial cells and the SV40 
transformed cell line were grown on tissue culture plastic and lysed directly into 
reducing sample buffer. A BioRad Mini-Protean II Multi Screen was used for 
western blot screening of Transduction Labs Apoptosis Sampler Kits I and II.
The proteins expressed in the SV40 transformed cell line were slightly different to 
those expressed in primary mouse corneal endothelial cultures. Expression of 
pro-apoptotic proteins CAS, RIP, caspase-3, Fas, Fas-L and Bad and anti- 
apoptotic proteins PARP and Bcl-2 was noted in primary mouse cultures (Figure 
3.7). However, the SV40 transformed cell line was found to express fewer pro- 
apoptotic proteins, Apaf-1, CAS, RIP, Fas and Bad, and more anti-apototic 
proteins, Bcl-2, Bcl-XL and Bax (Figure 3.8). The expression of increased 
numbers of anti-apoptotic proteins in the SV40 transformed cell line is a typical 
feature of the subversive effect of transforming oncogenes and may make these 
cells more resistant to apoptosis.
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Figure 3.8 Apoptotic markers expressed in an SV40 transformed mouse corneal 
endothelial cell line. Cell lysates of SV40 transformed mouse corneal endothelial cells 
cultured on tissue culture plastic were used to determine the expression of a number of 
apoptotic markers, using the Transduction Labs Apoptosis Sampler Kits I and II. SV40 
transformed cells showed expression of Apaf-1, CAS, RIP, Fas, Bcl-2, Bcl-XL, Bax and 
Bad (bands highlighted with pink boxes). A number of other non-specific bands also 
appeared on the blot but these did not correspond with correct molecular weight for the 
expected product.
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3.5 Mitochondrial morphology changes during apoptosis
Because of the observed differences in apoptotic proteins between 
primary mouse corneal endothelial cells and SV40 transformed mouse corneal 
endothelial cells, it was of interest to examine whether or not this might reflect 
differences in the susceptibility of the cells to an apoptotic stimulus. Changes in 
mitochondrial morphology are known to accompany loss of functional integrity 
and mitochondrial pore transition and are an early indication of apoptosis. As 
metabolically active cells, the corneal endothelium contains an extensive 
mitochondrial network, so alterations in mitochondrial morphology can be 
measured to provide an early indicator of apoptosis. Mouse cultures were 
loaded with 100nM MitoTracker Red to monitor changes in mitochondrial 
morphology and mitochondrial membrane integrity during apoptosis. Differences 
in kinetics and strength of signal required to initiate apoptosis in both primary 
cultures and the SV40 transformed cell line were compared.
Induction of apoptosis with 200nM staurosporine resulted in dramatic 
changes to mitochondrial morphology in primary mouse corneal endothelial cells 
within 1 hour of treatment. Untreated cells displayed a mitochondrial reticulum 
throughout the cell, appearing in confocal cross section as numerous bright dots 
and lines (Figure 3.9A). 10 minutes after staurosporine treatment there was little 
change in mitochondrial morphology (Figure 3.9B) but after 50 minutes of 
treatment, the mitochondria appeared as large, bright clumps or vesicles within 
the cell (Figure 3.9C). These vesicles likely represented mitochondrial tubules 
which have coalesced. By 1 hour of treatment with staurosporine, the 
mitochondrial vesicles appeared to have migrated from being uniformly 
distributed around the cytoplasm, to clusters surrounding the nucleus (Figure 
3.9D). As the mitotracker dye appears fainter than in previous images, Figure 
3.9D also reports the loss of mitochondrial membrane potential that occurs at 
mitochondrial pore transition, allowing Mitotracker Red dye sequestered in the 
mitochondria to leak out. Coalescence of the mitochondria and breakdown of 
mitochondrial membranes are an early indicator of apoptosis. In primary corneal
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endothelial cells, these features were visible in most cells within an hour of 
treatment with 200nM staurosporine.
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Figure 3.9 Mitochondrial morphology of primary mouse corneal endothelial cells 
is disrupted by staurosporine. Primary mouse corneal endothelial cells cultured on 
glass coverslips were loaded with 100nM Mitotracker Red and treated with 200nM 
staurosporine for 0 minutes (A), 10 minutes (B), 50 minutes (C) and 1 hour (D). 
Confocal images of mitochondrial morphology were captured on a Zeiss axiovert 
microscope with Lasersharp 2000 software. The morphology of the mitrochondria 
change dramatically after 50 minutes. After 1 hour of treatment with staurosporine, the 
mitochondria have coalesced and the weaker signal suggests that the mitochondrial 
membranes are breaking down.
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Figure 3.10 Effects of staurosporine on SV40 transformed mouse corneal 
endothelial cell mitochondrial morphology. SV40 transformed mouse corneal 
endothelial cells cultured on glass coverslips were loaded with 100 nM Mitotracker Red 
and treated with 500nM staurosporine for 2 hours. Confocal images of mitochondrial 
morphology were captured on a Leica AOBS microscope with LCS (v.2) software. 
Mitochondrial morphology begins to alter dramatically after 45 minutes of exposure to 
staurosporine. After 2 hours of treatment with staurosporine, the mitochondria have 
coalesced and the weaker signal suggests that the mitochondrial membranes are 
breaking down.
Induction of apoptosis in the SV40 transformed mouse corneal endothelial 
cell line required a higher dose of staurosporine. Changes were noted in the 
mitochondrial morphology of all cells after two hours of treatment with 500nM 
staurosporine. Untreated SV40 transformed cells had a similar mitochondrial 
morphology to that of primary cultures, with the mitochondrial reticulum 
appearing as numerous dots and lines in confocal cross section (Figure 3.10A). 
There was little change to mitochondrial morphology after 20 minutes of 
exposure to staurosporine (Figure 3.10B), but coalescence of mitochondria was 
evident after approximately 45 minutes (Figure 3.10C). After two hours of
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exposure, all cells showed significant alterations to mitochondrial morphology 
including rounding up of mitochondria and breakdown of mitochondrial 
membranes (Figure 3.1 OF).
The SV40 transformed cell line and primary cells thus required different doses 
of staurosporine to induce apoptosis, and displayed different kinetics with regard 
to mitochondrial breakdown. Specifically, the SV40 transformed cell line required 
a higher dose and longer time period for all cells to show significant changes in 
mitochondrial morphology. These differences suggest that the SV40 transformed 
mouse corneal endothelial cells are more resistant to apoptosis than the primary 
mouse corneal endothelial cells, and are consistent with the identification of more 
anti-apoptotic proteins present in the SV40 transformed cell line.
3.6 Summary
Primary mouse corneal endothelial cell cultures were established with the 
development of an explant culture model. This model of mouse corneal 
endothelial cell culture generates a reproducible culture system that is relatively 
simple in comparison to that described by Joo et al. (1994). In addition, work in 
this chapter provides a more extensive characterisation of primary mouse 
corneal endothelial cells. In the explant model the cells migrate off the cornea 
onto tissue culture dishes to form a halo of growing endothelial cells. These 
migrating cells have a different morphology to cells found in the intact monolayer. 
Migrating cells take on a triangular shape, with three cytoplasmic projections 
extending away from the cell body, and focal adhesions concentrated at the ends 
of these projections. With time in culture, these cells cease to proliferate and 
form a monolayer. The densities of these monolayers are much lower than those 
of corneal endothelial monolayers in situ, but the cells still display a relatively 
cobblestoned appearance. The densities of these monolayers were highest 
close to where endothelial cell migration from the cornea was first initiated and 
densities were lowest at the edge of the monolayer. The shape of cells towards 
the edge of the monolayer was also more variable and this region contained a
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large number of giant cells. These trends were unaffected by culture of the cells 
on various matrices.
Overall, the gross appearance of the SV40 transformed mouse corneal 
endothelial cell line was found to exhibit significant differences to that of the 
primary cultures. First, migrating cells typically had many more than three 
projections extending from the cell body. Second, cells were uniformly 
distributed throughout the entire tissue culture dish, and were fairly 
homogeneous in shape and size. Finally, and perhaps most importantly, SV40 
transformed cells continued to proliferate after the monolayer had become 
established, resulting in cell overgrowth and multiple cell layers. This final 
difference suggests that cell contact inhibition, which normally feeds back to 
control proliferation, may be overridden in the SV40 transformed cell line. Cell 
contact inhibition of proliferation has been shown to play an important role in 
corneal endothelial cell proliferation in vivo (Senoo et al., 2000), and elimination 
of this control as a result of oncogenic transformation may explain its highly 
proliferative nature.
Since corneal endothelial cells are the only cell type within the cornea known 
to express type VIII collagen, expression of a1 type VIII collagen by RT-PCR in 
both primary and SV40 transformed mouse corneal endothelial cells was used to 
confirm that these cultures were indeed endothelial (Kapoor et al., 1988).
Corneal endothelial cells are also known to form tight junctions, as a part of their 
barrier function (Waring, III et al., 1982) and several studies have used the tight 
junction associated protein ZO-1 as a marker of tight junction formation in 
corneal endothelial monolayers (Senoo et al., 2000, Petroll et al., 1999). Here, 
ZO-1 was used to compare the junctions in corneal endothelial monolayers in 
culture with those in situ. On whole corneal tissue, ZO-1 was found to be in a 
tight band around the cell borders with apparent discontinuities at the Y- 
junctions. This pattern of ZO-1 staining has been described previously in the 
corneal endothelium of a number of species, including rat (Gordon, 2002), cat 
{Petroll, 1999 426 /id} and human (Senoo et al., 2000){Petroll, 1999 426 /id}. A 
close approximation of this staining pattern was noted in primary mouse corneal
endothelial cells which had been in culture for a few months, with ZO-1 
distributed in a fairly regular band around the cell with spaces at the Y-junctions. 
The establishment of more authentic junctions in these cells may contribute to 
cessation of proliferation and difficulties passaging cells after prolonged culture.
In contrast, short term cultures of primary cells showed a discontinuous band of 
ZO-1 around the cell borders, similar to the distribution of ZO-1 in the SV40 
transformed cell line. Such localization of ZO-1 is consistent with immature 
junction formation. As previously mentioned, the SV40 transformed cell line 
appears to be able to override cell contact inhibition of proliferation, and 
incomplete junction formation may contribute to this characteristic. Similarly, 
primary cells which have spent little time in culture may remain proliferative due 
to their incomplete junction formation.
Electron microscopy has revealed the presence of tight junctions in the 
corneal endothelium in situ, thus transmembrane tight junction proteins must be 
present in the corneal endothelial tight junction plaque (Waring, III et al., 1982). 
Consistent with this, the transmembrane tight junction protein claudin-1 was 
noted in corneal endothelial cell monolayers in situ. However, occludin was not 
observed in corneal endothelial monolayers. It is highly unlikely that occludin 
does not form a part of the corneal endothelial tight junction plaque, the absence 
of staining is instead likely due to steric hinderance by tight junction associated 
proteins, including ZO-1. However, this explanation cannot account for the clear 
absence of both claudin-1 and occludin in primary mouse corneal endothelial 
cells in culture. As ZO-1 distribution in primary cultures varies depending on time 
in culture, there may also be a time dependent effect on the distribution of 
transmembrane tight junction proteins. Tight junctions in endothelial cells of the 
developing cornea are known to mature over long periods of time. While corneal 
endothelial cell proliferation ceases by the third month of gestation, tight junction 
formation does not begin until the fourth month of gestation and junctions do not 
mature until the fifth month (Bron et al., 2001). The apparent organization of ZO- 
1 in primary cells that have been cultured for longer periods, suggests that in 
these cells junctions may be properly constructed. As proper organization of ZO-
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1 is known to be required prior to the assembly of transmembrane tight junction 
proteins, it is possible that more prolonged culture of primary mouse corneal 
endothelial cells might eventually reveal the expression of transmembrane tight 
junction proteins (Bazzoni and Dejana, 2004).
Corneal endothelial densities decrease with time due to corneal endothelial 
cell G1 phase arrest and cell death. Apoptosis is thought to be the primary mode 
of cell death in the corneal endothelium (Albon et al., 2000; Komuro et al., 1999). 
An assessment of apoptotic markers in both primary mouse corneal endothelial 
cell cultures and the SV40 transformed mouse corneal endothelial cell line 
revealed that the cell line expressed more anti-apoptotic proteins and fewer pro- 
apoptotic proteins than the primary cultures. In general, expression of cell death 
receptors, such as Fas and RIP, were noted in both the cell line and primary 
cultures. Members of the Bel family of proteins, Bcl-2 and Bad, were detected in 
both the cell line and the primary cells, and additional anti-apoptotic members of 
the Bel family, BcI-Xl and Bax, were also observed in the cell line. Homo or 
heterodimers of anti-apoptotic Bel proteins, Bcl-2, Bcl-XL and Bax, offer 
protection from cell death. Pro-apoptotic Bad, however, interrupts these dimers 
to induce apoptosis (Adams and Cory, 1998). A balance of pro- and anti- 
apoptotic proteins thus determines cell susceptibility to cell death. While the 
SV40 transformed cell line was found to express a wider range of anti-apoptotic 
Bel proteins than primary cultures, further investigations of levels of expression of 
these proteins would be needed to determine whether these differences 
contribute significantly to cell survival.
The analysis of apoptotic protein expression also revealed some surprising 
results, particularly the identification of the cellular apoptosis susceptibility (CAS) 
protein. Typically, elevated levels of CAS are noted in rapidly dividing cells, with 
levels decreasing during growth arrest. Consistent with this, the SV40 
transformed cell line is known to be highly proliferative and shows an expected 
expression of CAS. However, primary cultures exhibited reduced levels of 
proliferation and are largely thought to be G1 phase arrested, making expression 
of CAS unexpected in these cells. It would be of interest to know whether or not
corneal endothelial cells in situ express CAS. Also surprising was the expression 
of poly(ADP-ribose) polymerase (PARP) by primary cultures but not by the SV40 
transformed cell line. As a molecular nick sensor, central to DNA repair, PARP is 
thought to be constitutively and ubiquitously expressed. It may be that levels of 
PARP in the SV40 transformed cell line were low and thus undetectable by 
western blotting. Similarly, pro-apoptotic Apaf-1, a component of the large 
apoptosome complex for caspase activation (Reed, 2000), was found to be 
expressed solely in the SV40 transformed cell line.
In addition to apoptotic markers expressed, mitochondrial morphology and 
mitochondrial membrane integrity were investigated during the apoptotic 
response of both the primary mouse corneal endothelial cell cultures and the 
SV40 transformed cell line. The protein kinase C inhibitor, staurosporine, was 
used to induce apoptosis. Sensitivity to staurosporine differed in the two 
experimental models, with the cell line requiring a dose of staurosporine two and 
a half times greater than that required for the primary cultures to induce 
apoptosis. Staurosporine (200nM) has been reported to induce corneal 
endothelial cell death in both bovine and human corneal endothelial cell cultures 
(Joo et al., 1999; Thuret et al., 2003). The same dose of staurosporine induced 
significant changes in mitochondrial morphology and compromised mitochondrial 
membrane integrity after 1 hour of treatment in primary mouse corneal 
endothelial cells. Mitochondria coalesced to form blebs within the cell, and 
failure of mitochondrial membrane potential was demonstrated by leakage of dye 
into the cytoplasm. A dose of 500nM staurosporine was required to induce a 
similar response in the SV40 transformed mouse corneal endothelial cell line. 
While mitochondria began to coalesce after 45 minutes of exposure to 
staurosporine in some cells, mitochondrial membranes appeared to remain intact 
at this time. Only after two hours did all the cells show fragmentation and 
rounding up of mitochondria and loss of mitochondrial membrane integrity. This 
is the first report of mitochondrial changes associated with apoptosis in corneal 
endothelial cells. Because the corneal endothelium is rich in mitochondria, and 
these changes take place over a relatively short time frame, mitochondrial
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morphology changes provide an early indicator of apoptosis in the corneal 
endothelium. The increased dose of staurosporine required to induce apoptosis 
and the kinetics of the apoptotic response in SV40 transformed mouse corneal 
endothelial cells, suggests that these cells are more resistant to apoptosis. This 
cytoprotection may be limited to the expression of certain apoptotic proteins, 
particularly anti-apoptotic members of the Bel family.
In conclusion, work presented in this chapter provides new insight into the 
isolation and characterisation of primary mouse corneal endothelial cells. While 
Joo et al. (1994) found no differences between primary mouse corneal 
endothelial cells and the SV40 transformed mouse corneal endothelial cell line, 
our results demonstrate that there are a number of significant differences 
between the two. First, the SV40 transformed cell line is not contact inhibited. 
Second, expression of various apoptotic markers differs between the cell line and 
primary cells, which may explain the different sensitivities to staurosporine- 
induced apoptosis. This analysis shows that care must be taken in the 
interpretation of results obtained using the SV40 immortalized cell line, since it 
does not fully replicate all the characteristics of either primary cultured mouse 
corneal endothelial cells, or endothelial cells in an intact monolayer.
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Chapter 4: Proliferative response of primary mouse corneal 
endothelial cells
It is generally accepted that the normal adult human corneal endothelium has 
virtually no mitotic activity, with cells held in G1 phase arrest. Mitotic activity is 
essentially complete by birth. Injury to the corneal endothelium resulting in 
cellular attrition leads predominantly to enlargement and translocation of 
remaining endothelial cells, rather than replacement of lost cells by mitosis. 
During this atypical wound healing response, there is an increase in variation in 
cell shape (pleomorphism) and variation in cell size (polymegathism). These 
changes may compromise the barrier function of the monolayer. It would 
therefore be beneficial to have therapeutic strategies designed to restore 
endothelial cell density and regenerate damaged monolayers. As growth factors 
are multifunctional regulatory proteins that have the potential to drive cells from 
G1 arrest into the cell cycle, a set of experiments was undertaken to examine the 
full effects of growth factors on the proliferative response of newly established 
primary mouse corneal endothelial cell cultures (see Chapter 3). The growth 
factors investigated were epidermal growth factor (EGF), which in most contexts 
is not mitogenic, basic fibroblast growth factor (FGF-2) and platelet derived 
growth factor BB (PDGF BB), the latter both being mitogenic in other cell types. 
These factors were chosen as primary mouse corneal endothelial cell cultures 
and SV40 transformed mouse corneal endothelial cells have both been 
demonstrated to express EGF and PDGF BB receptors at similar levels, and 
FGF-2 is known to be synthesized by and act on corneal endothelial cell cultures 
(Joo et al., 1994; Choi et al., 2000).
However, relatively little is known about the intracellular events that mediate 
proliferation in corneal endothelial cells. Studies on rabbit corneal endothelium 
indicate that the PI3 kinase pathway is important for the proliferative response 
(Kay et al., 1998). Evidence from other cell types demonstrate that the mitogen- 
activated protein kinase (MAPK) pathway is also typically activated in a 
proliferative response (Murphy et al., 2002). In order to determine whether the
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MAPK pathway is involved in the corneal endothelial proliferative response, the 
kinetics of extracellular signal regulated /cinase (ERK) activation in response to 
growth factor stimulation were investigated by western blotting. In addition, 
specific inhibitors of various intracellular signalling pathways were used to further 
delineate the relative importance of these signalling pathways in the proliferative 
response.
Studies were conducted in parallel in both the SV-40 transformed mouse 
corneal endothelial cell line and in primary mouse corneal endothelial cell 
cultures. Comparisons between these two model systems determined whether 
intracellular signalling pathways underlying the proliferative response were the 
same in the primary cultures as the cell line. This would provide insight as to the 
utility of the transformed cell line as a model for primary cultures.
4.1 Proliferative response of mouse corneal endothelial cells
It has been suggested that rodent corneal endothelium is unrepresentative of 
the human corneal endothelium as it is highly proliferative. However, this view is 
based largely upon studies conducted in the corneal endothelium of the rat, and 
results presented in chapter 3 suggest that mouse corneal endothelial cells do 
not readily proliferate. Moreover, the appearance of rat and mouse corneal 
endothelial monolayers displays a major difference between these two species. 
Primary rat corneal endothelial monolayers tend to be composed of cells with an 
elongated or fibroblastic appearance, while primary mouse corneal endothelial 
monolayers generally adopt a cobblestone appearance, similar to that which is 
noted in situ. Since phenotypic differences exist between the two species, it is 
also possible that mouse corneal endothelial cells might differ from the rat 
endothelium in their proliferative potential and therefore more closely resemble 
the human corneal endothelium. To gain futher insight into these issues, the 
proliferative responses of primary mouse corneal endothelial cultures were 
assessed following exposure to a number of different growth factors, including 
EGF, FGF-2 and PDGF BB.
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4.1.1 Proliferative response of a mouse corneal endothelial cell line 
Growth factor-induced proliferation was first investigated in the SV40
transformed mouse corneal endothelial cell line in order to establish optimal 
doses of growth factor. Subconfluent cultures were serum starved for 24 hours 
prior to experimentation. Cultures were then concomitantly treated with 5-bromo- 
2-deoxyuridine (BrdU) and growth factors overnight. BrdU is a thymidine analog 
that is incorporated into DNA during S-phase of the cell cycle and can therefore 
be used as a reporter of cell proliferation. Immunofluorescence staining using an 
anti-Brdll antibody allowed visualisation of cells which had entered the cell cycle 
during the period of treatment. Propidium iodide staining of all cell nuclei allowed 
the proportion of BrdU positive cells to be identified as a percentage of the total 
cell population (Figure 4.1 A-F). Representative fields of cells were counted. Due 
to the high basal levels of proliferation in the SV-40 transformed cell line, 
however, growth factor stimulation did not exert any additional or discernable 
effect on the proliferative response. Approximately 80-90% of cells underwent at 
least one round of cell division, even in the absence of mitotic factors (Figure
4.1 G). Due to this high basal level of proliferation, it was therefore impossible to 
test the proliferative response to each growth factor. Doses of growth factor 
selected for use in experiments with primary cultures were chosen based on 
those published in the literature. EGF was used at 100ng/ml, a saturating dose 
typically used to stimulate most cultured cells. A dose of 25ng/ml FGF-2 has 
been reported to stimulate corneal endothelial cells (Hoppenreijs et al., 1994) 
and 50ng/ml PDGF BB is the dose used to stimulate corneal 
keratocytes/fibroblasts (Hoppenreijs et al., 1993).
4.1.2 Proliferative response of primary mouse corneal endothelial cell cultures to 
growth factor stimulation
Primary mouse corneal endothelial cell cultures were treated in a similar 
manner to the SV-40 transformed cell line. Cultures were serum starved for 24 
hours prior to treatment for either 24 or 48 hours with growth factor and BrdU.
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Figure 4.1. Proliferative response to growth factor stimulation in an SV40- 
transformed mouse corneal endothelial cell line. Sub-confluent mouse corneal 
endothelial cell cultures were used to investigate growth factor-induced proliferation. 
Cells were treated concomitantly with BrdU and growth factor. Propidium iodide was 
used to stain the total cell population, while antibody staining for BrdU was used to 
identify the proliferating cells. Yellow nuclei, indicated with arrowheads, represent 
proliferating cells, while red nuclei represent quiescent cells. The proportion of BrdU 
positive nuclei were counted as a proportion of the total cell population. At least 3000 
cells were counted for each treatment. Basal levels of proliferation (A), however, were 
extremely high and it was impossible to distinguish the effects of growth factors 
(B,C,D,E) or serum treatment (F). Results for all growth factors are displayed in a graph, 
showing no difference between treatments (G). (n=3)
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Proliferating cells were identified as a percentage of the total cell population 
(Figure 4.2A-F). Random fields of cells were counted from all areas of the 
primary cell monolayers. Untreated cultures were used as a negative control, 
and these elicited almost no proliferation. Cells cultured in normal growth media
(containing 10% fetal calf serum) were used as a positive control, and exhibited (2%, 
just over 40% of the cell population entering into S-phase after 48 hours.
EGF and FGF-2 both induced only a modest degree of proliferation. After 48 ($
hours of treatment with either growth factor, 10% of the cell population yielded 
BrdU positive nuclei (Figure 4.2B,C). The proliferative response to PDGF BB 
stimulation was slightly greater, with approximately 15% of the cell population 
entering into the cell cycle after 48 hours of exposure to growth factor (Figure 
4.2D). While none of the individual growth factors provided a strong stimulus for 
proliferation, the response to both FGF-2 and PDGF BB after 48 hours of 
treatment, was significant (p < 0.05) as compared to untreated cells. Cells 
treated with serum were also found to have significantly higher levels of 
proliferation with respect to untreated cells after both 24 and 48 hours of 
treatment (p < 0.05).
Treatment of cultures with growth factor for 48 hours appeared to produce an 
approximate doubling in the numbers of proliferating cells as compared to the 
response observed after 24 hours. However, this was not apparent for cultures 
treated with serum, in which the relative increase in proliferation during the 
second 24 hour period was comparatively small. Interestingly, proliferation in all 
groups appeared to take place in patches rather than along the edge of the 
monolayer, as might have been expected.
4.1.3 Proliferative response of primary mouse corneal endothelial cell cultures to 
stimulation with multiple growth factors
Primary mouse corneal endothelial cell cultures were treated with 
combinations of two or more growth factors to investigate the possibility of 
synergistic actions of multiple mitogens on the proliferative response. Cultures 
were serum starved for 24 hours, prior to treatment with BrdU and growth factor
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Figure 4.2. Proliferative response of primary mouse corneal endothelial cells to 
growth factor stimulation. Established cultures of primary mouse corneal endothelial 
cells were treated with both growth factors and BrdU for 24 or 48 hours. Nuclei were 
stained with propidium iodide and antibody staining for BrdU was used to identify 
proliferating cells. BrdU positive nuclei (yellow nuclei, indicated with arrowheads) were a 
measured as a percentage of the total cell population. At least 5000 cells were counted 
per treatment. Untreated cells showed little or no proliferation and were used as a 
negative control (A), while cells treated with 10% serum were used as a positive control 
(F). 100ng/ml EGF (B) appeared to stimulate proliferation but the response was not 
significant. 25ng/ml FGF-2 (C) and 50ng/ml PDGF BB (D) stimulated a significantly 
greater amount of proliferation than untreated cells. * represent cell populations with a 
significantly (p<0.05) higher proliferative response as compared to unstimulated cells. 
(n>3)
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Figure 4.3. Proliferative response of primary mouse corneal endothelial cultures 
to combinations of growth factors. Established cultures of mouse corneal endothelial 
cells were treated with growth factors and BrdU for 24 or 48 hours prior to being fixed 
and stained with an anti-BrdU antibody. BrdU positive nuclei were identified as a 
percentage of the total cell population. At least 5000 cells were counted per treatment. 
Untreated cells showed little or no proliferation and were used as a negative control, 
while 10% serum was used as a positive control. Combination of 100ng/ml EGF and 
25ng/ml FGF-2 stimulated low levels of proliferation, comparable to that either growth 
factor alone. Combinations of growth factors containing 50ng/ml PDGF BB, however, 
stimulated levels of proliferation far above those of single growth factors. After 48 hours 
of treatment, the combination of 25ng/ml FGF-2 and 50ng/ml PDGF BB stimulated a 
level of proliferation almost equivalent to that induced by a combination of all 3 growth 
factors (all GFs) or serum. Responses significantly above that of unstimulated cells are 
represented as follows: * p<0.05, **<0.01 (n > 3)
for a further 24 or 48 hours. Untreated cells were again used as a negative 
control, while those treated with growth media containing 10% serum, were used 
as a positive control.
Most of the combinations of growth factors produced an additive rather than 
synergistic effect on proliferation. Combinations of EGF + PDGF BB, and EGF + 
FGF-2 + PDGF BB, elicited proliferative responses that appeared to represent 
the additive effects of the proliferative responses of each growth factor used
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alone. The maximal proliferative response was noted in cultures treated with all 
three growth factors, in which the percentage of BrdU positive nuclei was almost 
equivalent to that observed with serum after 48 hours. This response was 
significant (p<0.01) with respect to that of untreated cells (Figure 4.3).
Interestingly, the combination of EGF + FGF-2 gave a response little different to 
that of either growth factor used alone. Treatment with the combination of FGF-2 
+ PDGF BB appeared to produce an additive effect after 24 hours of treatment, 
however, a synergistic effect on proliferation was observed after 48 hours. FGF- 
2 + PDGF BB elicited a response approximating that seen with serum after 48 
hours of treatment. Both the additive response and the synergistic response of 
the FGF-2 + PDGF BB combination were found to be significantly higher 
(p<0.05) than the proliferative response of untreated cells (Figure 4.3).
4.2 Kinetics of ERK activation in mouse corneal endothelial cells
Mitogen-activated protein kinase (MAPK) involvement in growth factor- 
induced proliferation has been well documented {Weber, 1997 431 /id}. The (V
classical MAPKs in mammalian cells are the Extracellular signal Regulated 
Kinases (ERK) 1 and 2, and these are activated by phosphorylation downstream 
of the small GTPases Ras and Raf. In order to test whether the growth factors 
used to stimulate proliferation also activate the MAPK pathway, western blotting 
of phospho-ERK1/2 was performed on lysates of growth factor treated cell 
cultures.
4.2.1 ERK activation in a mouse corneal endothelial cell line
SV-40 transformed mouse corneal endothelial cells were serum starved for at 
least 2 hours prior to treatment with 100ng/ml EGF, 25ng/ml FGF-2 or 50ng/ml 
PDGF BB for 0, 5, 15, 30, 60, 90 or 120 minutes. Cell lysates were western 
blotted for the phosphorylated and unphosphorylated forms of ERK 1/2. All 
growth factors showed a similar pattern of ERK 1/2 phosphorylation, peaking 
after 5 minutes of exposure to growth factor (Figure 4.4). The same blots were
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also probed for a-tubulin to ensure equal protein loading. Quantitative evaluation 
revealed little difference in the kinetics of ERK1/2 activation, irrespective of 
growth factor used. These results are reasonably consistent with the proliferation 
data (Figure 4.2).
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Figure 4.4 ERK 1/2 activation in an SV40 transformed mouse corneal endothelial 
cell line. Cells in culture were serum starved for at least 2 hours prior to treatment with 
growth factor. 25ng/ml FGF-2, 100ng/ml EGF or 50ng/ml PDGF BB was added to 
serum-free culture media at 0, 5, 15, 30, 60 and 120 minute intervals. Lysates were 
made directly in reducing sample buffer. Western blotting revealed that all 3 growth 
factors elicited a similar pattern of ERK activation following growth factor stimulation.
ERK phosphorylation peaked after 5 minutes of treatment with growth factor and 
returned to basal levels after 2 hours. Levels of total protein per sample were assessed 
to be equal by blotting samples for a-tubulin and total levels of ERK 1/2. This also 
revealed that levels of ERK 1/2 remained unchanged.
4.2.2 ERK activation in primary mouse corneal endothelial cell cultures
Primary mouse corneal endothelial cultures showed a different pattern of ERK 
activation to that observed in the cell line. Cultures were serum starved 
overnight prior to treatment with growth factor for 0, 5, 15, 30, 60, 90 or 120 
minutes. Growth factors were used at the same concentrations as in previous 
experiments to stimulate cell proliferation; namely 100ng/ml EGF, 25ng/ml FGF-2 
or 50ng/ml PDGF BB. Whole cell lysates were western botted for 
phosphorylated and unphosphorylated ERK 1/2 and a-tubulin.
EGF stimulated cultures demonstrated a peak in ERK 1/2 activation after 5 
minutes of stimulation, which was sustained after 15 minutes of EGF stimulation.
FGF-2
EGF
PDGF BB
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After 30 minutes of treatment with EGF, however, levels of phosphorylated ERK 
1/2 had returned to approximately basal levels (Figure 4.5).
PDGF BB stimulated cultures produced a more sustained ERK 1/2 activation. 
ERK 1/2 becomes activated after only 5 minutes of stimulation PDGF BB, with a 
peak in activation after 15 minutes. By 30 minutes, levels of phospho-ERK 1/2 
had decreased by approximately 50%, and after 60 minutes of exposure to 
growth factor, levels of activated ERK 1/2 again decreased by 50% with respect 
to the previous time point, and remained relatively constant at this level 
thereafter.
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Figure 4.5 ERK 1/2 activation in primary mouse corneal endothelial cells treated 
with growth factors. Cells in culture were serum starved for at least 2 hours prior to 
treatment with growth factor. 25ng/ml FGF-2, 100ng/ml EGF or 50ng/ml PDGF BB was 
added to serum-free culture media at 0, 5, 15, 30, 60 and 120 minute intervals. Lysates 
were made directly in reducing sample buffer. Both EGF and PDGF BB showed a peak 
in ERK 1/2 activation after 15 minutes of treatment with growth factor. FGF-2 stimulated 
a biphasic activation of ERK 1/2, with the first peak in activation after 30 minutes of 
stimulation and the second after 90 minutes of stimulation. Levels of total protein per 
sample were assessed to be equal by blotting samples for a-tubulin and total levels of 
ERK 1/2. This also revealed that levels of ERK 1/2 remained unchanged.
Cells stimulated with FGF-2 showed the most distinctive pattern of ERK 1/2 
activation, eliciting a biphasic profile of ERK 1/2 activation over a 2 hour time 
frame. This was a highly reproducible observation, which showed the first peak 
in activation occurs after 30 minutes of stimulation, and the second 90 minutes 
after stimulation. In this experiment activated ERK 1/2 began to accumulate in 
the cell after 5 minutes, and continued to increase in intensity resulting in a peak
FGF-2
EGF
PDGF BB
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after 30 minutes. By 60 minutes, levels of activated ERK 1/2 had fallen to almost 
basal levels, before peaking again after 90 minutes. At the end of 120 minutes of 
treatment, the levels of activated ERK 1/2 return to almost basal level. It is 
possible that further cycles of ERK 1/2 activation might occur in longer kinetic 
experiments.
4.3 Inhibition of the proliferative response
While it is clear from these experiments that the MAPK pathway is activated 
following growth factor stimulation of corneal endothelial cells, the question 
arises as to whether this pathway is vital to the proliferative response. Other 
intracellular pathways, including the PI3 kinase pathway, have also been 
implicated in growth factor-induced proliferation of the corneal endothelium (Kay 
et al., 1998). In order to investigate the roles of various intracellular pathways in 
the mitotic response of the corneal endothelium, proliferation assays were 
repeated in the presence of specific inhibitors targeting downstream effectors of 
the activated growth factor receptor tyrosine kinases. Three specific inhibitors 
were investigated. First, the selective and cell-permeable inhibitor of MAPK 
kinase (MEK), PD98059 (2’-amino-3’-methoxyflavone), was used to block the 
MAPK pathway. PD98059 inhibits the activation of MAPK and subsequent 
phosphorylation of MAPK substrates. Second, the potent, specific and cell- 
permeable inhibitor of PI3 kinase, LY294002 (2-(4-morpholinyl)-8-phenyl-4H-1- 
benzopyran-4-one), acts on the ATP-binding site of the kinase to block the PI3 
kinase pathway. Third, the non-specific protein tyrosine kinase inhibitor, 
genistein (4’,5,7-trihydroxyisoflavone), was used as a general inhibitor of tyrosine 
phosphorylation. The effects of each of these inhibitors were investigated with 
regard to the proliferative responses of primary mouse corneal endothelial 
cultures to serum and various growth factors.
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4.3.1 Dose response curves of inhibitor concentrations in a mouse corneal 
endothelial cell line
In order to determine the appropriate concentrations of inhibitor to use for 
these studies, dose response curves were conducted for each inhibitor on the 
SV40 transformed mouse corneal endothelial cell line. Cells in culture media, 
containing 10% serum, were treated with BrdU and four different doses of 
inhibitor overnight. BrdU positive cells were counted as a percentage of the total 
cell population. Western blotting was used to reveal the effects on downstream 
signalling molecules of various concentrations of inhibitor.
Doses of PD98059 tested included 1, 10, 50 and 100pM, with a dose of 50pM 
producing a maximal, though modest, inhibitory effect on proliferation. Doses of 
2, 10, 20 and 40jnM of inhibitor LY294002 produced a typical dose response 
curve, with a dose of 20pM LY294002 halving the proliferative response. Doses 
of 10, 50, 100 and 250pM genistein also produced a typical dose response 
curve, with 100pM proving to be the optimal inhibiting dose (Figure 4.6).
Western blotting was used to confirm that the inhibitors were indeed targeting 
the anticipated intracellular pathways. The effects of PD98059 were tested by 
blotting for phosphorylated ERK 1/2, which was found to be decreased with 
50pM PD98059. Phosphorylation of Akt (Protein Kinase B), a downstream 
effector of PI3 kinase, was appropriately decreased with treatment of 20pM 
LY294002, and a decrease in tyrosine phosphorylated polypeptides was also 
noted at a dose of 100pM genistein (Figure 4.6).
While each of these studies was completed over a 16 hour time course, the 
results were similar for cells treated for 24 hours. From the dose response 
curves, concentrations of inhibitors were selected for use in studies on primary 
cells. 50pM PD98059, 20(iM LY294002 and 100pM genistein were used for all 
further inhibitor studies. Taken together, these results suggest that tyrosine 
phosphorylation, and activation of the PI3 kinase pathway, contribute more to the 
proliferative response than the MAPK pathway in the SV40 transformed mouse 
corneal endothelial cell line.
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Figure 4.6 Inhibition of serum-induced proliferation in an SV40 transformed 
mouse corneal endothelial cell line. Cells were treated with serum and various 
inhibitors; PI3 kinase inhibitor, LY294002 (A), MAPK inhibitor, PD98059 (B) and tyrosine 
kinase inhibitor, genistein (C) for 16 hours. BrdU staining was used to visualise 
proliferating cells. 20jJVI LY294002 halved the proliferative response to serum and also 
reduced levels of phosphorylated Akt (A). 50pM PD98059 inhibited corneal endothelial 
cell proliferation and significantly decreased levels of phophorylated ERK1/2 (B). 
Treatment with 1 0 0 jiM  genistein produced a significant decrease in tyrosine 
phosphorylation coinciding with a reduction in serum-induced proliferation (C).
4.3.2 Inhibition of serum-induced primary mouse corneal endothelial cell 
proliferation
Initially, the effects of these inhibitors were tested on serum-induced 
proliferation of primary mouse corneal endothelial cells. Following a 24 hour 
serum starvation, the cells were treated with BrdU, 10% serum and the minimal 
doses of inhibitors that gave maximal inhibition of proliferation in the SV40 
transformed cell line. All inhibitors appeared to attenuate serum-induced 
proliferation. The general tyrosine kinase inhibitor, genistein, reduced serum 
stimulated proliferation to a lesser degree than blocking specific intracellular 
pathways (Figure 4.7). Treatment with either PD98059 or LY294002 
substantially reduced serum-induced proliferation to approximately a third of the 
original response, suggesting that both of these intracellular pathways play a role
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Figure 4.7 Effects of various inhibitors on serum-induced proliferation of primary 
mouse corneal endothelial cells. Mouse corneal endothelial cell cultures were treated 
with BrdU, 10% serum and inhibitor for 24 hours. BrdU positive nuclei were identified as 
a percentage of the total cell population. The strength of inhibition of the serum-induced 
proliferative response is as follows: MAPK inhibitor (PD98059) > PI3 kinase inhibitor 
(LY294002) > tyrosine kinase inhibitor (genistein). The combination of both PD98059 
and LY294002 produced a greater inhibitory effect than either of the two inhibitors alone. 
Serum-induced proliferation was significantly reduced with PD98059 and a combination 
of PD98059 and LY294002 (*p < 0.05). None of the inhibitors or combinations of 
inhibitors completely abolished the proliferative response of mouse corneal endothelial 
cells to serum. (n=3)
10% serum + PD 98059 + LY294002 + genistein + PD98059 +
LY294002
inhibitors
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in the serum-induced proliferative response, however, only PD98059 yielded a 
statistically significantly reduced serum stimulated proliferation (p<0.05). The 
combination of these two inhibitors produced a greater effect on serum-induced 
proliferation than either of
the inhibitors alone. This result was also found to be significant (p<0.05).
4.3.3 Inhibition of EGF-induced primary mouse corneal endothelial cell 
proliferation
Primary mouse corneal endothelial cell cultures were serum starved for 24 
hours prior to treatment with 100ng/ml EGF, BrdU and a panel of inhibitors for 48 
hours. The proliferative response elicited by EGF treatment was modest with 
approximately 3.5% of the total cell population entering mitosis. Treatment with 
any of the inhibitors, however, reduced this proliferative response to levels 
approximating basal levels of proliferation. These results suggest that EGF- 
induced proliferation is dependent on both the MAPK and PI3 kinase pathways.
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Figure 4.8 Effects of various inhibitors on EGF-induced proliferation on mouse 
corneal endothelial cells. Primary mouse corneal endothelial cell cultures were treated 
with BrdU, 100ng/ml EGF and inhibitor for 48 hours prior to fixation and staining for 
BrdU. BrdU positive nuclei were identified as a percentage of the total cell population 
Only the inhibitory effects of genistein was found to significantly reduce EGF-induced 
proliferation (* p<0.05). (n=3)
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Additionally, tyrosine phosphorylation of various intracellular targets clearly plays 
a vital role in the proliferative response, as inhibition of tyrosine phosphorylation 
significantly reduced EGF stimulated proliferation (Figure 4.8).
As these studies revealed the proliferative response of primary mouse 
corneal endothelial cell cultures to EGF to be very low, the effects of inhibitors in 
this experiment are unavoidably limited, hence it is not possible to draw 
conclusions from these results.
4.3.4 Inhibition of FGF-2-induced primary mouse corneal endothelial cell 
proliferation
Primary cultures were serum starved for 24 hours prior to treatment with 
25ng/ml FGF-2, BrdU and various inhibitors for 48 hours. Both PD98059 and 
LY294002 inhibited FGF-2-induced proliferation to a greater degree than 
genistein, though all three inhibitors significantly reduced FGF-2 stimulated 
proliferation (p<0.05). Treatment with genistein more than halved the 
proliferative response to FGF-2, while treatment with either PD98059 or 
LY294002 inhibited FGF-2 induced proliferation by approximately 65% (Figure 
4.9). The inhibitory effects of the combination of PD98059 and LY294002 
appeared to be less than those obtained with either of the two inhibitors alone. 
However, this counter-intuitive result conceals the fact that the combination of 
inhibitors PD98059 and LY294002 also induced cell death. The remaining living 
cells thus represented only a fraction of the original population, a number of 
which were BrdU positive. It is therefore likely that inhibition of both of these 
intracellular pathways results in a decreased capacity for cell survival when cells 
are treated with FGF-2 alone, which would be consistent with the known role of 
PI3 kinase as a survival factor, through its phosphorylation of Akt (Dudek et al., 
1997).
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Figure 4.9 Effects of various inhibitors on FGF-2-induced proliferation on mouse 
corneal endothelial cells. Primary mouse corneal endothelial cell cultures were treated 
with BrdU, 25ng/ml FGF-2 and inhibitor for 48 hours. BrdU positive cells were identified 
by antibody staining, and identified as a percentage of the total cell population. Ether 
MAPK inhibitor, PD98059, and PI3 kinase inhibitor, LY294002, produced a greater 
inhibitory effect than tyrosine kinase inhibitor, genistein. However, each of these 
inhibitors significantly reduced FGF-2 stimulated proliferation (p<0.05). The combination 
of PD98059 and LY294002 produced far less of an inhibitory effect on the FGF-2- 
induced proliferative response than PD98059 or LY294002 alone. This result may be 
unrepresentative, as the combination of both inhibitors also promoted cell death. None 
of the inhibitors, or combinations of inhibitors, were able completely abolished the 
proliferative response of mouse corneal endothelial cells to FGF-2.
4.3.5 Inhibition of PDGF BB-induced primary mouse corneal endothelial cell 
proliferation
Primary cultures were serum starved for 24 hours prior to testing the effects 
of inhibitors on PDGF BB-induced proliferation. LY294002 inhibited PDGF BB- 
induced proliferation to a lesser degree than either PD98059 or genistein, both of 
which significantly reduced PDGF BB stimulated proliferation (p<0.05).
LY294002 approximately halved the mitotic response to PDGF BB, while 
PD98059 and genistein were more potent in reducing the proliferative response 
to 15% of the control value (Figure 4.10). The combination of both PD98059 and 
LY294002 produced a similar effect to PD98059 alone, though this result was not
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statistically significant. These results suggest that the MAPK pathway may be 
more important that the PI3 kinase pathway in PDGF BB-induced proliferation.
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Figure 4.10 Effects of various inhibitors on PDGF BB-induced proliferation on 
mouse corneal endothelial cells. Primary mouse corneal endothelial cell cultures 
were treated with BrdU, 50ng/ml PDGF BB and inhibitor for 48 hours. BrdU positive 
nuclei were identified as a percentage of the total cell population. Treatment with MAPK 
inhibitor, PD98059, and tyrosine kinase inhibitor, genistein, both showed significant 
inhibition of PDGF BB-induced proliferation (*p<0.05). PI3 kinase inhibitor, LY294002, 
decreased PDGF BB-induced proliferation but to a lesser degree than that induced by 
the other inhibitors. Combination of both PD98059 and LY294002 did not inhibit 
proliferation more than PD98059 alone. None of the inhibitors or combinations of 
inhibitors completely abolished the proliferative response of mouse corneal endothelial 
cells to PDGF BB. (n=3)
4.4 Summary
Unstimulated, confluent primary mouse corneal endothelial cultures showed 
negligible levels of proliferation. However, even this very low level of proliferation 
was unexpected as corneal endothelial cells are generally considered to be G1- 
phase arrested. This low level of proliferation may be related to the lack of 
proper junction formation. Cell junctions have been demonstrated to play an 
important role in maintaining the non-proliferative status of the corneal
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endothelium (Senoo et al., 2000) and, as primary cultures do not form junctions 
as effectively as endothelium in situ, the lack of cell contact inhibition may 
account for a modest degree of cell proliferation. Treatment with 10% serum 
induced the greatest proliferative response with approximately 40% of the cell 
population entering the cell cycle. This is likely attributable to the host of factors 
present in serum. The overall pattern that emerges from experiments using 
single growth factors is one of a hierarchy of mitogenic capacity, such that PDGF 
BB > FGF-2 > EGF. Reports of corneal endothelial cell proliferation in other 
species have suggested a similar hierarchy of mitogenic capacity (Zhu and 
Joyce, 2004; Hoppenreijs et al., 1996). Despite many reports regarding 
proliferation of corneal endothelial cells in response to growth factors, few studies 
have investigated the intracellular signalling pathways involved. Studies of FGF- 
2-induced proliferation in rabbit corneal endothelium suggest proliferation is 
dependent upon the PI3 kinase pathway, as the inhibitor LY294002 completely 
abolishes the mitotic response to FGF-2 (Lee and Kay, 2003b). Though 
LY294002 significantly reduced FGF-2 stimulated proliferation in mouse corneal 
endothelial cultures, it did not completely abolish the proliferative response. 
Additionally, the MAPK inhibitor, PD98059, and the tyrosine kinase inhibitor, 
genistein, also significantly reduced FGF-2 induced proliferation. The 
discrepancy between these results may be due to the difference in proliferative 
potential of the corneal endothelium of the species used in each study. Lee and 
Kay (2003b) used a model of rabbit corneal endothelium, which is known to be 
relatively proliferative even when unstimulated. In contrast, unstimulated mouse 
corneal endothelial cultures showed a negligible amount of proliferation, this was 
far below that noted in rabbit corneal endothelium. Furthermore, treatment of 
FGF-2 stimulated mouse corneal endothelial cultures with a combination of 
inhibitors LY294002 and PD98059 was found to induce cell death. Therefore, it 
seems likely that these pathways play a role not only in the proliferative 
response, but also in the maintenance of mouse corneal endothelial cell survival.
Intracellular signalling pathways initiated by EGF or PDGF BB stimulation 
have not been investigated in the corneal endothelium. While both the MAPK
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inhibitor, PD98059, and the PI3 kinase inhibitor, LY294002, reduced EGF 
stimulated proliferation of mouse corneal endothelial cultures, only the tyrosine 
kinase inhibitor, genistein, provided a significant block to EGF-induced 
proliferation. It is, however, difficult to draw conclusions from these data, since 
EGF increased levels of proliferation only marginally above those observed in 
unstimulated cells. Conversely, PDGF BB elicited the greatest mitogenic 
response in mouse corneal endothelial cultures. Only PD98059 and genistein 
were able to significantly reduce the proliferative effects of PDGF BB. While 
LY294002 reduced PDGF BB stimulated proliferation, the reduction in 
proliferation was not significant. These results suggest that PDGF BB induced 
proliferation is more reliant on the MAPK pathway than the PI3 kinase pathway.
Similar studies were perfomed in parallel in the SV40 transformed cell line.
No difference was noted between the proliferative response of unstimulated cells 
and those treated with growth factors or serum, due to the high intrinsic 
proliferative capacity of these cells, however, the effects of inhibitors on this 
proliferative response were easily discernable. LY294002 and genistein reduced 
proliferation more potently than PD98059 in the SV40 transformed cell line.
Differences between primary cells and the SV40 transformed cell line were 
also apparent in MAPK activation, in response to growth factor stimulation. Both 
the kinetics and the pattern of ERK signalling differed between the SV40 
transformed mouse corneal endothelial cell line and primary mouse corneal 
endothelial cultures. The overall kinetics of activation appeared to be slower in 
the primary cells as compared to the cell line. Growth factor treatment initiated a 
peak in ERK 1/2 phosphorylation after 5 minutes in the cell line, while a peak in 
ERK 1/2 activation required at least 15 minutes of stimulation in primary cells. 
However, the most dramatic discrepancy between primary cells and the cell line 
was noted in FGF-2 treated cultures. The SV40 transformed cell line responded 
to FGF-2 treatment with a small peak in activation after 5 minutes, which then 
returned to basal levels after 15 minutes. Primary cells treated with FGF-2, 
however, showed a biphasic pattern of ERK1/2 activation. The first peak 
occurred after 30 minutes of FGF-2 stimulation and the second after 90 minutes.
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The implications of this difference in ERK1/2 signalling are unclear but warrant 
attention as the MAPK pathway has been demonstrated to be an important 
mediator of growth factor-induced proliferation. Biphasic activation of MAPK has 
previously been reported (Meloche et al., 1992) and is suggested to be 
necessary for a full mitogenic response. Presumably, SV40 transformation 
overrides the mechanism that regulates this pathway.
Unsurprisingly, studies in this chapter show that the proliferative responses of 
the SV40 transformed mouse corneal endothelial cell line and primary mouse 
corneal endothelial cells are different. SV40 transformation clearly provides a 
driving force for proliferation that cannot be matched in primary cultures, even 
when these are subjected to optimal concentrations of serum and growth factors. 
Further study suggests that these differences in proliferation may be the 
consequence of changes to intracellular signalling pathways involved in the 
growth factor induced proliferative response.
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Chapter 5: Primary human corneal endothelial cell culture
The techniques for primary culture of human corneal endothelial cells are well 
established (Baum et al., 1984; Engelmann et al., 1988; Engelmann and Friedl, 
1989). Isolation of endothelial cells from the human cornea involves separation 
of Descemet’s membrane and the associated monolayer of endothelial cells from 
the corneal stroma. Cells can then be detached from Descemet’s membrane by 
treatment with EDTA. Culture medium for human corneal endothelial cells is 
routinely supplemented with growth factors to enhance proliferation and assist 
survival. At present, it remains unclear which growth factors are responsible for 
the proliferative response and which growth factors play a role in cell survival. To 
gain insight into these questions, studies in this chapter make use of three 
growth factors; EGF, FGF-2 and PDGF BB. Both EGF and FGF-2 are routinely 
used to supplement human corneal endothelial culture media and their 
proliferative effects have been investigated in both culture (Samples et al., 1991; 
Senoo and Joyce, 2000; Zhu and Joyce, 2004) and wound healing models 
(Hoppenreijs et al., 1992). Only one study has investigated the proliferative 
effects of PDGF BB on human corneal endothelial cells (Zhu and Joyce, 2004). 
The intracellular pathways which mediate the proliferative response of the human 
corneal endothelium have not been investigated. Because cell contact has been 
demonstrated to play a role in human corneal endothelial cell expansion (Senoo 
et al., 2000), analysis of cell junctions was also undertaken in conjunction with 
cell proliferation studies. Analysis of cell junctions and growth factor-induced 
proliferation enable comparisons to be made between human and mouse corneal 
endothelial cultures, and thus develop an informed view as to whether mouse 
corneal endothelial cultures present an appropriate model for human corneal 
endothelium.
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5.1 Characterisation of primary human corneal endothelial cultures
5.1.1 Human corneal endothelial cell morphology
Following previously described methods for the isolation of human corneal 
endothelial cells, Descemet’s membrane was separated from the cornea and 
endothelial cells were detached using trypsin and EDTA. Dissociation of corneal 
endothelial cells from Descemet’s membrane typically resulted in patches of the 
endothelial monolayer separating from the matrix. Isolated corneal endothelial 
cells were plated into tissue culture dishes coated with a mixture of matrix 
proteins. Initial densities of human corneal endothelial cultures were low (Figure
5.1 A), allowing the cells to spread and proliferate and adopt a variety of 
morphologies. Generally, the cells spread and flattened and come into close 
contact with neighbouring cells, resulting in enlarged surface areas and nuclei, 
which appeared as bulges in the membrane (Figure 5.1 A). As the cells 
continued to proliferate, cultures reached a higher density and eventually 
covered the cell culture dish. Overall, densities of corneal endothelial cells varied 
over the surface of the tissue culture dish, with the greatest density of cells at the 
centre (Figure 5.1 C) and the lowest densities at the perimeter of the culture dish 
(Figure 5.1 D). The heterogeneous cell population at the edge of the culture dish 
included large flattened cells with nuclei forming a low bulge at the cell surface, 
similar to those noted in low density cultures (Figure 5.1 D). The central region of 
the dish contained a relatively homogeneous population in which cells displayed 
a more regular morphology (Figure 5.1C). Phase images also appeared to 
suggest a decrease in cell surface area, which is likely the result of progression 
from thin, flattened cells to columnar shaped cells. As the cells became 
columnar in shape, they no longer displayed protruding nuclei (Figure 5.1C). The 
characteristics of human corneal endothelial cultures were distinctive from those 
of potentially contaminating corneal keratocytes/fibroblasts. Unlike corneal 
endothelial cells, corneal keratocyte cultures quickly proliferated to form layers of 
elongated cells in swirling patterns (Figure 5.1B).
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Figure 5.1 Phase images of human corneal endothelial and keratocyte cultures.
Human corneal endothelial cell cultures were established by separating Descemet’s 
membrane from organ cultured corneas and isolating the endothelial cell population from 
this membrane. At the beginning of culture, the cells are large, as they spread to fill the 
available space (A). After approximately 8-12 weeks in culture, cell populations become 
densely packed and begin to more closely resemble endothelial monolayers of the 
cornea. Towards the centre of the culture dish, the cells form a densely packed 
monolayer (C), however, at the edge of the culture dish, a less dense, heterogeneous 
cell population exists (D). While the phenotype of corneal endothelial cells varies 
depending on cell density, it consistently remains distinct from that of corneal 
keratocytes/fibroblasts (B). As the cells are passaged, the endothelial monolayers 
generated in culture become increasingly heterogeneous.
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Figure 5.2 The F-actin phenotype of human corneal endothelial cells at high and 
low density. To examine the cytoskeletal morphology of human corneal endothelial 
cells at high and low density, cultures were fixed in paraformaldehyde for 
immunofluorescence staining of F-actin and paxillin. At low density, human corneal 
endothelial cells had a variable cell shape. The majority of cells showed cortical actin 
with a patchy distribution of paxillin (A). Low density cultures also contained a number of 
cells with actin stress fibres (B). Overall, very little paxillin was present in low density 
cultures. At higher density, cells consistently showed cortical actin and punctate paxillin 
along the basal membrane (C).
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In order to further investigate the morphological differences between low and 
high density human corneal endothelial cell cultures, the expression of F-actin 
and paxillin within the cell was examined. The majority of the cell population 
were essentially round with some membrane ruffling. These cells tended to 
display a ring of cortical actin (Figure 5.2A). Occasionally, cells also displayed 
cytoplasmic extensions from the cell body. Membranes at the edge of the 
elongated area typically displayed ruffles and these cells also tended to have 
actin stress fibres (Figure 5.2B). The distribution of paxillin suggested that focal 
adhesions were unevenly distributed along the basal membrane of the cells 
(Figure 5.2). Cultures at high density contained cells with a thick band of cortical 
actin and a punctate distribution of focal adhesions along the basal membrane 
(Figure 5.2C).
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Figure 5.3 Nuclear morphology of human corneal endothelial cells. Primary human 
corneal endothelial cultures were fixed with cold methanol and stained using anti-lamin B 
antibodies. The majority of the cell population had an oval shaped nucleus (B,C), 
however, occasionally cells contained nuclei with large folds in the nuclear envelope (A). 
The nuclear envelope was identified by staining, lamin B.
lamin B nuclear stain combined phase image
10nm
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The majority of cells in both low and high density primary human corneal 
endothelial cell cultures had oval shaped nuclei (Figure 5.3B&C), however, some 
low density cultures also contained cells with aberrations in nuclear morphology. 
The most frequent variation in nuclear morphology was manifest as folds in the 
nuclear envelope, which were visualized by immunofluorescence staining of 
lamin B (Figure 5.3A). The significance of these unusual folds in the nuclear 
envelope is unclear. However, as high density cultures did not contain these 
unusual shaped nuclei, it is likely that these cells alter their nuclear morphology 
to become oval shaped or die.
5.1.2 Verification of human corneal endothelial cell cultures
Despite displaying a typical endothelial phenotype, it was necessary to verify 
that primary cultures were indeed corneal endothelial cells and not contaminating 
corneal keratocytes. These two corneal cell types are known to express a 
different profile of matrix proteins, with only corneal endothelial cells expressing 
type VIII collagen. RT-PCR for a1 type VIII collagen was therefore used as one 
method of verification that cultures of human cells were indeed corneal 
endothelium. Primers for the PCR reaction were designed such that the forward 
primer-binding site lay in exon 1 of the a1 type VIII collagen gene, while the 
reverse primer-binding site was located in exon 2 of the same gene. The total 
length of the expected PCR product amplified from reverse transcribed mRNA 
was 478 base pairs. The length of a potential PCR product amplified from 
contaminating genomic DNA would have been much longer (5.7kb), as it would 
also contain the intron, thus ensuring that a PCR product of the correct predicted 
size could only be amplified from precursor mRNA. RT-PCR reactions from 
corneal keratocyte cultures and corneal endothelial cell cultures both showed 
mRNA expression of p-aetin, demonstrating acceptable mRNA quality, however, 
only the corneal endothelial cell cultures demonstrated the 478bp band indicating 
mRNA expression of a1 type VIII collagen (Figure 5.4).
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Figure 5.4 Primary human corneal endothelial cells express a1 type VIII collagen.
Total RNA was extracted from primary cultures of human corneal endothelial cells and 
human corneal keratocytes. RT-PCR was used to generate cDNA and amplify a1 type 
VIII collagen expression in both cultures. Primary human corneal endothelial cell 
cultures were demonstrated to express a1 type VIII collagen mRNA, while primary 
human corneal keratocyte cultures do not. Expression of p-actin confirms the quality of 
mRNA preparations from both corneal endothelial and corneal keratocyte cultures.
In addition to demonstrating mRNA expression of type VIII collagen, a cell 
type specific antibody was used as a second determinant of corneal endothelial 
cells. In order to help identify corneal endothelial cultures, Engelmann et al. 
(2001) generated a monoclonal antibody, known as mab 9.3E, which recognizes 
a protein of 130kDa that is enriched along corneal endothelial cell membranes. 
While the protein targeted by the antibody is also present in a number of other 
cell types, including Schwann cells and adipocytes, only the corneal endothelium 
is identified in ocular tissue (Engelmann et al., 2001). Cells at confluence 
demonstrated distribution of this protein along the cell borders, while 
subconfluent cells showed a diffuse staining with occasional focal blebs within 
the cell (Engelmann et al., 2001). Human corneal endothelial cultures at a 
density similar to that in Figure 5.1B were stained with mab 9.3E, yielding a 
diffuse cytoplasmic immunoreactivity with occasional blebs or vesicular staining, 
as previously described by Engelmann et al. (2001) for subconfluent cultures 
(Figure 5.5A). In contrast, mab 9.3E staining of human corneal endothelial 
monolayers in situ, showed a distribution along the cell borders (Figure 5.5B). 
These results suggest that while cultures of human corneal endothelial cells may 
appear confluent when judged by phase microscopy, they do not exhibit the 
same degree of junctional integrity as endothelial monolayers in situ.
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Figure 5.5 Antibody 9.3E stains primary human corneal endothelial cultures.
Cultured human corneal endothelial cells and whole corneal tissue were fixed in cold 
methanol and stained with monoclonal antibody 9.3E. Images were captured on a Leica 
AOBS microscope with LCS (v.2) software. In ocular tissue, only the corneal 
endothelium is recognized by monoclonal antibody 9.3E, which targets a 130kDa 
protein. Both cultured cells and whole corneal tissue were fixed in methanol and stained 
with antibody 9.3E. Subconfluent cultures display a different pattern of staining to 
confluent cultures with antibody 9.3E. Immunofluorescence staining with antibody 9.3E 
shows a diffuse stain with occasional blebs in the cytoplasm in primary human corneal 
endothelial cultures (A). This pattern of antibody 9.3E staining is consistent with that 
noted for subconfluent cultures, despite human corneal endothelial cultures appearing 
confluent by phase microscopy. Immunofluorescence staining of human corneal 
endothelial monolayers in situ, however, shows the 130kDa protein to be distributed at 
the cell borders (B).
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5.1.3 Junctional integrity of human corneal endothelial cells
Corneal hydration and transparency is maintained by the barrier of the 
corneal endothelium. The formation of tight junctions within the corneal 
endothelial monolayer is vital to its barrier function. While tight junction formation 
between corneal endothelial cells has been demonstrated by electron 
microscopy, the proteins that make up the tight junction plaque are largely 
unknown. Studies of the corneal endothelium generally use the distribution of 
tight junction associated protein ZO-1 as a marker of tight junction integrity. 
Primary human corneal endothelial cultures display a slightly different distribution 
of ZO-1 to human corneal endothelial monolayers in situ. While ZO-1 distribution 
in primary cultures is discontinuous around the cell borders (Figure 5.6A), ZO-1 
is organised in a tight band surrounding the cells in endothelial monolayers in situ 
(Figure 5.6B). The pattern of staining noted in primary cultures is not
primary cultures whole cornea (32 yrs)
Figure 5.6 Distribution of ZO-1 in human corneal endothelial cells. Whole corneal 
tissue and confluent primary human corneal endothelial cultures were fixed in cold 
methanol and stained for tight junction protein ZO-1. Primary human corneal endothelial 
cultures were composed of larger, flatter cells than cells in corneal endothelial 
monolayers in situ. ZO-1 is distributed to cell borders in primary human corneal 
endothelial cultures, however, it does not appear as a tight band surrounding the cell, as 
expected during tight junction formation (A). The discontinuous staining at the cell 
borders noted in primary human corneal endothelial cultures (A) may represent ZO-1 
distribution at adherens junctions or immature tight junctions. Human corneal 
endothelial monolayers in situ are known to form a tight junction barrier, which can be 
visualised in a strong band of ZO-1 staining around the cell borders (B). Distribution of 
ZO-1 on the corneal endothelial monolayer in situ also demonstrates the complex 
interdigitations between neighbouring cells (inset). The corneal button used to visualise 
ZO-1 distribution originated from a 32 year old keratoconus patient.
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Figure 5.7 Distribution of tight junction proteins in human corneal endothelial 
monolayers. Corneal buttons from keratoconus patients were used to investigate the 
expression of tight junction proteins in the corneal endothelial monolayer. Corneal 
buttons were fixed in cold methanol and stained with antibodies to various tight junction 
proteins. Images were captured using a Leica AOBS microscope with LCS (v.2) 
software. Transmembrane tight junction proteins occludin (A) and claudin-1 (B) both co­
localized with ZO-1 at the cell borders. Tight junction associated proteins PAR-3 (C) and 
ZO-2 (D) also co-localized with ZO-1 at the cell borders. Corneal tissue was received 
from patients of different ages; 20 years (C), 22 years (B), 36 years (A) and 37 years 
(D).
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regarded as representative of mature tight junctions, but rather immature tight 
junctions or adherens junctions.
Despite its distinctive distribution in culture, the use of ZO-1 organisation as a 
marker of tight junction formation may be misrepresentative, as cells without tight 
junctions also exhibit ZO-1 enrichment at cell borders at the adherens junctions.
In order to better assess the human corneal endothelial tight junction, the 
distribution of a number of other tight junction associated proteins was 
investigated. Transmembrane tight junction proteins occludin and claudin-1 both 
stained positively at the human corneal endothelial cell-cell contact points (Figure 
5.7A&B). Similarly, adaptor tight junction proteins ZO-2 and PAR-3 were also 
identified at the human corneal endothelial cell borders (Figure 5.7C&D). All of 
these proteins colocalized with ZO-1. While these four tight junction proteins all 
stained readily in human corneal endothelial monolayers in situ, none were 
detected in primary human corneal endothelial cell cultures (not shown).
claudin-1 ZO-1 nuclear stain combined
Figure 5.8 Distribution of tight junction proteins in the corneal endothelial 
monolayer of a patient with Fuchs’ corneal endothelial dystrophy. The corneal 
button was fixed in cold methanol and stained with antibodies targeting tight junction 
proteins ZO-1 and claudin-1. Both tight junction proteins were found at the cell borders 
of corneal endothelial cells. Interestingly, some endothelial cells in the monolayer 
appeared to have no nuclei. It is likely that this is not the case, but rather the nuclei 
have shifted in position with alterations in Descemet’s membrane, below the endothelial 
cell layer. The deposition of discrete excrescences of matrix by the corneal endothelium 
is one of the hallmarks of Fuchs’ corneal endothelial dystrophy.
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The distribution of tight junction proteins ZO-1 and claudin-1 was also 
assessed in the endothelial cell monolayer of a corneal button removed from a 
55 year old patient with Fuchs’ corneal endothelial dystrophy. Although ZO-1 
and claudin-1 localized correctly to cell-cell contacts in corneal endothelial cells 
in the Fuchs’ cornea (Figure 5.8), there was marked heterogeneity of cell size 
and shape, and the nuclei were highly disorganized, such that some cells 
appeared to lack a nucleus. This effect is likely the consequence of alterations in 
cell shape to accommodate discrete excrescences of matrix laid down by the 
diseased endothelium. The fact that corneal endothelial tight junctions remain 
intact indicates the importance of this feature to the function of the corneal 
endothelial monolayer.
5.2 Proliferation of human corneal endothelial cultures
Tissue culture media for human corneal endothelial cells is routinely 
supplemented with growth factors to enhance proliferation and assist survival. 
Chen’s media for human corneal endothelial cell culture contains 5ng/ml 
epidermal growth factor (EGF), 20ng/ml nerve growth factor (NGF) and 
100mg/ml pituitary extract, known to contain a high concentration of fibroblast 
growth factor (FGF). The proliferative effects of three growth factors, EGF, FGF- 
2 and PDGF BB, were thus investigated in primary human corneal endothelial 
cell cultures.
Human corneal endothelial cultures used for proliferation studies were 
passaged once and then maintained in serum and growth factor-free media for 
24 hours prior to experimentation. Cultures were then treated for 24 or 48 hours 
with growth factor and BrdU, a reporter of cell proliferation as described in 
Chapter 4. Proliferating (BrdU positive) cells were identified as a percentage of 
the total cell population. Random samples of cells were counted from all areas of 
the primary cell monolayers, and at least 3000 cells were counted per treatment. 
Cultures maintained in base media, containing no serum or growth factors, were
used as a negative control, and treatment with 10% foetal calf serum was used 
as a positive control.
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Figure 5.9 Proliferative response of human corneal endothelial cell cultures to 
growth factor stimulation. Human corneal endothelial cells were maintained in serum 
free media for 24 hours prior to treatment with growth factors. Cultures were 
concomitantly treated with BrdU and growth factors for a period of 24 or 48 hours. 
Proliferating cells were identified as a proportion of the total cell population with anti- 
BrdU antibody. Treatment with 100ng/ml EGF, 25ng/ml FGF-2 or 50ng/ml PDGF BB 
appeared to simulate a small amount of proliferation, however, this proliferative 
response were not significantly different compared to unstimulated cells. Similarly, a 
combination of all 3 growth factors stimulated a small amount of proliferation but this was 
also not significant with respect to that observed in unstimulated cultures. The 
proliferative response to treatment with 10% serum was significantly greater than that 
observed in unstimulated cultures, and was used as a positive control (*p<0.05). (n=4)
Surprisingly, unstimulated cells retained a low level of proliferation, with 
approximately 4% of the cell population staining BrdU positive. Supplementation 
of base media with individual growth factors did little to enhance this proliferation. 
Each growth factor was found to induce approximately 5% of the cell population 
to proliferate. While growth factor treatment consistently induced more 
proliferation than noted in unstimulated cultures, the increase was not 
significantly greater than in cells without growth factor stimulation. The
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combination of all three growth factors also produced consistently greater 
proliferation than observed in unstimulated cells, however, this again was also 
not statistically significant. Stimulation with 10% serum, however, did induce a 
proliferative response that was significantly greater than that of untreated cells 
(p<0.05) (Figure 5.9).
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Figure 5.10 Proliferative response of human corneal endothelial cells to varying 
concentrations of epidermal growth factor, EGF. Confluent cultures of human 
corneal endothelial cells were maintained in serum free media for 24 hours prior to 
treatment with EGF. Cells were treated with both EGF and BrdU for 48 hours prior to 
fixation and staining with an anti-BrdU antibody to recognize proliferative cells. 
Concentrations of EGF ranging from 5ng/ml to 100ng/ml showed no difference in the 
proliferative effects on corneal endothelial cells. Unstimulated cells were used to 
determine the basal level of proliferation, while cells treated with 10% serum were used 
as a positive control. Only serum stimulation of primary cultures significantly increased 
human corneal endothelial cell proliferation above unstimulated cultures (*p<0.05). (n=4)
It has been suggested that different doses of EGF can produce opposing 
cellular responses, with low doses of EGF inducing proliferation and high doses 
of EGF inhibiting proliferation. Previous growth factor studies involved high 
doses of EGF, while human corneal endothelial growth media contains a low 
concentration of EGF. To test whether different doses of EGF might produce 
variable effects in human corneal endothelial cultures, the proliferative response
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to 5ng/ml, 10ng/ml, 50ng/ml and 100ng/ml EGF was tested. Unstimulated cells 
were again used as a negative control and treatment with 10% serum as a 
positive control. At all concentrations tested, EGF failed to induce proliferation to 
an extent that was significantly different from proliferation noted in unstimulated 
cultures (Figure 5.10). Again, serum-induced proliferation was significantly 
greater than that of unstimulated cultures (p<0.05).
5.3 Kinetics of ERK activation of primary human corneal endothelial ceils
The failure of EGF, or indeed FGF-2 and PDGF BB, to induced a proliferative 
response in human corneal endothelial cells, might imply that either the 
respective receptors are not expressed in these cells, or that downstream 
signalling from these receptors is absent or inadequate. To determine whether 
the MAPK pathway was activated following growth factor stimulation of human 
corneal endothelial cells, western blotting of phospho-ERK1/2 was performed on 
whole cell lysates of growth factor treated cell cultures.
Primary human corneal endothelial cultures were serum starved overnight 
prior to growth factor stimulation. Cultures were treated with 100ng/ml EGF, 
25ng/ml FGF-2 or 50ng/ml PDGF BB for 0, 5, 15, 30, 60, 90 or 120 minutes. Cell 
lysates were western blotted for the phosphorylated forms of ERK 1/2. All growth 
factors showed a similar pattern of ERK 1/2 phosphorylation. Phosphorylated 
ERK1/2 began to accumulate after 5 minutes of treatment with growth factor and 
peaked after 15 minutes of stimulation (Figure 5.11). The same blots were also 
probed for a-tubulin to ensure equal protein loading. Quantitative evaluation 
revealed little difference in the kinetics of ERK1/2 activation, irrespective of 
growth factor used.
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Figure 5.11 ERK activation in human corneal endothelial cell cultures following 
treatment with growth factor. Cells were treated with 25ng/ml FGF-2, 100ng/ml EGF 
or 50ng/ml PDGF BB for 0, 5, 15, 30, 60, 90 and 120 minutes. Whole cell lysates were 
made directly in reducing sample buffer. Western blotting for phosphorylated ERK 
demonstrated ERK activation after 5 minutes of treatment with growth factor, with a peak 
in activation after 15 minutes of treatment with growth factor. A low level of sustained 
ERK phosphorylation appeared to be present after 2 hours in FGF-2 and EGF treated 
cultures. Levels of total protein in samples was normalised and checked by western 
blotting for a-tubulin.
5.4 Inhibition of serum-induced proliferation in primary human corneal 
endothelial cultures
The PI3 kinase pathway has been shown to play a vital role in FGF-2 induced 
proliferation of rabbit corneal endothelium, with the PI3 kinase inhibitor, 
LY294002, able to abolish FGF-2 induced proliferation (Lee and Kay, 2003b). 
However, the intracellular pathways responsible for regulating proliferation of 
human corneal endothelium remain largely unknown. As growth factor 
stimulation of human corneal endothelial cultures did not produce significantly 
different proliferative responses to that observed in unstimulated cells, it would 
have been impossible to assess the actions of inhibitors of specific growth factors 
on proliferation of human corneal endothelial cultures. As treatment with 10% 
serum induced a significant amount of cell proliferation, inhibitors were used to 
investigate the intracellular pathways involved in serum-induced human corneal 
endothelial cell proliferation. Cultures were simultaneously treated with BrdU,
FGF-2
EGF
PDGF BB
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10% serum and either PD98059, LY294002 or the tyrosine kinase inhibitor 
genistein. Proliferation was measured by counting numbers of BrdU positive 
nuclei. Concomitant treatment of human cultures with serum and any of the 
tested inhibitors resulted in a significant decrease in the proliferative response as 
compared to treatment with serum alone (p<0.05). Treatment with a combination 
of PD98059 and LY294002 also produced a significantly decreased amount of 
cell proliferation (p<0.05) (Figure 5.12). These results suggest that the MAPK 
pathway, PI3 kinase pathway and tyrosine phosphorylation all play a critical role 
in serum-induced proliferation of human corneal endothelium.
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Figure 5.12 Effects of inhibitors on serum-induced proliferation of primary human 
corneal endothelial cultures. Confluent cultures were serum starved overnight prior to 
experimentation and then treated with BrdU, 10% serum and various inhibitors, including 
PI3 kinase inhibitor (LY294002), MAPK inhibitor (PD98059) and tyrosine kinase inhibitor 
(genistein). Anti-BrdU antibody was used to identify proliferating cells as a percentage 
of the total cell population. Each inhibitor significantly reduced serum stimulated 
proliferation to approximately basal levels (*p<0.05). The combination of inhibitors 
LY294002 and PD98059 also significantly reduced serum stimulated proliferation 
(*p<0.05). (n<3)
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5.5 Development of a human corneal endothelial cell line
Because human corneal tissue is prioritised for transplantation, it is difficult to 
obtain material for research. One way to rectify this problem would be the 
development of a representative, high quality human corneal endothelial cell line, 
though the generation of such a line has yet to be achieved. A human corneal 
endothelial cell line was developed by Wilson et al. (1993) by transfection with 
SV40 large T antigen, however, this cell line is highly proliferative and, as was 
observed in the SV40 transformed mouse corneal endothelial cell line (Chapter 
3), likely continues to proliferate beyond the monolayer to form multiple cell 
layers. As the corneal endothelium in vivo is contact inhibited, such a cell line is 
thus unrepresentative. A human corneal endothelial cell line with inducible 
proliferation, such that proliferation can be “turned on” to generate large cell 
numbers and then “switched off’ when the monolayer is at an appropriate cell 
density, would be ideal.
Pharmaceutical company ReNeuron has generated an inducible, recombinant 
retroviral vector for the purpose of human neural cell conditional immortalization. 
This system utilizes a pLNC vector containing the c-myc proto-oncogene. The c- 
myc protein is a gene regulator and has been shown to enhance transcription of 
a number of direct target genes, which positively and negatively regulate cell 
growth. Deregulated c-myc expression has been associated with tumorigenesis 
and overexpression of c-myc induces telomerase expression, which is 
associated with extended lifespan. Within the specified vector, the c-myc protein 
is fused to a transcriptionally inactive mutant mouse oestrogen receptor, such 
that functional activity of c-myc is dependent upon the presence of exogenously 
applied 4-hydroxytamoxifen.
Aliquots of human and mouse corneal endothelial cell media containing 
replication incompetent retroviruses were obtained from ReNeuron. Primary 
human and mouse corneal endothelial cells were incubated in virus-containing 
media for a total of 48 hours, with media refreshed every 12 hours. Cells
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transfected with the pLNC-cmycER™ vector were selected with 600pg/ml 
geneticin. Selection resulted in cultures of very few, sparse corneal endothelial 
cells. These cells spread to become giant cells but did not proliferate. Treatment 
with 100nM 4-hydroxytamoxifen is known to induce transformed neural cells to 
proliferate but did not affect transformed corneal endothelial cells. Upon 
prolonged culture, transfected corneal endothelial cells failed to thrive, and it 
ultimately proved impossible to clone out a conditionally immortalized cell line.
5.6 Summary
Methods described for the isolation and culture of human corneal endothelial 
cells involve separation of the endothelial monolayer and its associated 
extracellular matrix (Descemet’s membrane) from the cornea. Endothelial cells 
at low density spread by flattening and membrane ruffling, and proliferated to fill 
the tissue culture dish. Some cells showed cytoplasmic elongations, which 
contained stress fibres during cell spreading, though most showed a ring of 
cortical actin, similar to that observed in cells at confluence. Stress fibres have 
also been noted in rabbit corneal endothelial cultures upon prolonged treatment 
with FGF-2, and are thought to be involved in endothelial to mesenchymal 
transformation (EMT) (Lee et al., 2004; Lee and Kay, 2003a). Unlike rabbit 
corneal endothelial cells, primary human corneal endothelial cells which 
displayed stress fibres, did not alter their morphology to become elongated with 
mesenchymal characteristics, but instead grew to form a heterogeneous 
monolayer. Primary human corneal endothelial monolayers varied in density but 
all cells displayed cortical actin and focal adhesions along the basal cell 
membrane.
In order to confirm that established growing cells were endothelial, 
morphological characteristics noted by phase microscopy, a1 type VIII collagen 
expression and positive staining with corneal endothelial specific antibody 9.3E 
were used to assess the primary cultures. All three criteria indicated that primary 
cultures were indeed corneal endothelial. However, the distribution of
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monoclonal antibody 9.3E was unexpected. Antibody 9.3E staining of 
subconfluent cultures displayed a diffuse staining with small focal blebs, while 
confluent cultures stained at the cell border with antibody 9.3E (Engelmann et al., 
2001). Primary human corneal endothelial cultures, which appeared confluent by 
phase microscopy, were stained with monoclonal antibody 9.3E to reveal a 
staining pattern consistent with subconfluent cultures. Zhu & Joyce (2004) noted 
the same pattern of antibody 9.3E staining in primary human cultures. It is 
possible that the protein target of antibody 9.3E accumulates at the cell borders 
only in monolayers with proper junction formation. As the discontinuous 
distribution of ZO-1 at the cell borders noted in primary human cultures indicates 
improper junction formation, this may explain the unexpected results in staining 
with antibody 9.3E. While primary human corneal endothelial cultures form 
immature junctions, endothelial monolayers in situ form mature tight junctions as 
indicated by the distribution of ZO-1 in a tight band around the cell borders.
While a number of studies have investigated the distribution of adherens junction 
proteins in the corneal endothelium, including catenins and cadherins, tight 
junction proteins have not been extensively studied. Transmembrane tight 
junction proteins occludin and claudin-1 were found to be present in endothelial 
monolayers in situ but not in primary cultures. Similarly, the tight junction adaptor 
proteins ZO-2 and PAR-3 were also expressed in endothelial monolayers in situ. 
PAR-3 has been demonstrated to form an active complex with PAR-6 and aPKC, 
which is important to tight junction formation and cell polarization (Lin, 2000). Its 
presence at the corneal endothelial tight junction reveals the cells of the 
monolayer to be polarized and contain functional tight junctions. The absence of 
PAR-3 in primary cultures suggests that tight junction formation is not complete 
and that cells are therefore unlikely to be fully polarized.
Incomplete junction formation may also help explain the surprising 
proliferative responses of primary human corneal endothelial cells to growth 
factor stimulation. While stimulation with EGF, FGF-2, PDGF BB or a 
combination of the three growth factors, consistently increased the rate of 
proliferation over that observed in unstimulated cells, these responses were not
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significantly different. Corneal endothelial cells in vivo are known to be G1-phase 
arrested and cell contact inhibition is thought to play a vital role in the 
maintenance of G1 -phase arrest (Senoo et al., 2000). Because human corneal 
endothelial cultures do not form mature junctions in the same manner as human 
corneal endothelial monolayers in situ, cultured cells are not properly contact 
inhibited, which is consistent with the observed low levels of proliferation. Zhu & 
Joyce (2004) also studied the proliferation of primary human corneal endothelial 
cell cultures treated with growth factors over a prolonged period of time and 
found a hierarchy of mitogenic action such that PDGF BB > FGF > EGF. The 
discrepancy between these results may be a factor of time, as differences in 
mitogenic effects of these growth factors were only noted after weeks of 
treatment, but not after 48 hours.
The intracellular signalling pathways induced by growth factor stimulation 
remain largely unknown in the human corneal endothelium. While the PI3 kinase 
pathway has been shown to be vital to FGF-2 induced proliferation in rabbit 
corneal endothelium (Lee and Kay, 2003b), inhibitor studies of serum-induced 
human corneal endothelial cell proliferation suggest that both the MAPK and PI3 
kinase pathways are important. In addition, tyrosine phosphorylation appears to 
play a vital role in the human corneal endothelial proliferative response. 
Downstream targets of MAPK, ERK 1/2 were investigated following stimulation 
with EGF, FGF-2 and PDGF BB. Each growth factor elicited a similar response 
with a peak in ERK 1/2 activation following 15 minutes of growth factor 
stimulation. The failure of these growth factors to induce proliferation despite 
activating the MAPK pathway and in the absence of cell-cell contact inhibition, 
appears paradoxical. The fact that proliferation was observed with serum, 
indicates that further factor(s) must be present that provide additional stimuli or 
remove an unknown cellular block to cell cycle entry.
Because so little is known about the intracellular signalling of corneal 
endothelial cells, and corneal tissue available for research is rare, a 
representative model for the corneal endothelium would be ideal. Using the 
pLNC-cymcER construct from ReNeuron, attempts were made to generate an
148
inducible human corneal endothelial cell line. Unfortunately, a number of 
attempts to isolate an inducible cell line failed. The reasons for this are unclear, 
though there are a number of possibilities. First, viral titres in media used for 
infection (from ReNeuron) were not quantitated and may have been too low. 
Second, it has been suggested, by ReNeuron, that the virus incorporates readily 
into actively cycling cultures of cells but not into non-proliferative cultures. As the 
rate of proliferation in primary human corneal endothelial cultures is low, the 
chance of infection was reduced. Third, cells which appeared to have been 
infected with virus, after selection with G418, continued to die in normal growth 
media, after the selection process. The cells remaining at the end of the 
selection process were typically isolated cells spread around the tissue culture 
dish. These cells spread and flattened to form giant cells but then proceeded to 
die. It is unclear why treatment with 4-hydroxytamoxifen at this stage did not 
induce these cells to proliferate. Nevertheless, the generation of a representative 
cell line remains a much-needed objective for researchers in this area.
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Chapter 6: Discussion
The primary goal of this work was to evaluate the utility of models of primary 
human corneal endothelial tissue. Bovine, rabbit and rat corneal endothelium are 
the most commonly used models for research on corneal endothelium, but while 
these tissues are readily available, they are not representative of the human 
corneal endothelial monolayer for the fundamental reason that they are highly 
proliferative. An alternative model, which has remained virtually unstudied, is the 
mouse corneal endothelium. Joo et al. (1994) described a complex methodology 
for the isolation and culture of mouse corneal endothelial cells, which were 
compared to a mouse corneal endothelial cell line generated by transformation 
with SV40 large T-antigen. Based on the cells’ similar propensity to adhere to 
Descemet’s membrane, and equivalent expression of EGF receptor and PDGF 
receptors a and p, it was concluded that the SV40 transformed mouse corneal 
endothelial cell line was indeed an appropriate model for primary mouse corneal 
endothelial cells (Joo et al., 1994). In this project, using a mechanistically 
simpler explant model of mouse corneal endothelium, it was found that there are 
in fact significant differences between primary mouse corneal endothelial cultures 
and SV40 transformed mouse corneal endothelial cells. The five major 
differences between primary and SV40 transformed mouse corneal endothelial 
cells are reviewed in detail below.
First, the propensity for SV40 transformed mouse corneal endothelial cultures 
to proliferate is unsurprisingly far greater than that of primary cultures. While 
primary cultures form a heterogeneous monolayer of cells, which cease to 
proliferate with time in culture, the SV40 transformed cell line forms a 
homogeneous monolayer of cells that continues to proliferate beyond the point of 
contact inhibition to form multiple cell layers. Additionally, whereas primary 
corneal endothelial cell proliferation is significantly increased by stimulation with 
growth factors FGF-2 or PDGF BB, the proliferative effects of growth factors on 
the SV40 transformed cell line are negligible due to the high levels of intrinsic 
proliferation. Schonthal et al. (1999) reported differences in the expression of
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cell cycle proteins that might be responsible for differences in proliferation 
between primary and SV40 transformed human corneal endothelial cells. 
Elevated levels of cyclin A, and to a lesser extent cyclin D, CDK2 and CDK4, as 
well as a drop in the levels of cell cycle inhibitors p27Kip1 and p21Waf1, 
correlated with an increased proliferative potential of the SV40 transformed 
human corneal endothelial cells (Schonthal et al., 1999). Alterations in the 
expression levels of various cell cycle proteins may similarly account for the 
increased proliferation of SV40 transformed mouse corneal endothelial cells. 
However, the proliferative responses of the SV40 transformed cell line described 
in this thesis contradict those reported by Joo et al. (1994), who reported the 
SV40 transformed mouse corneal endothelial cells to be contact inhibited and 
require serum stimulation to induce proliferation. Additionally, Joo et al. (1994) 
suggested that serum stimulation of primary mouse corneal endothelial cells 
alone is insufficient to induce proliferation, but rather requires supplementation 
with growth factors. Discrepancies between these results may be explained 
either by different culture techniques, or differences between subclones of SV40 
transformed cell lines.
Second, the kinetics of ERK 1/2 activation in response to growth factor 
stimulation were found to be different in primary cultures as compared to the 
SV40 transformed cell line. Overall, peak ERK 1/2 activation due to growth 
factor stimulation, occurred more rapidly in the SV40 transformed cell line than in 
primary cells, and FGF-2 stimulation elicited biphasic ERK 1/2 activation in 
primary mouse corneal endothelial cultures. This biphasic response was not 
noted in the SV40 transformed cell line, and the implications of this difference in 
corneal endothelial ERK 1/2 signalling remain unknown. A similar timeline of 
biphasic ERK activation was noted in the mitogenic response of hamster 
fibroblasts (CCL39), with the proliferative potential correlating to the second peak 
(1-2 hours) and further sustained (beyond 4 hours) activation of ERK (Meloche et 
al., 1992). Longer time points of FGF-2 stimulated ERK activation in mouse 
corneal endothelial cells should be investigated to determine whether sustained 
ERK activation is also a feature of these cells, and whether ablation of the
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second peak in activation affects the mitogenic response to FGF-2. Interestingly, 
PDGF BB, which also showed a strong proliferative response, did not induce this 
second peak in ERK activation.
Third, differences in junctional integrity were noted between the SV40 
transformed mouse corneal endothelial cells and primary mouse corneal 
endothelial cells. While SV40 transformed cells consistently show a 
discontinuous distribution of ZO-1 at the cell borders, typically associated with 
immature junction formation, the distribution of ZO-1 in primary cultures changed 
with time in culture. Primary cells that had been in culture for short periods of 
time showed a discontinuous distribution of ZO-1 at the cell borders, similar to 
the SV40 transformed cell line, but following culture for prolonged periods, ZO-1 
localized in a band around the cell borders, typical of that associated with mature 
junction formation. As cell contact inhibition and junction formation play a major 
part in the maintenance of growth arrest in corneal endothelial cells (Senoo et al., 
2000), these differences in junctional integrity may offer a partial explanation for 
the differences in proliferation between the SV40 transformed cell line and 
primary cells. Altered distributions of tight junction proteins have been described 
with proliferation in other cell types. In subconfluent cultures of MDCK cells, the 
Y-box transcription factor ZONAB does not bind to the tight junction plaque but 
instead is sequestered in the nucleus, where it binds promoter sequences of 
ErbB-2 and other cell cycle regulators that drive cell proliferation (Baida and 
Matter, 2000; Baida et al., 2003). Conversely, confluent cultures of MDCK cells 
sequester ZONAB at the tight junction, thus inhibiting cell proliferation (Baida et 
al., 2003). The localization of ZO-1 has also been observed to be transiently 
altered during EGF-induced proliferation in A431 cells (Van Itallie et al., 1995). 
Investigations of the distribution of ZONAB and ZO-1, following growth factor 
stimulation of mouse corneal endothelial cells, may provide additional insight into 
the involvement of these tight junction proteins in the corneal endothelial cell 
proliferative response.
Fourth, expression of apoptotic proteins differed in the SV40 transformed 
mouse corneal endothelial cells as compared to primary cultures. Overall, SV40
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transformed cells expressed more anti-apoptotic proteins and fewer pro-apoptotic 
proteins than primary cultures. The Bel family of proteins, members of which are 
expressed in both primary and SV40 transformed cultures, are known to form 
homo- or heterodimers of pro- and anti-apoptotic molecules and the ratios 
between these molecules determines the susceptibility of a cell to undergo 
apoptosis (Gross et al., 1999). Neutralising competition offered by the 
expression of more anti-apoptotic Bel family members in SV40 transformed cells 
may offer greater protection against apoptotic stimuli, and therefore increased 
cell survival.
Finally, and consistent with the observations described above, SV40 
transformed cultures were somewhat more resistant to staurosporine induced 
apoptosis than primary cultures, as they required a stronger dose of 
staurosporine over a longer time period to induce changes in mitochondrial 
morphology associated with apoptosis.
While Joo et al. (1994) suggest that the SV40 transformed mouse corneal 
endothelial cell line provides an appropriate model for primary mouse corneal 
endothelial cells, the five differences highlighted above clearly demonstrate that 
SV40 transformed cell line is a comparatively poor representative of the corneal 
endothelium. Not only do the five distinctions between the SV40 transformed 
mouse corneal endothelial cell line and primary cultures encompass differences 
in both the proliferative and apoptotic responses of the corneal endothelium, 
certain defining characteristics of the corneal endothelium are not fulfilled by the 
SV40 transformed cell line, including the formation of a G1-phase arrested 
monolayer. These findings indicate that caution is required when using the SV40 
transformed mouse corneal endothelial cell line as a model for primary mouse 
corneal endothelial culture.
Nevertheless, a representative model of the human corneal endothelium 
would undoubtedly be of value to future research into human corneal endothelial 
cell biology. As previously mentioned, most current models of the corneal 
endothelium, namely rat, rabbit and bovine corneal endothelium, are 
unrepresentative as they are highly proliferative, in contrast to human corneal
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endothelial monolayers in vivo. However, the explant model of mouse corneal 
endothelium, developed in this thesis, has proved to be relatively representative 
of human corneal endothelial cultures, with comparisons between the two 
cultures revealing a number of similarities. First, both mouse and human primary 
corneal endothelial cultures form heterogeneous monolayers with varying cell 
densities. The cells in the monolayer display cortical actin and focal adhesions 
on the basal membrane, that anchor the cell to underlying matrix proteins on the 
tissue culture dish. Second, the junctional maturity of both the primary cultures 
and endothelial monolayers in situ was similar in mouse and human. Most 
primary cultures showed a faint, discontinuous distribution of ZO-1 around cell 
borders suggesting the presence of immature junctions. This distribution of ZO-1 
is different from that noted in endothelial monolayers in situ, which display a 
bright band of ZO-1 around the cell borders, a localization consistent with mature 
junction formation. This pattern of ZO-1 expression is consistent with changes 
noted during proliferation and junctional maturation in other cell types. Down- 
regulation of ZO-1 was observed in breast cancer tissues and during corneal 
wound repair, thus expression levels of ZO-1 have been suggested to be related 
to the proliferation state of epithelial cells (Hoover et al., 1998; Cao et al., 2002). 
These findings are supported by the observation that ZO-1 becomes stabilized in 
confluent cultures of MDCK cells and that expression levels increase with cell 
density (Baida and Matter, 2000; Baida et al., 2003). Additionally, endothelial 
monolayers in situ revealed localization of a number of other tight junction 
proteins at cell borders. These were not observed in primary endothelial 
cultures, though their presence may be a function of time in culture, since 
prolonged periods of culture appeared to yield cultures with more mature 
junctions. In developing foetuses, corneal endothelial cells begin to form proper 
tight junctions a month after proliferation has ceased (Waring, III et al., 1982). 
Because both primary mouse and human cells continued to exhibit very low 
levels of proliferation during culture ex vivo, it is possible that junction formation 
remains incomplete. Proper arrangement of the actin cytoskeleton has also been 
shown to be regulate the distribution of ZO-1 (Van Itallie et al., 1995). While the
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F-actin phenotype of primary mouse and human corneal endothelial cells was 
similar, there may be differences between the F-actin phenotypes of primary 
cultures and corneal endothelial cells in situ that can account for the discrepancy 
in the distribution of ZO-1.
Despite the similarities noted between primary mouse and human corneal 
endothelial cultures, a number of species-specific differences were also 
observed. First, the migrating phenotype and nuclear morphology of primary 
mouse corneal endothelial cells was found to be different from those of human 
cells. Migrating primary mouse corneal endothelial cells showed a number of 
projections from the cell body with focal adhesions localized at their ends, while 
migrating primary human cells were more rounded in shape. Additionally, 
prolonged culture of primary mouse corneal endothelial cultures resulted in a 
larger proportion of bean-shaped nuclei, as compared to oval shaped nuclei. 
Similar nuclear morphology has been described for corneal keratocytes near 
Descemet’s membrane in situ (Lwigale, 1999). Conversely, prolonged culture of 
primary human corneal endothelial cultures resulted in a larger proportion of 
smooth, oval shaped nuclei, as compared to nuclei with large folds in the nuclear 
envelope. Both primary mouse and human corneal endothelial cultures 
demonstrated a correlation between time in culture and numbers of binucleate 
cells.
Second, the proliferative response to growth factor stimulation was found to 
be readily detectable in primary mouse corneal endothelial cultures but not in 
primary human cultures. Indeed, the mitotic response of primary mouse corneal 
endothelial cultures to all stimuli was greater than that of primary human cultures, 
whereas the basal level of proliferation exhibited by unstimulated cells was more 
rapid in primary human cultures than in primary mouse cultures (Figure 6.1).
Both FGF-2 and PDGF BB induced a significantly greater amount of proliferation 
in mouse corneal endothelial cultures as compared to unstimulated cells. While 
these growth factors also modestly induced human corneal endothelial cell 
proliferation, the response was not significantly different from that of unstimulated 
cells. A similar study of growth factor induced proliferation in primary human
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Figure 6.1 Proliferative responses of primary mouse and human corneal 
endothelial cultures to 48 hour growth factor stimulation. Primary cultures of 
mouse and human corneal endothelial cells were simultaneously treated with BrdU and 
growth factors. Proliferative cells were measured as a proportion of the total cell 
population. Unstimulated cells were used as a negative control and 10% serum as a 
positive control. Primary mouse corneal endothelial cultures treated with growth factors 
(white bars) showed a significant amount of proliferation compared to unstimulated cells 
(* p<0.05). However, growth factor treatment of primary human corneal endothelial 
cultures (black bars) did not. Levels of proliferation in unstimulated cells were higher in 
primary human cultures as compared to primary mouse cultures.
corneal endothelial cultures, however, revealed a hierarchy of mitogenic potential 
akin to that of primary mouse corneal endothelial cultures; PDGF BB > FGF > 
EGF (Zhu and Joyce, 2004). The apparent discrepancy between these results 
may reflect differences in the duration of the experiment, since the mitogenic 
potential of factors used by these authors were noticeable only after a few 
weeks, not 48 hours. Therefore, it is possible that the species-differences 
between the primary mouse and human corneal endothelial cell proliferative 
response may also be a factor of time, with primary mouse corneal endothelial 
cells responding to growth factor simulation faster than primary human cultures.
156
These results may also reflect differences in the age of the tissue, as primary 
mouse corneal endothelial tissues were taken from mice at approximately 3 
weeks of age, while the age of donors for primary human cultures tended to be 
above 50 years and the kinetics of human corneal endothelial cell proliferation 
was reported to be slower in aged populations (Senoo and Joyce, 2000). 
However, such explanations do not account for the observation that serum 
induced proliferation of human corneal endothelial cells over a short time course.
The final and most significant difference noted between primary mouse and 
human corneal endothelial cultures was the variation in ERK 1/2 activation 
following treatment with FGF-2. Stimulation with EGF or PDGF BB induced a 
similar ERK 1/2 response in both primary mouse and human corneal endothelial 
cultures. However, primary human corneal endothelial corneal cultures showed 
a single peak in ERK 1/2 activation following treatment with FGF-2, while primary 
mouse cultures showed biphasic ERK 1/2 activation, with a second peak in 
activation after 90 minutes of stimulation. As previously mentioned, the
effects of the second peak in activation, which has been suggested to affect 
mitogenic activity in CCL39 cells (Meloche et al., 1992), warrants further 
investigation.
Overall, work in this thesis has shown that primary mouse corneal endothelial 
cultures are relatively similar to human corneal endothelial cultures, with only two 
major differences between the two; namely, the kinetics of the proliferative 
response to growth factor stimulation and FGF-2 induced ERK 1/2 activation.
While these variations are significant, primary mouse corneal endothelial cultures 
are more similar to primary human corneal endothelium than many other 
currently available models. The corneal endothelial model most often used for 
cell biology studies is the highly proliferative rabbit corneal endothelium. In 
addition to being highly proliferative, investigations into the intracellular signalling q;  
pathways illustrate further differences between the rabbit, mouse and human 
corneal endothelium. Both mouse and human corneal endothelial cells were 
demonstrated to utilize the MAPK and PI3 kinase pathways during growth factor
implications of this difference in ERK 1/2 activation remain unclear, thought the
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induced proliferation, while studies in rabbit corneal endothelium have suggested 
FGF-2 induced proliferation to be wholly reliant on the PI3 kinase pathway (Lee 
and Kay, 2003b). Additionally, stimulation of rabbit corneal endothelial cells with 
FGF-2 was shown to induces changes in cell shape associated with cell motility 
and a transformation to a mesenchymal phenotype (Lee et al., 2004). These 
changes are associated with rearrangement of the actin cytoskeleton and were 
shown to be mediated by the PI3 kinase pathway, but not the MAPK pathway 
(Lee and Kay, 2003a). Effects of the PI3 kinase inhibitor on FGF-2 induced 
mouse corneal endothelial cell proliferation may therefore be tied to changes in 
cell shape and the endothelial to mesenchymal transformation, with decreased 
cell proliferation being a secondary effect of other changes. Treatment of 
primary mouse corneal endothelial cells with PDGF BB did not induce changes in 
cell shape associated with transformation to a mesenchymal phenotype, and 
inhibitor studies of PDGF BB-induced proliferation indicated a greater role for the 
MAPK pathway than the PI3 kinase pathway in this proliferative response. This 
reveals that the rabbit corneal endothelium is not only more proliferative than 
mouse and human corneal endothelial cultures, but also that the intracellular 
signals which underlie this response are different. This provides further 
justification for the preferential use of a mouse corneal endothelial model.
Primary mouse corneal endothelial cells have the additional advantage of the 
possibility for research using genetically modified animals.
Although primary mouse corneal endothelial cultures comprise a reasonable 
model for primary human corneal endothelial cultures, the reliability of all primary 
corneal endothelial cell cultures as a model for corneal endothelial monolayers in 
vivo is questionable. For example, investigations into junctional integrity suggest 
that primary human corneal endothelial cultures are not truly representative of 
corneal endothelial monolayers in vivo. The broken distribution of ZO-1 
observed at the cell borders of primary cultures is dissimilar from the tight band 
of ZO-1 staining seen in endothelial monolayers in situ. These patterns of ZO-1 
localization suggest that junctions in forming monolayers are at different stages 
of maturity, and that primary cultures generally only form immature junctions. As
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previously suggested, the pattern of expression of ZO-1 may be related to the 
arrangement of the actin cytoskeleton (Van Itallie et al., 1995). As proliferation is 
known to be affected by junctional integrity (Senoo et al., 2000), differences in 
junctional organisation may be functionally tied into differences in proliferative 
potential, as is highlighted by the proliferation observed in unstimulated human 
corneal endothelial cultures. With even primary human corneal endothelial 
cultures being unrepresentative of corneal endothelial monolayers in vivo, the 
creation of a representative corneal endothelial cell line would provide a valuable 
tool for future research. Ideally, a corneal endothelial cell line should contain an 
inducible vector, which could stimulate proliferation to form an intact monolayer. 
With formation of the monolayer, removal of the growth stimulus would allow the 
cells to return to G1-phase arrest and form an authentic barrier with mature tight 
junctions. With further understanding of the intracellular processes involved in 
regulating cell viability, such a cell line may also be able to repopulate denuded 
portions of Descemet’s membrane to be used as a treatment to corneal 
endothelial disease. However, attempts at generating such a cell line have not 
been fruitful with either the pLNC-cmycER construct used in this thesis or a 
dexamethasone-inducible version of large T-antigen used by Wilson et al. (1995).
While initial investigations have begun to define the proliferative and apoptotic 
response to a number of factors, there remains one major aspect of corneal 
endothelial cell biology that merits further attention; namely the interactions 
between corneal endothelial cells and Descemet’s membrane. Studies of matrix 
effects on corneal endothelial cell proliferation and cellular organisation have 
been conducted previously (Blake et al., 1997; Gordon, 1990; Gospodarowicz 
and III, 1980). Similar studies were also performed using vascular endothelial 
cells cultured on extracellular matrix generated by corneal endothelial cells 
(cECM), which demonstrated increased vascular endothelial cell proliferation and 
the formation of a closely apposed, non-overlapping and contact-inhibited 
endothelial cell monolayer (Fridman et al., 1985). Cultures of vascular 
endothelial cells on extracellular matrix generated by fibroblasts did not elicit the 
same response, indicating that specific components of extracellular matrix may
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have a role in shaping the characteristic morphological appearance of these cells 
(Fridman et al., 1985). While cultures of primary mouse corneal endothelial cells 
on various matrices (type I and IV collagen, laminin and fibronectin) did not 
produce any noticeable phenotypic effects (not shown), different combinations of 
matrix components of Descemet’s membrane may influence endothelial cell gene 
expression and hence function. Type VIII collagen is a matrix component unique 
to Descemet’s membrane and other specialized membranes (Shuttleworth,
1997), but which is unfortunately unavailable from commercial or other sources. 
Homo- or heterotrimers of two distinct a-chains make type VIII collagen a non- 
fibrillar, short-chain collagen (Greenhill et al., 2000; lllidge et al., 1998). In 
Descemet’s membrane, type VIII collagen exists as a heterotrimer with two 
a1 (VIII) chains for every a2(VIII) chain (Mann et al., 1990). In addition to its 
structural function, type VIII collagen may also play a role in the mediation of 
cellular responses. During vascular injury, increased proliferation of vascular 
smooth muscle cells (VSMC) has been shown to coincide with increased 
expression of type VIII collagen (MacBeath et al., 1996; Sibinga et al., 1997). A 
similar increase in proliferation and type VIII collagen expression is noted in 
VSMC treated with PDGF BB (Bendeck et al., 1996). As PDGF BB also induced 
a significant proliferative response in corneal endothelial cultures, it would be 
interesting to know whether type VIII collagen is also upregulated by PDGF BB 
treatment in corneal endothelial cultures, and whether this upregulation of type 
VIII collagen plays a role in the proliferative response to PDGF BB.
By contrast, cleavage of type VIII collagen has been shown to play a role in 
cell survival. The NC1 (non-triple-helical domain) of type VIII collagen, known as 
vastatin, has been shown to inhibit FGF-2 induced proliferation, arrest cells at 
G0/G1 phase of the cell cycle and induce apoptosis (Xu et al., 2001). Thus, 
expression of matrix metalloproteinases responsible for the cleavage of type VIII 
collagen, may affect corneal endothelial cell survival.
In addition to type VIII collagen, a number of other components of Descemet’s 
membrane may influence corneal endothelial cell viability. Proteoglycans, which 
are common constituents of Descemet’s membrane, are thought to be more than
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inert structural molecules and may modulate cellular responses to external 
stimuli (Yamada and Kemler, 2002). Additionally, the pericellular matrix is a 
compartment of the extracellular matrix (ECM) containing growth factors, 
cytokines, proteases and other bioactive molecules that interact at the cell 
surface (Bornstein and Sage, 2002). The combination of these factors, matrix 
molecules and other soluble proteins have been shown to influence cell motility, 
proliferation, differentiation and predisposition to apoptosis (Bornstein and Sage, 
2002). This portion of ECM also contains the matricellular proteins, which 
modulate cell function but do not appear to contribute directly to the organization 
or physical properties of structures such as fibrils or basal laminae. One such 
protein, SPARC (secreted protein, acidic and rich in cysteine), which influences 
cell adhesion and proliferation, is known to be upregulated during corneal wound 
repair (Berryhill et al., 2003). A host of factors present in Descemet’s membrane 
and their effects on the corneal endothelium have yet to be adequately described 
and may largely influence the response of corneal endothelial cells to various 
stimuli in vivo.
At present, difficulties in obtaining human corneal endothelial tissue and 
isolation and maintenance of human corneal endothelial cultures mean that little 
is known about the cell biology of the corneal endothelium. By establishing 
animal models of the human corneal endothelium, the constraints of tissue 
supply are relieved, and the field can advance. Work in this thesis has shown 
that an explant model of the mouse corneal endothelium is more representative 
of human corneal endothelium than other current models and may therefore 
provide more useful information with respect to the proliferative response. The 
use of such a model to gain new insight into corneal endothelial cell biology may 
aid in the identification of potential candidate molecules that may be targeted in 
the treatment of corneal endothelial disease. At present, the only available 
treatment for primary corneal endothelial disease involves corneal 
transplantation. A better understanding of corneal endothelial cell biology may 
reveal factors which can initiate corneal endothelial cell proliferation or enhance
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corneal endothelial cell survival. Such factors may supplement corneal organ 
culture media, allowing prolonged storage of donor organ corneas both for 
transplantation and for research. Additionally, identification of intracellular 
targets to enhance corneal endothelial cell viability may, in future, eliminate the 
need for corneal transplantation and give rise to less invasive treatments for 
primary corneal endothelial disease.
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